Diagnoses of HIV Infection in the United States and Dependent Areas, 2021: Tables
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 30,444 | — | 29,602 | — | 28,809 | — | 24,174 | — | 28,304 | — |
Female | 7,288 | — | 7,055 | — | 6,900 | — | 5,421 | — | 6,554 | — |
Transgender woman/girlb | 651 | — | 661 | — | 692 | — | 676 | — | 811 | — |
Transgender man/boyb | 32 | — | 48 | — | 45 | — | 41 | — | 56 | — |
Additional gender identityc | 18 | — | 19 | — | 32 | — | 23 | — | 44 | — |
Age at diagnosis (yr) | ||||||||||
< 13 | 105 | 0.2 | 86 | 0.2 | 57 | 0.1 | 60 | 0.1 | 53 | 0.1 |
13–14 | 25 | 0.3 | 20 | 0.2 | 21 | 0.3 | 12 | 0.1 | 15 | 0.2 |
15–19 | 1,791 | 8.5 | 1,722 | 8.2 | 1,652 | 7.8 | 1,264 | 5.9 | 1,452 | 6.7 |
20–24 | 6,481 | 29.4 | 6,123 | 28.1 | 5,987 | 27.7 | 4,849 | 22.6 | 5,460 | 25.4 |
25–29 | 7,720 | 33.0 | 7,682 | 32.6 | 7,382 | 31.4 | 6,080 | 26.7 | 6,713 | 30.0 |
30–34 | 5,680 | 25.9 | 5,664 | 25.6 | 5,645 | 25.1 | 5,199 | 22.7 | 6,368 | 27.6 |
35–39 | 4,254 | 20.1 | 4,186 | 19.4 | 4,102 | 18.9 | 3,400 | 15.3 | 4,403 | 19.7 |
40–44 | 2,981 | 15.2 | 2,964 | 15.1 | 2,946 | 14.8 | 2,474 | 12.0 | 3,140 | 14.9 |
45–49 | 2,926 | 14.0 | 2,759 | 13.3 | 2,571 | 12.6 | 2,044 | 10.1 | 2,326 | 11.8 |
50–54 | 2,637 | 12.4 | 2,435 | 11.7 | 2,303 | 11.3 | 1,828 | 8.8 | 2,116 | 10.1 |
55–59 | 1,869 | 8.5 | 1,824 | 8.3 | 1,837 | 8.4 | 1,558 | 7.1 | 1,786 | 8.3 |
60–64 | 1,082 | 5.4 | 1,042 | 5.1 | 1,106 | 5.4 | 879 | 4.2 | 1,095 | 5.2 |
≥ 65 | 882 | 1.7 | 878 | 1.7 | 869 | 1.6 | 688 | 1.3 | 842 | 1.5 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 193 | 8.0 | 170 | 7.1 | 194 | 8.0 | 190 | 7.8 | 223 | 9.1 |
Asian | 919 | 5.0 | 850 | 4.5 | 728 | 3.8 | 612 | 3.1 | 739 | 3.8 |
Black/African American | 16,163 | 39.8 | 15,642 | 38.2 | 15,327 | 37.2 | 12,678 | 30.4 | 14,555 | 34.8 |
Hispanic/Latinod | 10,010 | 17.1 | 9,931 | 16.7 | 9,858 | 16.3 | 8,046 | 13.0 | 10,070 | 16.1 |
Native Hawaiian/other Pacific Islander | 47 | 8.1 | 57 | 9.6 | 59 | 9.8 | 64 | 10.3 | 76 | 12.1 |
White | 9,558 | 4.8 | 9,338 | 4.7 | 8,992 | 4.6 | 7,744 | 3.9 | 9,063 | 4.6 |
Multiracial | 1,543 | 22.0 | 1,397 | 19.4 | 1,320 | 17.9 | 1,001 | 13.1 | 1,043 | 13.4 |
Transmission categorye | ||||||||||
Male sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||
Male-to-male sexual contactg | 25,345 | — | 24,464 | — | 23,870 | — | 20,460 | — | 23,855 | — |
Injection drug useh | 1,291 | — | 1,376 | — | 1,362 | — | 1,170 | — | 1,415 | — |
Male-to-male sexual contactg and injection drug useh |
1,517 | — | 1,531 | — | 1,581 | — | 1,185 | — | 1,373 | — |
Heterosexual contacti | 2,882 | — | 2,839 | — | 2,643 | — | 2,006 | — | 2,460 | — |
Perinatalj | 14 | — | 16 | — | 22 | — | 9 | — | 11 | — |
Otherk | 18 | — | 17 | — | 20 | — | 16 | — | 18 | — |
Subtotal | 31,067 | 23.3 | 30,242 | 22.6 | 29,498 | 21.9 | 24,846 | 18.1 | 29,132 | 21.1 |
Female sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||
Injection drug useh | 1,109 | — | 1,117 | — | 1,182 | — | 895 | — | 1,075 | — |
Heterosexual contacti | 6,106 | — | 5,892 | — | 5,695 | — | 4,494 | — | 5,456 | — |
Perinatalj | 40 | — | 40 | — | 38 | — | 34 | — | 49 | — |
Otherk | 6 | — | 7 | — | 7 | — | 6 | — | 5 | — |
Subtotal | 7,261 | 5.2 | 7,057 | 5.0 | 6,923 | 4.9 | 5,429 | 3.8 | 6,584 | 4.6 |
Child (< 13 yrs at diagnosis) | ||||||||||
Perinatal | 89 | — | 69 | — | 47 | — | 51 | — | 39 | — |
Otherk | 16 | — | 17 | — | 10 | — | 9 | — | 14 | — |
Subtotal | 105 | 0.2 | 86 | 0.2 | 57 | 0.1 | 60 | 0.1 | 53 | 0.1 |
Region of residencel | ||||||||||
Northeast | 5,998 | 10.7 | 5,560 | 9.9 | 5,323 | 9.5 | 4,252 | 7.4 | 4,993 | 8.7 |
Midwest | 5,119 | 7.5 | 4,953 | 7.3 | 4,774 | 7.0 | 4,115 | 6.0 | 4,824 | 7.0 |
South | 19,707 | 15.9 | 19,273 | 15.5 | 18,982 | 15.1 | 15,566 | 12.3 | 18,728 | 14.7 |
West | 7,609 | 9.8 | 7,599 | 9.8 | 7,399 | 9.4 | 6,402 | 8.1 | 7,224 | 9.2 |
Total | 38,433 | 11.8 | 37,385 | 11.4 | 36,478 | 11.1 | 30,335 | 9.2 | 35,769 | 10.8 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Data include transgender and additional gender identity persons.
g Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
h Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
i Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
j Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
k Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
l Data are based on residence at time of diagnosis of HIV infection.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 30,811 | — | 29,980 | — | 29,148 | — | 24,435 | — | 28,641 | — |
Female | 7,382 | — | 7,136 | — | 6,983 | — | 5,467 | — | 6,636 | — |
Transgender woman/girlb | 653 | — | 665 | — | 694 | — | 679 | — | 812 | — |
Transgender man/boyb | 32 | — | 48 | — | 45 | — | 41 | — | 56 | — |
Additional gender identityc | 18 | — | 19 | — | 32 | — | 23 | — | 44 | — |
Age at diagnosis (yr) | ||||||||||
< 13 | 105 | 0.2 | 86 | 0.2 | 57 | 0.1 | 60 | 0.1 | 53 | 0.1 |
13–14 | 25 | 0.3 | 20 | 0.2 | 21 | 0.2 | 12 | 0.1 | 15 | 0.2 |
15–19 | 1,804 | 8.4 | 1,740 | 8.2 | 1,658 | 7.8 | 1,272 | 5.8 | 1,460 | 6.7 |
20–24 | 6,547 | 29.3 | 6,188 | 28.0 | 6,045 | 27.6 | 4,893 | 22.5 | 5,512 | 25.3 |
25–29 | 7,782 | 33.0 | 7,759 | 32.6 | 7,442 | 31.3 | 6,124 | 26.6 | 6,793 | 30.0 |
30–34 | 5,741 | 25.9 | 5,723 | 25.6 | 5,703 | 25.2 | 5,237 | 22.7 | 6,411 | 27.5 |
35–39 | 4,306 | 20.1 | 4,222 | 19.4 | 4,142 | 18.9 | 3,438 | 15.3 | 4,448 | 19.8 |
40–44 | 3,017 | 15.2 | 3,005 | 15.1 | 2,984 | 14.8 | 2,502 | 12.0 | 3,186 | 14.9 |
45–49 | 2,968 | 14.0 | 2,805 | 13.4 | 2,609 | 12.7 | 2,067 | 10.1 | 2,359 | 11.8 |
50–54 | 2,687 | 12.5 | 2,484 | 11.8 | 2,334 | 11.3 | 1,859 | 8.8 | 2,160 | 10.2 |
55–59 | 1,906 | 8.6 | 1,853 | 8.4 | 1,875 | 8.5 | 1,585 | 7.1 | 1,807 | 8.3 |
60–64 | 1,105 | 5.5 | 1,062 | 5.2 | 1,133 | 5.4 | 896 | 4.2 | 1,116 | 5.2 |
≥ 65 | 903 | 1.8 | 901 | 1.7 | 899 | 1.6 | 700 | 1.3 | 869 | 1.5 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 193 | — | 170 | — | 194 | — | 190 | — | 223 | — |
Asian | 922 | — | 854 | — | 735 | — | 612 | — | 740 | — |
Black/African American | 16,168 | — | 15,654 | — | 15,335 | — | 12,685 | — | 14,561 | — |
Hispanic/Latinod | 10,456 | — | 10,369 | — | 10,257 | — | 8,347 | — | 10,478 | — |
Native Hawaiian/other Pacific Islander | 50 | — | 59 | — | 63 | — | 65 | — | 76 | — |
White | 9,562 | — | 9,344 | — | 8,998 | — | 7,745 | — | 9,068 | — |
Multiracial | 1,545 | — | 1,398 | — | 1,320 | — | 1,001 | — | 1,043 | — |
Transmission categorye | ||||||||||
Male sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||
Male-to-male sexual contactg | 25,587 | — | 24,742 | — | 24,110 | — | 20,660 | — | 24,107 | — |
Injection drug useh | 1,325 | — | 1,401 | — | 1,385 | — | 1,189 | — | 1,436 | — |
Male-to-male sexual contactg and injection drug useh |
1,529 | — | 1,542 | — | 1,594 | — | 1,190 | — | 1,375 | — |
Heterosexual contacti | 2,962 | — | 2,906 | — | 2,709 | — | 2,046 | — | 2,523 | — |
Perinatalj | 14 | — | 16 | — | 22 | — | 9 | — | 11 | — |
Otherk | 18 | — | 17 | — | 20 | — | 16 | — | 18 | — |
Subtotal | 31,436 | 23.3 | 30,624 | 22.6 | 29,839 | 21.9 | 25,110 | 18.1 | 29,470 | 21.1 |
Female sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||
Injection drug useh | 1,118 | — | 1,120 | — | 1,188 | — | 898 | — | 1,077 | — |
Heterosexual contacti | 6,190 | — | 5,970 | — | 5,773 | — | 4,536 | — | 5,536 | — |
Perinatalj | 40 | — | 40 | — | 38 | — | 34 | — | 49 | — |
Otherk | 6 | — | 7 | — | 7 | — | 6 | — | 5 | — |
Subtotal | 7,355 | 5.2 | 7,138 | 5.0 | 7,006 | 4.9 | 5,475 | 3.8 | 6,666 | 4.6 |
Child (< 13 yrs at diagnosis) | ||||||||||
Perinatal | 89 | — | 69 | — | 47 | — | 51 | — | 39 | — |
Otherk | 16 | — | 17 | — | 10 | — | 9 | — | 14 | — |
Subtotal | 105 | 0.2 | 86 | 0.2 | 57 | 0.1 | 60 | 0.1 | 53 | 0.1 |
Region of residencel | ||||||||||
Northeast | 5,998 | 10.7 | 5,560 | 9.9 | 5,323 | 9.5 | 4,252 | 7.4 | 4,993 | 8.7 |
Midwest | 5,119 | 7.5 | 4,953 | 7.3 | 4,774 | 7.0 | 4,115 | 6.0 | 4,824 | 7.0 |
South | 19,707 | 15.9 | 19,273 | 15.5 | 18,982 | 15.1 | 15,566 | 12.3 | 18,728 | 14.7 |
West | 7,609 | 9.8 | 7,599 | 9.8 | 7,399 | 9.4 | 6,402 | 8.1 | 7,224 | 9.2 |
U.S. dependent areas | 463 | 12.4 | 463 | 12.9 | 424 | 11.8 | 310 | 8.4 | 420 | 11.5 |
Total | 38,896 | 11.8 | 37,848 | 11.5 | 36,902 | 11.1 | 30,645 | 9.1 | 36,189 | 10.8 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Data include transgender and additional gender identity persons.
g Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
h Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
i Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
j Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
k Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
l Data are based on residence at time of diagnosis of HIV infection.
American Indian/Alaska Native | Asian | Black/African American | Hispanic/Latinoa | Native Hawaiian/other Pacific Islander | White | Multiracial | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | |
Gender | ||||||||||||||||
Male | 167 | — | 627 | — | 10,611 | — | 8,626 | — | 60 | — | 7,412 | — | 801 | — | 28,304 | — |
Female | 46 | — | 93 | — | 3,540 | — | 1,159 | — | 10 | — | 1,505 | — | 201 | — | 6,554 | — |
Transgender woman/girlc | 10 | — | 17 | — | 374 | — | 257 | — | 6 | — | 112 | — | 35 | — | 811 | — |
Transgender man/boyc | 0 | — | 2 | — | 18 | — | 14 | — | 0 | — | 19 | — | 3 | — | 56 | — |
Additional gender identityd | 0 | — | 0 | — | 12 | — | 14 | — | 0 | — | 15 | — | 3 | — | 44 | — |
Age at diagnosis (yr) | ||||||||||||||||
< 13 | 0 | 0.0 | 2 | 0.1 | 33 | 0.5 | 11 | 0.1 | 0 | 0.0 | 5 | 0.0 | 2 | 0.1 | 53 | 0.1 |
13–14 | 0 | 0.0 | 0 | 0.0 | 8 | 0.7 | 6 | 0.3 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 15 | 0.2 |
15–19 | 12 | 6.7 | 23 | 2.0 | 825 | 28.2 | 368 | 6.9 | 6 | 13.9 | 156 | 1.4 | 62 | 7.6 | 1,452 | 6.7 |
20–24 | 21 | 11.6 | 94 | 7.7 | 2,864 | 94.8 | 1,480 | 29.8 | 5 | 11.7 | 814 | 7.1 | 182 | 25.6 | 5,460 | 25.4 |
25–29 | 49 | 25.9 | 142 | 9.7 | 2,776 | 84.8 | 2,082 | 42.8 | 15 | 31.7 | 1,447 | 12.1 | 202 | 32.6 | 6,713 | 30.0 |
30–34 | 42 | 22.4 | 132 | 7.8 | 2,443 | 74.5 | 1,931 | 40.9 | 13 | 24.2 | 1,617 | 12.8 | 190 | 38.3 | 6,368 | 27.6 |
35–39 | 33 | 20.1 | 96 | 5.7 | 1,515 | 52.9 | 1,368 | 29.7 | 12 | 23.1 | 1,263 | 10.1 | 116 | 29.0 | 4,403 | 19.7 |
40–44 | 16 | 10.6 | 75 | 4.9 | 1,052 | 38.8 | 929 | 21.2 | 9 | 19.9 | 976 | 8.2 | 83 | 24.2 | 3,140 | 14.9 |
45–49 | 15 | 10.8 | 48 | 3.3 | 823 | 33.0 | 658 | 16.6 | 3 | 7.8 | 721 | 6.3 | 58 | 20.6 | 2,326 | 11.8 |
50–54 | 19 | 13.2 | 59 | 4.5 | 701 | 27.2 | 523 | 14.7 | 7 | 19.0 | 746 | 5.7 | 61 | 23.7 | 2,116 | 10.1 |
55–59 | 6 | 3.9 | 31 | 2.7 | 707 | 27.0 | 354 | 11.5 | 2 | 5.6 | 640 | 4.5 | 46 | 19.5 | 1,786 | 8.3 |
60–64 | 6 | 4.1 | 19 | 1.8 | 456 | 18.6 | 206 | 8.4 | 2 | 6.3 | 389 | 2.6 | 17 | 7.8 | 1,095 | 5.2 |
≥ 65 | 4 | 1.2 | 18 | 0.7 | 352 | 6.7 | 154 | 3.0 | 2 | 3.0 | 288 | 0.7 | 24 | 5.0 | 842 | 1.5 |
Transmission categorye | ||||||||||||||||
Male sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||||||||
Male-to-male sexual contactg | 141 | — | 573 | — | 8,879 | — | 7,757 | — | 59 | — | 5,758 | — | 688 | — | 23,855 | — |
Injection drug useh | 10 | — | 14 | — | 371 | — | 299 | — | 1 | — | 679 | — | 41 | — | 1,415 | — |
Male-to-male sexual contactg and injection drug useh |
16 | — | 17 | — | 244 | — | 325 | — | 4 | — | 714 | — | 54 | — | 1,373 | — |
Heterosexual contacti | 11 | — | 40 | — | 1,470 | — | 506 | — | 3 | — | 379 | — | 52 | — | 2,460 | — |
Perinatalj | 0 | — | 0 | — | 8 | — | 3 | — | 0 | — | 0 | — | 0 | — | 11 | — |
Otherk | 0 | — | 1 | — | 6 | — | 4 | — | 0 | — | 6 | — | 1 | — | 18 | — |
Subtotal | 177 | 17.7 | 644 | 8.1 | 10,978 | 66.5 | 8,895 | 35.7 | 66 | 25.5 | 7,536 | 8.9 | 836 | 32.7 | 29,132 | 21.1 |
Female sex at birth (≥ 13 yrs at diagnosis)f | ||||||||||||||||
Injection drug useh | 17 | — | 6 | — | 300 | — | 161 | — | 3 | — | 553 | — | 35 | — | 1,075 | — |
Heterosexual contacti | 29 | — | 85 | — | 3,207 | — | 997 | — | 7 | — | 962 | — | 169 | — | 5,456 | — |
Perinatalj | 0 | — | 2 | — | 35 | — | 6 | — | 0 | — | 5 | — | 1 | — | 49 | — |
Otherk | 0 | — | 1 | — | 2 | — | 0 | — | 0 | — | 2 | — | 0 | — | 5 | — |
Subtotal | 46 | 4.4 | 93 | 1.1 | 3,544 | 19.5 | 1,164 | 4.8 | 10 | 3.9 | 1,522 | 1.8 | 205 | 7.6 | 6,584 | 4.6 |
Child (< 13 yrs at diagnosis) | ||||||||||||||||
Perinatal | 0 | — | 1 | — | 26 | — | 8 | — | 0 | — | 3 | — | 1 | — | 39 | — |
Otherk | 0 | — | 1 | — | 7 | — | 3 | — | 0 | — | 2 | — | 1 | — | 14 | — |
Subtotal | 0 | 0.0 | 2 | 0.1 | 33 | 0.5 | 11 | 0.1 | 0 | 0.0 | 5 | 0.0 | 2 | 0.1 | 53 | 0.1 |
Region of residencel | ||||||||||||||||
Northeast | 5 | 3.8 | 141 | 3.5 | 1,952 | 30.0 | 1,625 | 18.5 | 4 | 17.2 | 1,094 | 3.0 | 172 | 16.2 | 4,993 | 8.7 |
Midwest | 47 | 11.2 | 80 | 3.3 | 2,102 | 28.8 | 725 | 12.4 | 6 | 14.6 | 1,700 | 3.3 | 164 | 11.0 | 4,824 | 7.0 |
South | 56 | 6.8 | 210 | 4.4 | 9,259 | 37.9 | 4,422 | 18.5 | 19 | 18.3 | 4,220 | 6.0 | 542 | 20.7 | 18,728 | 14.7 |
West | 115 | 10.7 | 308 | 3.7 | 1,242 | 34.1 | 3,298 | 13.7 | 47 | 10.3 | 2,049 | 5.3 | 165 | 6.3 | 7,224 | 9.2 |
Total | 223 | 9.1 | 739 | 3.8 | 14,555 | 34.8 | 10,070 | 16.1 | 76 | 12.1 | 9,063 | 4.6 | 1,043 | 13.4 | 35,769 | 10.8 |
Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution.
a Hispanic/Latino persons can be of any race.
b Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
c “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
d Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Data presented include transgender and additional gender identity persons.
g Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
h Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
i Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
j Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
k Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
l Data are based on residence at time of diagnosis of HIV infection.
American Indian/Alaska Native | Asian | Black/African American | Hispanic/Latinoa | Native Hawaiian/other Pacific Islander | White | Multiracial | Total | |
---|---|---|---|---|---|---|---|---|
No. | No. | No. | No. | No. | No. | No. | No. | |
Gender | ||||||||
Male | 167 | 628 | 10,616 | 8,952 | 60 | 7,417 | 801 | 28,641 |
Female | 46 | 93 | 3,541 | 1,240 | 10 | 1,505 | 201 | 6,636 |
Transgender woman/girlb | 10 | 17 | 374 | 258 | 6 | 112 | 35 | 812 |
Transgender man/boyb | 0 | 2 | 18 | 14 | 0 | 19 | 3 | 56 |
Additional gender identityc | 0 | 0 | 12 | 14 | 0 | 15 | 3 | 44 |
Age at diagnosis (yr) | ||||||||
< 13 | 0 | 2 | 33 | 11 | 0 | 5 | 2 | 53 |
13–14 | 0 | 0 | 8 | 6 | 0 | 1 | 0 | 15 |
15–19 | 12 | 23 | 825 | 376 | 6 | 156 | 62 | 1,460 |
20–24 | 21 | 94 | 2,865 | 1,531 | 5 | 814 | 182 | 5,512 |
25–29 | 49 | 143 | 2,776 | 2,160 | 15 | 1,448 | 202 | 6,793 |
30–34 | 42 | 132 | 2,444 | 1,973 | 13 | 1,617 | 190 | 6,411 |
35–39 | 33 | 96 | 1,515 | 1,412 | 12 | 1,264 | 116 | 4,448 |
40–44 | 16 | 75 | 1,052 | 975 | 9 | 976 | 83 | 3,186 |
45–49 | 15 | 48 | 823 | 690 | 3 | 722 | 58 | 2,359 |
50–54 | 19 | 59 | 703 | 565 | 7 | 746 | 61 | 2,160 |
55–59 | 6 | 31 | 708 | 373 | 2 | 641 | 46 | 1,807 |
60–64 | 6 | 19 | 457 | 225 | 2 | 390 | 17 | 1,116 |
≥ 65 | 4 | 18 | 352 | 181 | 2 | 288 | 24 | 869 |
Transmission categoryd | ||||||||
Male sex at birth (≥ 13 yrs at diagnosis)e | ||||||||
Male-to-male sexual contactf | 141 | 574 | 8,883 | 8,000 | 59 | 5,762 | 688 | 24,107 |
Injection drug useg | 10 | 14 | 373 | 318 | 1 | 679 | 41 | 1,436 |
Male-to-male sexual contactf and injection drug useg |
16 | 17 | 244 | 327 | 4 | 714 | 54 | 1,375 |
Heterosexual contacth | 11 | 40 | 1,470 | 569 | 3 | 379 | 52 | 2,523 |
Perinatali | 0 | 0 | 8 | 3 | 0 | 0 | 0 | 11 |
Otherj | 0 | 1 | 6 | 4 | 0 | 6 | 1 | 18 |
Subtotal | 177 | 645 | 10,983 | 9,222 | 66 | 7,541 | 836 | 29,470 |
Female sex at birth (≥ 13 yrs at diagnosis)e | ||||||||
Injection drug useg | 17 | 6 | 301 | 162 | 3 | 553 | 35 | 1,077 |
Heterosexual contacth | 29 | 85 | 3,208 | 1,077 | 7 | 962 | 169 | 5,536 |
Perinatali | 0 | 2 | 35 | 6 | 0 | 5 | 1 | 49 |
Otherj | 0 | 1 | 2 | 0 | 0 | 2 | 0 | 5 |
Subtotal | 46 | 93 | 3,545 | 1,245 | 10 | 1,522 | 205 | 6,666 |
Child (< 13 yrs at diagnosis) | ||||||||
Perinatal | 0 | 1 | 26 | 8 | 0 | 3 | 1 | 39 |
Otherj | 0 | 1 | 7 | 3 | 0 | 2 | 1 | 14 |
Subtotal | 0 | 2 | 33 | 11 | 0 | 5 | 2 | 53 |
Region of residencek | ||||||||
Northeast | 5 | 141 | 1,952 | 1,625 | 4 | 1,094 | 172 | 4,993 |
Midwest | 47 | 80 | 2,102 | 725 | 6 | 1,700 | 164 | 4,824 |
South | 56 | 210 | 9,259 | 4,422 | 19 | 4,220 | 542 | 18,728 |
West | 115 | 308 | 1,242 | 3,298 | 47 | 2,049 | 165 | 7,224 |
U.S. dependent areas | 0 | 1 | 6 | 408 | 0 | 5 | 0 | 420 |
Total | 223 | 740 | 14,561 | 10,478 | 76 | 9,068 | 1,043 | 36,189 |
Note: Numbers less than 12 should be interpreted with caution.
a Hispanic/Latino persons can be of any race.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
e Data include transgender and additional gender identity persons.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on residence at time of diagnosis of HIV infection.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 13 | 0.3 | 11 | 0.3 | 12 | 0.3 | 6 | 0.1 | 8 | 0.2 |
15–19 | 1,541 | 14.3 | 1,480 | 13.8 | 1,449 | 13.5 | 1,107 | 10.1 | 1,250 | 11.3 |
20–24 | 5,711 | 50.5 | 5,399 | 48.3 | 5,262 | 47.5 | 4,288 | 39.2 | 4,840 | 44.1 |
25–29 | 6,741 | 56.7 | 6,738 | 56.1 | 6,443 | 53.6 | 5,310 | 45.9 | 5,867 | 51.6 |
30–34 | 4,667 | 42.1 | 4,713 | 42.1 | 4,690 | 41.2 | 4,391 | 37.9 | 5,411 | 46.3 |
35–39 | 3,338 | 31.5 | 3,265 | 30.3 | 3,202 | 29.4 | 2,693 | 24.0 | 3,475 | 30.9 |
40–44 | 2,241 | 23.1 | 2,175 | 22.2 | 2,189 | 22.1 | 1,911 | 18.4 | 2,368 | 22.4 |
45–49 | 2,165 | 20.9 | 2,040 | 19.9 | 1,885 | 18.7 | 1,493 | 14.7 | 1,676 | 17.0 |
50–54 | 1,976 | 18.8 | 1,780 | 17.3 | 1,680 | 16.7 | 1,379 | 13.3 | 1,543 | 14.8 |
55–59 | 1,311 | 12.3 | 1,286 | 12.1 | 1,322 | 12.4 | 1,139 | 10.5 | 1,283 | 12.1 |
60–64 | 751 | 7.9 | 722 | 7.4 | 758 | 7.7 | 614 | 6.0 | 809 | 7.8 |
≥ 65 | 612 | 2.7 | 633 | 2.7 | 606 | 2.5 | 515 | 2.1 | 602 | 2.4 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 150 | 15.7 | 140 | 14.5 | 150 | 15.4 | 149 | 15.0 | 177 | 17.7 |
Asian | 797 | 10.9 | 742 | 9.9 | 624 | 8.2 | 527 | 6.7 | 644 | 8.1 |
Black/African American | 11,861 | 75.4 | 11,621 | 73.1 | 11,476 | 71.5 | 9,744 | 59.5 | 10,978 | 66.5 |
Hispanic/Latinoc | 8,814 | 38.9 | 8,729 | 37.7 | 8,673 | 36.7 | 7,115 | 29.1 | 8,895 | 35.7 |
Native Hawaiian/other Pacific Islander | 39 | 16.5 | 53 | 21.9 | 52 | 21.1 | 49 | 19.3 | 66 | 25.5 |
White | 8,128 | 9.7 | 7,865 | 9.4 | 7,473 | 8.9 | 6,445 | 7.6 | 7,536 | 8.9 |
Multiracial | 1,278 | 58.0 | 1,092 | 47.9 | 1,050 | 44.5 | 817 | 33.1 | 836 | 32.7 |
Region of residenced | ||||||||||
Northeast | 4,662 | 20.2 | 4,332 | 18.7 | 4,161 | 18.0 | 3,362 | 14.0 | 3,942 | 16.5 |
Midwest | 4,155 | 14.9 | 4,016 | 14.3 | 3,798 | 13.5 | 3,366 | 11.8 | 3,922 | 13.7 |
South | 15,580 | 31.1 | 15,302 | 30.2 | 15,133 | 29.6 | 12,552 | 24.2 | 14,996 | 28.7 |
West | 6,670 | 20.9 | 6,592 | 20.4 | 6,406 | 19.7 | 5,566 | 16.9 | 6,272 | 18.9 |
Subtotal | 31,067 | 23.3 | 30,242 | 22.6 | 29,498 | 21.9 | 24,846 | 18.1 | 29,132 | 21.1 |
Female sex at birthb | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 12 | 0.3 | 9 | 0.2 | 9 | 0.2 | 6 | 0.1 | 7 | 0.2 |
15–19 | 250 | 2.4 | 242 | 2.3 | 203 | 2.0 | 157 | 1.5 | 202 | 1.9 |
20–24 | 770 | 7.2 | 724 | 6.8 | 725 | 6.9 | 561 | 5.3 | 620 | 5.9 |
25–29 | 979 | 8.5 | 944 | 8.2 | 939 | 8.2 | 770 | 6.9 | 846 | 7.7 |
30–34 | 1,013 | 9.3 | 951 | 8.7 | 955 | 8.6 | 808 | 7.1 | 957 | 8.4 |
35–39 | 916 | 8.6 | 921 | 8.6 | 900 | 8.3 | 707 | 6.4 | 928 | 8.4 |
40–44 | 740 | 7.5 | 789 | 8.0 | 757 | 7.6 | 563 | 5.5 | 772 | 7.3 |
45–49 | 761 | 7.2 | 719 | 6.9 | 686 | 6.7 | 551 | 5.4 | 650 | 6.6 |
50–54 | 661 | 6.1 | 655 | 6.2 | 623 | 6.0 | 449 | 4.3 | 573 | 5.5 |
55–59 | 558 | 4.9 | 538 | 4.8 | 515 | 4.6 | 419 | 3.7 | 503 | 4.6 |
60–64 | 331 | 3.2 | 320 | 3.0 | 348 | 3.2 | 265 | 2.5 | 286 | 2.6 |
≥ 65 | 270 | 1.0 | 245 | 0.8 | 263 | 0.9 | 173 | 0.6 | 240 | 0.8 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 43 | 4.3 | 30 | 3.0 | 43 | 4.2 | 40 | 3.9 | 46 | 4.4 |
Asian | 114 | 1.4 | 102 | 1.2 | 98 | 1.1 | 83 | 1.0 | 93 | 1.1 |
Black/African American | 4,246 | 24.1 | 3,972 | 22.3 | 3,820 | 21.3 | 2,899 | 16.0 | 3,544 | 19.5 |
Hispanic/Latinoc | 1,181 | 5.3 | 1,192 | 5.2 | 1,178 | 5.0 | 922 | 3.9 | 1,164 | 4.8 |
Native Hawaiian/other Pacific Islander | 7 | 3.0 | 4 | 1.7 | 7 | 2.9 | 14 | 5.6 | 10 | 3.9 |
White | 1,415 | 1.6 | 1,458 | 1.7 | 1,512 | 1.7 | 1,287 | 1.5 | 1,522 | 1.8 |
Multiracial | 255 | 10.9 | 299 | 12.3 | 265 | 10.6 | 184 | 7.1 | 205 | 7.6 |
Region of residenced | ||||||||||
Northeast | 1,326 | 5.4 | 1,220 | 4.9 | 1,156 | 4.7 | 879 | 3.5 | 1,046 | 4.2 |
Midwest | 944 | 3.2 | 925 | 3.2 | 969 | 3.3 | 740 | 2.5 | 893 | 3.0 |
South | 4,065 | 7.7 | 3,923 | 7.3 | 3,817 | 7.1 | 2,985 | 5.5 | 3,707 | 6.8 |
West | 926 | 2.9 | 989 | 3.0 | 981 | 3.0 | 825 | 2.5 | 938 | 2.8 |
Subtotal | 7,261 | 5.2 | 7,057 | 5.0 | 6,923 | 4.9 | 5,429 | 3.8 | 6,584 | 4.6 |
Total | 38,328 | 14.1 | 37,299 | 13.6 | 36,421 | 13.2 | 30,275 | 10.9 | 35,716 | 12.7 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population.
b Data include transgender and additional gender identity persons.
c Hispanic/Latino persons can be of any race.
d Data are based on residence at time of diagnosis of HIV infection.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 13 | 0.3 | 11 | 0.3 | 12 | 0.3 | 6 | 0.1 | 8 | 0.2 |
15–19 | 1,551 | 14.2 | 1,496 | 13.7 | 1,455 | 13.4 | 1,115 | 10.0 | 1,256 | 11.3 |
20–24 | 5,772 | 50.4 | 5,455 | 48.3 | 5,315 | 47.5 | 4,327 | 39.1 | 4,883 | 44.0 |
25–29 | 6,792 | 56.5 | 6,808 | 56.1 | 6,498 | 53.5 | 5,350 | 45.7 | 5,944 | 51.7 |
30–34 | 4,721 | 42.2 | 4,766 | 42.2 | 4,739 | 41.3 | 4,428 | 37.9 | 5,449 | 46.2 |
35–39 | 3,378 | 31.6 | 3,297 | 30.3 | 3,236 | 29.4 | 2,728 | 24.1 | 3,507 | 30.9 |
40–44 | 2,270 | 23.1 | 2,208 | 22.3 | 2,215 | 22.1 | 1,932 | 18.4 | 2,401 | 22.4 |
45–49 | 2,192 | 20.9 | 2,072 | 20.0 | 1,912 | 18.8 | 1,511 | 14.7 | 1,702 | 17.0 |
50–54 | 2,014 | 19.0 | 1,818 | 17.5 | 1,704 | 16.7 | 1,405 | 13.4 | 1,576 | 14.9 |
55–59 | 1,335 | 12.4 | 1,307 | 12.1 | 1,347 | 12.5 | 1,158 | 10.6 | 1,301 | 12.1 |
60–64 | 769 | 8.0 | 737 | 7.5 | 779 | 7.8 | 628 | 6.1 | 823 | 7.9 |
≥ 65 | 629 | 2.8 | 649 | 2.8 | 627 | 2.6 | 522 | 2.1 | 620 | 2.4 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 150 | — | 140 | — | 150 | — | 149 | — | 177 | — |
Asian | 800 | — | 746 | — | 631 | — | 527 | — | 645 | — |
Black/African American | 11,863 | — | 11,632 | — | 11,481 | — | 9,749 | — | 10,983 | — |
Hispanic/Latinoc | 9,171 | — | 9,087 | — | 8,993 | — | 7,372 | — | 9,222 | — |
Native Hawaiian/other Pacific Islander | 42 | — | 55 | — | 55 | — | 50 | — | 66 | — |
White | 8,131 | — | 7,871 | — | 7,479 | — | 6,446 | — | 7,541 | — |
Multiracial | 1,279 | — | 1,093 | — | 1,050 | — | 817 | — | 836 | — |
Region of residenced | ||||||||||
Northeast | 4,662 | 20.2 | 4,332 | 18.7 | 4,161 | 18.0 | 3,362 | 14.0 | 3,942 | 16.5 |
Midwest | 4,155 | 14.9 | 4,016 | 14.3 | 3,798 | 13.5 | 3,366 | 11.8 | 3,922 | 13.7 |
South | 15,580 | 31.1 | 15,302 | 30.2 | 15,133 | 29.6 | 12,552 | 24.2 | 14,996 | 28.7 |
West | 6,670 | 20.9 | 6,592 | 20.4 | 6,406 | 19.7 | 5,566 | 16.9 | 6,272 | 18.9 |
U.S. dependent areas | 369 | 24.4 | 382 | 26.0 | 341 | 23.1 | 264 | 17.4 | 338 | 22.2 |
Subtotal | 31,436 | 23.3 | 30,624 | 22.6 | 29,839 | 21.9 | 25,110 | 18.1 | 29,470 | 21.1 |
Female sex at birthb | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 12 | 0.3 | 9 | 0.2 | 9 | 0.2 | 6 | 0.1 | 7 | 0.2 |
15–19 | 253 | 2.4 | 244 | 2.3 | 203 | 1.9 | 157 | 1.5 | 204 | 1.9 |
20–24 | 775 | 7.1 | 733 | 6.8 | 730 | 6.8 | 566 | 5.3 | 629 | 5.9 |
25–29 | 990 | 8.5 | 951 | 8.2 | 944 | 8.1 | 774 | 6.8 | 849 | 7.6 |
30–34 | 1,020 | 9.3 | 957 | 8.7 | 964 | 8.6 | 809 | 7.1 | 962 | 8.3 |
35–39 | 928 | 8.7 | 925 | 8.5 | 906 | 8.3 | 710 | 6.4 | 941 | 8.4 |
40–44 | 747 | 7.5 | 797 | 8.0 | 769 | 7.6 | 570 | 5.5 | 785 | 7.4 |
45–49 | 776 | 7.3 | 733 | 6.9 | 697 | 6.7 | 556 | 5.4 | 657 | 6.6 |
50–54 | 673 | 6.1 | 666 | 6.2 | 630 | 6.0 | 454 | 4.3 | 584 | 5.5 |
55–59 | 571 | 5.0 | 546 | 4.8 | 528 | 4.6 | 427 | 3.8 | 506 | 4.6 |
60–64 | 336 | 3.2 | 325 | 3.0 | 354 | 3.3 | 268 | 2.5 | 293 | 2.7 |
≥ 65 | 274 | 1.0 | 252 | 0.9 | 272 | 0.9 | 178 | 0.6 | 249 | 0.8 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 43 | — | 30 | — | 43 | — | 40 | — | 46 | — |
Asian | 114 | — | 102 | — | 98 | — | 83 | — | 93 | — |
Black/African American | 4,249 | — | 3,973 | — | 3,823 | — | 2,901 | — | 3,545 | — |
Hispanic/Latinoc | 1,270 | — | 1,272 | — | 1,257 | — | 966 | — | 1,245 | — |
Native Hawaiian/other Pacific Islander | 7 | — | 4 | — | 8 | — | 14 | — | 10 | — |
White | 1,416 | — | 1,458 | — | 1,512 | — | 1,287 | — | 1,522 | — |
Multiracial | 256 | — | 299 | — | 265 | — | 184 | — | 205 | — |
Region of residenced | ||||||||||
Northeast | 1,326 | 5.4 | 1,220 | 4.9 | 1,156 | 4.7 | 879 | 3.5 | 1,046 | 4.2 |
Midwest | 944 | 3.2 | 925 | 3.2 | 969 | 3.3 | 740 | 2.5 | 893 | 3.0 |
South | 4,065 | 7.7 | 3,923 | 7.3 | 3,817 | 7.1 | 2,985 | 5.5 | 3,707 | 6.8 |
West | 926 | 2.9 | 989 | 3.0 | 981 | 3.0 | 825 | 2.5 | 938 | 2.8 |
U.S. dependent areas | 94 | 5.6 | 81 | 5.0 | 83 | 5.0 | 46 | 2.7 | 82 | 4.8 |
Subtotal | 7,355 | 5.2 | 7,138 | 5.0 | 7,006 | 4.9 | 5,475 | 3.8 | 6,666 | 4.6 |
Total | 38,791 | 14.1 | 37,762 | 13.6 | 36,845 | 13.2 | 30,585 | 10.8 | 36,136 | 12.7 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
b Data include transgender and additional gender identity persons.
c Hispanic/Latino persons can be of any race.
d Data are based on residence at time of diagnosis of HIV infection.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 1 |
15–19 | 67 | 48 | 44 | 34 | 58 |
20–24 | 164 | 175 | 180 | 156 | 227 |
25–29 | 174 | 195 | 177 | 212 | 172 |
30–34 | 114 | 98 | 138 | 127 | 167 |
35–39 | 59 | 72 | 63 | 49 | 77 |
40–44 | 31 | 33 | 42 | 35 | 51 |
45–49 | 22 | 22 | 19 | 32 | 25 |
50–54 | 8 | 6 | 16 | 19 | 12 |
55–59 | 7 | 6 | 8 | 6 | 12 |
60–64 | 5 | 4 | 4 | 5 | 8 |
≥ 65 | 0 | 2 | 1 | 1 | 1 |
Race/ethnicity | |||||
American Indian/Alaska Native | 2 | 9 | 5 | 8 | 10 |
Asian | 19 | 11 | 11 | 14 | 17 |
Black/African American | 324 | 317 | 341 | 327 | 374 |
Hispanic/Latinob | 196 | 219 | 226 | 220 | 257 |
Native Hawaiian/other Pacific Islander | 4 | 3 | 5 | 3 | 6 |
White | 80 | 69 | 79 | 73 | 112 |
Multiracial | 26 | 33 | 25 | 31 | 35 |
Exposure categoryc | |||||
Sexual contactd | 592 | 596 | 616 | 611 | 716 |
Injection drug usee | 4 | 4 | 2 | 1 | 3 |
Sexual contactd and injection drug usee |
40 | 53 | 58 | 44 | 56 |
Otherf | 15 | 8 | 16 | 20 | 36 |
Region of residenceg | |||||
Northeast | 104 | 117 | 105 | 111 | 110 |
Midwest | 108 | 108 | 96 | 102 | 139 |
South | 294 | 290 | 310 | 298 | 352 |
West | 145 | 146 | 181 | 165 | 210 |
Subtotal | 651 | 661 | 692 | 676 | 811 |
Transgender mana | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 1 |
15–19 | 3 | 2 | 0 | 1 | 6 |
20–24 | 7 | 9 | 11 | 12 | 8 |
25–29 | 16 | 18 | 18 | 10 | 17 |
30–34 | 1 | 9 | 13 | 8 | 13 |
35–39 | 2 | 4 | 1 | 6 | 6 |
40–44 | 0 | 4 | 0 | 2 | 2 |
45–49 | 2 | 1 | 2 | 1 | 0 |
50–54 | 0 | 1 | 0 | 1 | 1 |
55–59 | 1 | 0 | 0 | 0 | 1 |
60–64 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 1 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asian | 2 | 0 | 1 | 0 | 2 |
Black/African American | 11 | 17 | 17 | 10 | 18 |
Hispanic/Latinob | 6 | 11 | 13 | 11 | 14 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 10 | 18 | 9 | 15 | 19 |
Multiracial | 3 | 2 | 5 | 5 | 3 |
Exposure categoryc | |||||
Sexual contactd | 27 | 40 | 35 | 30 | 47 |
Injection drug usee | 1 | 2 | 1 | 1 | 0 |
Sexual contactd and injection drug usee |
1 | 3 | 3 | 5 | 1 |
Otherf | 3 | 3 | 6 | 5 | 8 |
Region of residenceg | |||||
Northeast | 5 | 7 | 6 | 9 | 9 |
Midwest | 8 | 7 | 6 | 2 | 10 |
South | 12 | 16 | 18 | 24 | 22 |
West | 7 | 18 | 15 | 6 | 15 |
Subtotal | 32 | 48 | 45 | 41 | 56 |
Additional gender identityh | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 1 | 4 | 5 | 3 | 3 |
20–24 | 4 | 7 | 13 | 7 | 22 |
25–29 | 3 | 4 | 7 | 8 | 7 |
30–34 | 3 | 2 | 4 | 1 | 5 |
35–39 | 5 | 1 | 2 | 2 | 2 |
40–44 | 0 | 0 | 0 | 1 | 1 |
45–49 | 2 | 1 | 0 | 1 | 2 |
50–54 | 0 | 0 | 1 | 0 | 2 |
55–59 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 1 | 0 | 0 | 0 |
Asian | 1 | 2 | 0 | 1 | 0 |
Black/African American | 7 | 7 | 11 | 10 | 12 |
Hispanic/Latinob | 7 | 4 | 7 | 5 | 14 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 3 | 3 | 9 | 6 | 15 |
Multiracial | 0 | 2 | 5 | 1 | 3 |
Exposure categoryc | |||||
Sexual contactd | 16 | 19 | 29 | 20 | 38 |
Injection drug usee | 0 | 0 | 0 | 0 | 0 |
Sexual contactd and injection drug usee |
1 | 0 | 2 | 1 | 5 |
Otherf | 1 | 0 | 1 | 2 | 1 |
Region of residenceg | |||||
Northeast | 9 | 8 | 9 | 2 | 12 |
Midwest | 3 | 4 | 10 | 6 | 8 |
South | 6 | 5 | 9 | 7 | 9 |
West | 0 | 2 | 4 | 8 | 15 |
Subtotal | 18 | 19 | 32 | 23 | 44 |
Total | 701 | 728 | 769 | 740 | 911 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Hispanic/Latino persons can be of any race.
c Risk factor data for transgender and additional gender identity persons aged ≥ 13 years are presented using the exposure category classification which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
d For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
e Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
f Other risk factors, including perinatal, hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
g Data are based on residence at time of diagnosis of HIV infection.
h Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 1 |
15–19 | 67 | 48 | 44 | 34 | 58 |
20–24 | 165 | 176 | 181 | 158 | 227 |
25–29 | 175 | 196 | 178 | 212 | 172 |
30–34 | 114 | 99 | 138 | 128 | 167 |
35–39 | 59 | 73 | 63 | 49 | 77 |
40–44 | 31 | 33 | 42 | 35 | 52 |
45–49 | 22 | 22 | 19 | 32 | 25 |
50–54 | 8 | 6 | 16 | 19 | 12 |
55–59 | 7 | 6 | 8 | 6 | 12 |
60–64 | 5 | 4 | 4 | 5 | 8 |
≥ 65 | 0 | 2 | 1 | 1 | 1 |
Race/ethnicity | |||||
American Indian/Alaska Native | 2 | 9 | 5 | 8 | 10 |
Asian | 19 | 11 | 11 | 14 | 17 |
Black/African American | 324 | 317 | 341 | 327 | 374 |
Hispanic/Latinob | 198 | 223 | 228 | 223 | 258 |
Native Hawaiian/other Pacific Islander | 4 | 3 | 5 | 3 | 6 |
White | 80 | 69 | 79 | 73 | 112 |
Multiracial | 26 | 33 | 25 | 31 | 35 |
Exposure categoryc | |||||
Sexual contactd | 594 | 600 | 618 | 614 | 717 |
Injection drug usee | 4 | 4 | 2 | 1 | 3 |
Sexual contactd and injection drug usee |
40 | 53 | 58 | 44 | 56 |
Otherf | 15 | 8 | 16 | 20 | 36 |
Region of residenceg | |||||
Northeast | 104 | 117 | 105 | 111 | 110 |
Midwest | 108 | 108 | 96 | 102 | 139 |
South | 294 | 290 | 310 | 298 | 352 |
West | 145 | 146 | 181 | 165 | 210 |
US dependent areas | 2 | 4 | 2 | 3 | 1 |
Subtotal | 653 | 665 | 694 | 679 | 812 |
Transgender mana | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 1 |
15–19 | 3 | 2 | 0 | 1 | 6 |
20–24 | 7 | 9 | 11 | 12 | 8 |
25–29 | 16 | 18 | 18 | 10 | 17 |
30–34 | 1 | 9 | 13 | 8 | 13 |
35–39 | 2 | 4 | 1 | 6 | 6 |
40–44 | 0 | 4 | 0 | 2 | 2 |
45–49 | 2 | 1 | 2 | 1 | 0 |
50–54 | 0 | 1 | 0 | 1 | 1 |
55–59 | 1 | 0 | 0 | 0 | 1 |
60–64 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 1 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asian | 2 | 0 | 1 | 0 | 2 |
Black/African American | 11 | 17 | 17 | 10 | 18 |
Hispanic/Latinob | 6 | 11 | 13 | 11 | 14 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 10 | 18 | 9 | 15 | 19 |
Multiracial | 3 | 2 | 5 | 5 | 3 |
Exposure categoryc | |||||
Sexual contactd | 27 | 40 | 35 | 30 | 47 |
Injection drug usee | 1 | 2 | 1 | 1 | 0 |
Sexual contactd and injection drug usee |
1 | 3 | 3 | 5 | 1 |
Otherf | 3 | 3 | 6 | 5 | 8 |
Region of residenceg | |||||
Northeast | 5 | 7 | 6 | 9 | 9 |
Midwest | 8 | 7 | 6 | 2 | 10 |
South | 12 | 16 | 18 | 24 | 22 |
West | 7 | 18 | 15 | 6 | 15 |
US dependent areas | 0 | 0 | 0 | 0 | 0 |
Subtotal | 32 | 48 | 45 | 41 | 56 |
Additional gender identityh | |||||
Age at diagnosis (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 1 | 4 | 5 | 3 | 3 |
20–24 | 4 | 7 | 13 | 7 | 22 |
25–29 | 3 | 4 | 7 | 8 | 7 |
30–34 | 3 | 2 | 4 | 1 | 5 |
35–39 | 5 | 1 | 2 | 2 | 2 |
40–44 | 0 | 0 | 0 | 1 | 1 |
45–49 | 2 | 1 | 0 | 1 | 2 |
50–54 | 0 | 0 | 1 | 0 | 2 |
55–59 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 1 | 0 | 0 | 0 |
Asian | 1 | 2 | 0 | 1 | 0 |
Black/African American | 7 | 7 | 11 | 10 | 12 |
Hispanic/Latinob | 7 | 4 | 7 | 5 | 14 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 3 | 3 | 9 | 6 | 15 |
Multiracial | 0 | 2 | 5 | 1 | 3 |
Exposure categoryc | |||||
Sexual contactd | 16 | 19 | 29 | 20 | 38 |
Injection drug usee | 0 | 0 | 0 | 0 | 0 |
Sexual contactd and injection drug usee |
1 | 0 | 2 | 1 | 5 |
Otherf | 1 | 0 | 1 | 2 | 1 |
Region of residenceg | |||||
Northeast | 9 | 8 | 9 | 2 | 12 |
Midwest | 3 | 4 | 10 | 6 | 8 |
South | 6 | 5 | 9 | 7 | 9 |
West | 0 | 2 | 4 | 8 | 15 |
US dependent areas | 0 | 0 | 0 | 0 | 0 |
Subtotal | 18 | 19 | 32 | 23 | 44 |
Total | 703 | 732 | 771 | 743 | 912 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Hispanic/Latino persons can be of any race.
c Risk factor data for transgender and additional gender identity persons aged ≥ 13 years are presented using the exposure category classification which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
d For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
e Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
f Other risk factors, including perinatal, hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
g Data are based on residence at time of diagnosis of HIV infection.
h Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
Male-to-male sexual contact | Male-to-male sexual contact and injection drug use | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 2 | 7 | 6 | 5 | 10 | 0 | 0 | 0 | 0 | 0 |
20–24 | 19 | 24 | 25 | 19 | 19 | 3 | 2 | 3 | 5 | 1 |
25–29 | 29 | 21 | 25 | 25 | 32 | 5 | 7 | 5 | 5 | 1 |
30–34 | 15 | 19 | 15 | 18 | 26 | 6 | 4 | 1 | 3 | 6 |
35–39 | 15 | 8 | 18 | 13 | 21 | 0 | 2 | 3 | 5 | 4 |
40–44 | 10 | 7 | 6 | 12 | 10 | 2 | 1 | 0 | 2 | 1 |
45–49 | 6 | 7 | 7 | 6 | 6 | 1 | 2 | 1 | 0 | 1 |
50–54 | 8 | 6 | 7 | 10 | 8 | 0 | 0 | 1 | 1 | 2 |
55–59 | 2 | 3 | 3 | 5 | 3 | 0 | 0 | 0 | 0 | 0 |
60–64 | 2 | 0 | 1 | 1 | 5 | 1 | 0 | 0 | 0 | 0 |
≥ 65 | 1 | 3 | 0 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 2 | 4 | 3 | 5 | 4 | 0 | 0 | 0 | 0 | 0 |
Midwest | 10 | 13 | 8 | 9 | 19 | 3 | 4 | 1 | 5 | 6 |
South | 23 | 16 | 37 | 33 | 41 | 9 | 2 | 3 | 0 | 1 |
West | 73 | 71 | 65 | 70 | 76 | 6 | 13 | 10 | 15 | 8 |
Total | 108 | 103 | 113 | 117 | 141 | 18 | 19 | 14 | 21 | 16 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 25 | 23 | 19 | 17 | 21 | 0 | 0 | 0 | 0 | 0 |
20–24 | 147 | 105 | 94 | 58 | 82 | 2 | 0 | 2 | 1 | 1 |
25–29 | 151 | 163 | 126 | 120 | 122 | 4 | 5 | 3 | 4 | 4 |
30–34 | 111 | 117 | 93 | 89 | 113 | 6 | 2 | 6 | 3 | 4 |
35–39 | 88 | 71 | 73 | 49 | 72 | 1 | 3 | 1 | 0 | 4 |
40–44 | 74 | 62 | 41 | 45 | 47 | 0 | 1 | 1 | 2 | 1 |
45–49 | 64 | 57 | 51 | 40 | 39 | 2 | 0 | 1 | 0 | 1 |
50–54 | 34 | 22 | 34 | 22 | 39 | 0 | 0 | 0 | 0 | 0 |
55–59 | 21 | 21 | 16 | 13 | 23 | 0 | 0 | 0 | 0 | 1 |
60–64 | 10 | 11 | 8 | 11 | 8 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 7 | 10 | 8 | 9 | 6 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 127 | 121 | 99 | 71 | 109 | 2 | 1 | 2 | 0 | 2 |
Midwest | 73 | 65 | 53 | 53 | 56 | 0 | 0 | 1 | 1 | 3 |
South | 153 | 169 | 140 | 100 | 151 | 1 | 2 | 4 | 1 | 4 |
West | 380 | 307 | 270 | 247 | 256 | 12 | 9 | 7 | 10 | 8 |
Total | 733 | 661 | 563 | 472 | 573 | 15 | 12 | 14 | 12 | 17 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 4 | 7 | 7 | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
15–19 | 853 | 808 | 793 | 604 | 685 | 12 | 10 | 10 | 12 | 9 |
20–24 | 2,512 | 2,409 | 2,378 | 2,072 | 2,343 | 45 | 52 | 41 | 41 | 30 |
25–29 | 2,459 | 2,486 | 2,335 | 1,967 | 2,067 | 75 | 84 | 87 | 58 | 50 |
30–34 | 1,334 | 1,266 | 1,424 | 1,447 | 1,636 | 51 | 50 | 65 | 53 | 62 |
35–39 | 752 | 742 | 741 | 655 | 778 | 37 | 29 | 39 | 26 | 37 |
40–44 | 434 | 447 | 456 | 384 | 423 | 21 | 18 | 21 | 16 | 24 |
45–49 | 351 | 352 | 333 | 266 | 288 | 14 | 12 | 17 | 8 | 14 |
50–54 | 324 | 311 | 283 | 236 | 232 | 25 | 17 | 18 | 6 | 6 |
55–59 | 205 | 203 | 204 | 194 | 228 | 11 | 9 | 9 | 7 | 6 |
60–64 | 111 | 99 | 111 | 93 | 122 | 5 | 6 | 6 | 3 | 3 |
≥ 65 | 66 | 76 | 81 | 54 | 75 | 5 | 4 | 2 | 2 | 2 |
Region of residencea | ||||||||||
Northeast | 1,140 | 1,073 | 1,112 | 923 | 1,007 | 38 | 53 | 38 | 34 | 36 |
Midwest | 1,500 | 1,458 | 1,408 | 1,304 | 1,393 | 50 | 54 | 44 | 37 | 41 |
South | 5,955 | 5,853 | 5,835 | 5,033 | 5,659 | 161 | 142 | 178 | 119 | 131 |
West | 811 | 820 | 790 | 714 | 820 | 54 | 43 | 55 | 41 | 36 |
Total | 9,405 | 9,205 | 9,145 | 7,973 | 8,879 | 303 | 292 | 314 | 232 | 244 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 5 | 0 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
15–19 | 339 | 324 | 363 | 259 | 312 | 11 | 12 | 8 | 7 | 7 |
20–24 | 1,402 | 1,385 | 1,407 | 1,067 | 1,275 | 68 | 75 | 70 | 38 | 46 |
25–29 | 1,770 | 1,788 | 1,744 | 1,440 | 1,741 | 99 | 114 | 101 | 88 | 79 |
30–34 | 1,345 | 1,317 | 1,299 | 1,201 | 1,577 | 74 | 61 | 71 | 61 | 71 |
35–39 | 925 | 904 | 899 | 736 | 1,031 | 53 | 48 | 63 | 36 | 46 |
40–44 | 593 | 554 | 588 | 521 | 655 | 24 | 28 | 38 | 21 | 31 |
45–49 | 517 | 493 | 449 | 340 | 440 | 20 | 20 | 25 | 20 | 15 |
50–54 | 343 | 329 | 351 | 285 | 330 | 17 | 17 | 22 | 11 | 16 |
55–59 | 172 | 189 | 179 | 185 | 204 | 8 | 3 | 11 | 5 | 8 |
60–64 | 71 | 88 | 91 | 82 | 118 | 4 | 5 | 3 | 7 | 5 |
≥ 65 | 76 | 68 | 70 | 54 | 73 | 2 | 3 | 3 | 2 | 2 |
Region of residencea | ||||||||||
Northeast | 1,300 | 1,177 | 1,172 | 939 | 1,124 | 44 | 59 | 62 | 31 | 34 |
Midwest | 519 | 523 | 532 | 413 | 587 | 30 | 33 | 34 | 19 | 16 |
South | 3,224 | 3,151 | 3,135 | 2,560 | 3,438 | 132 | 121 | 156 | 112 | 116 |
West | 2,514 | 2,587 | 2,601 | 2,258 | 2,608 | 174 | 172 | 162 | 133 | 160 |
Total | 7,556 | 7,438 | 7,441 | 6,170 | 7,757 | 379 | 385 | 414 | 295 | 325 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 1 | 3 | 1 | 2 | 5 | 0 | 0 | 0 | 1 | 0 |
20–24 | 7 | 5 | 6 | 6 | 3 | 0 | 2 | 0 | 0 | 1 |
25–29 | 7 | 9 | 16 | 10 | 15 | 1 | 2 | 0 | 1 | 0 |
30–34 | 7 | 10 | 9 | 7 | 9 | 0 | 1 | 1 | 1 | 2 |
35–39 | 2 | 8 | 7 | 6 | 10 | 1 | 0 | 1 | 1 | 0 |
40–44 | 5 | 2 | 4 | 6 | 7 | 0 | 0 | 0 | 0 | 0 |
45–49 | 1 | 2 | 0 | 1 | 3 | 0 | 0 | 0 | 1 | 0 |
50–54 | 1 | 1 | 3 | 2 | 4 | 0 | 0 | 0 | 0 | 0 |
55–59 | 0 | 4 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 2 | 2 | 1 | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
Midwest | 3 | 1 | 4 | 3 | 6 | 0 | 0 | 0 | 1 | 0 |
South | 6 | 8 | 10 | 6 | 16 | 0 | 0 | 0 | 0 | 0 |
West | 21 | 34 | 33 | 28 | 35 | 2 | 5 | 2 | 4 | 3 |
Total | 31 | 45 | 48 | 41 | 59 | 2 | 5 | 2 | 5 | 4 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 160 | 166 | 129 | 119 | 106 | 12 | 11 | 13 | 3 | 3 |
20–24 | 905 | 782 | 707 | 583 | 603 | 91 | 71 | 81 | 54 | 52 |
25–29 | 1,181 | 1,099 | 1,076 | 896 | 1,006 | 175 | 188 | 167 | 126 | 119 |
30–34 | 865 | 942 | 863 | 826 | 1,009 | 128 | 147 | 147 | 112 | 173 |
35–39 | 718 | 650 | 648 | 525 | 718 | 100 | 122 | 116 | 108 | 120 |
40–44 | 489 | 509 | 448 | 434 | 547 | 64 | 59 | 67 | 52 | 100 |
45–49 | 606 | 546 | 461 | 395 | 426 | 62 | 51 | 55 | 46 | 55 |
50–54 | 669 | 530 | 499 | 435 | 465 | 38 | 44 | 38 | 32 | 42 |
55–59 | 436 | 429 | 459 | 404 | 434 | 24 | 27 | 33 | 24 | 21 |
60–64 | 243 | 248 | 236 | 202 | 263 | 17 | 6 | 14 | 10 | 19 |
≥ 65 | 181 | 213 | 184 | 181 | 180 | 11 | 7 | 10 | 4 | 11 |
Region of residencea | ||||||||||
Northeast | 825 | 745 | 687 | 560 | 668 | 79 | 80 | 65 | 72 | 82 |
Midwest | 1,202 | 1,082 | 959 | 923 | 1,081 | 107 | 136 | 150 | 100 | 142 |
South | 2,795 | 2,741 | 2,605 | 2,201 | 2,620 | 319 | 302 | 309 | 225 | 284 |
West | 1,632 | 1,545 | 1,459 | 1,318 | 1,389 | 217 | 217 | 220 | 174 | 207 |
Total | 6,454 | 6,113 | 5,710 | 5,002 | 5,758 | 721 | 734 | 742 | 570 | 714 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 64 | 48 | 51 | 44 | 54 | 3 | 2 | 2 | 0 | 0 |
20–24 | 245 | 221 | 189 | 138 | 149 | 13 | 12 | 6 | 9 | 6 |
25–29 | 272 | 218 | 218 | 168 | 145 | 15 | 30 | 22 | 13 | 14 |
30–34 | 162 | 138 | 136 | 102 | 125 | 14 | 14 | 27 | 6 | 16 |
35–39 | 94 | 95 | 83 | 74 | 65 | 14 | 13 | 8 | 7 | 8 |
40–44 | 59 | 55 | 58 | 51 | 46 | 5 | 2 | 11 | 8 | 1 |
45–49 | 59 | 47 | 40 | 43 | 31 | 5 | 5 | 1 | 5 | 4 |
50–54 | 59 | 36 | 20 | 31 | 32 | 6 | 4 | 2 | 2 | 1 |
55–59 | 24 | 18 | 39 | 16 | 23 | 4 | 0 | 1 | 0 | 2 |
60–64 | 13 | 12 | 11 | 8 | 6 | 0 | 0 | 1 | 1 | 0 |
≥ 65 | 7 | 11 | 8 | 11 | 13 | 0 | 1 | 1 | 0 | 1 |
Region of residencea | ||||||||||
Northeast | 177 | 151 | 150 | 108 | 111 | 12 | 11 | 8 | 5 | 6 |
Midwest | 167 | 124 | 101 | 100 | 103 | 11 | 16 | 14 | 11 | 16 |
South | 504 | 452 | 436 | 354 | 360 | 40 | 30 | 43 | 23 | 20 |
West | 209 | 172 | 164 | 124 | 115 | 17 | 28 | 16 | 12 | 12 |
Total | 1,057 | 898 | 852 | 685 | 688 | 79 | 84 | 81 | 51 | 54 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 10 | 8 | 10 | 4 | 5 | 0 | 1 | 0 | 0 | 1 |
15–19 | 1,444 | 1,377 | 1,362 | 1,049 | 1,193 | 39 | 37 | 34 | 23 | 19 |
20–24 | 5,237 | 4,931 | 4,805 | 3,944 | 4,473 | 222 | 214 | 203 | 147 | 137 |
25–29 | 5,870 | 5,784 | 5,540 | 4,623 | 5,128 | 372 | 430 | 384 | 295 | 268 |
30–34 | 3,838 | 3,807 | 3,838 | 3,689 | 4,496 | 278 | 280 | 318 | 240 | 334 |
35–39 | 2,592 | 2,479 | 2,468 | 2,059 | 2,694 | 206 | 217 | 231 | 182 | 218 |
40–44 | 1,665 | 1,635 | 1,600 | 1,453 | 1,735 | 116 | 109 | 138 | 102 | 159 |
45–49 | 1,605 | 1,505 | 1,341 | 1,090 | 1,232 | 105 | 91 | 99 | 80 | 91 |
50–54 | 1,438 | 1,235 | 1,197 | 1,023 | 1,109 | 85 | 82 | 80 | 53 | 67 |
55–59 | 860 | 865 | 900 | 818 | 914 | 47 | 40 | 54 | 36 | 38 |
60–64 | 450 | 458 | 459 | 397 | 525 | 28 | 18 | 25 | 20 | 28 |
≥ 65 | 338 | 380 | 350 | 311 | 350 | 19 | 14 | 17 | 8 | 16 |
Region of residencea | ||||||||||
Northeast | 3,572 | 3,273 | 3,225 | 2,609 | 3,025 | 175 | 204 | 175 | 142 | 160 |
Midwest | 3,474 | 3,266 | 3,064 | 2,805 | 3,244 | 201 | 243 | 244 | 176 | 225 |
South | 12,660 | 12,389 | 12,199 | 10,288 | 12,286 | 661 | 598 | 691 | 480 | 555 |
West | 5,639 | 5,536 | 5,382 | 4,758 | 5,300 | 480 | 487 | 472 | 387 | 434 |
Total | 25,345 | 24,464 | 23,870 | 20,460 | 23,855 | 1,517 | 1,531 | 1,581 | 1,185 | 1,373 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender and additional gender identity persons.
a Data are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
Male-to-male sexual contact | Male-to-male sexual contact and injection drug use | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 2 | 7 | 6 | 5 | 10 | 0 | 0 | 0 | 0 | 0 |
20–24 | 19 | 24 | 25 | 19 | 19 | 3 | 2 | 3 | 5 | 1 |
25–29 | 29 | 21 | 25 | 25 | 32 | 5 | 7 | 5 | 5 | 1 |
30–34 | 15 | 19 | 15 | 18 | 26 | 6 | 4 | 1 | 3 | 6 |
35–39 | 15 | 8 | 18 | 13 | 21 | 0 | 2 | 3 | 5 | 4 |
40–44 | 10 | 7 | 6 | 12 | 10 | 2 | 1 | 0 | 2 | 1 |
45–49 | 6 | 7 | 7 | 6 | 6 | 1 | 2 | 1 | 0 | 1 |
50–54 | 8 | 6 | 7 | 10 | 8 | 0 | 0 | 1 | 1 | 2 |
55–59 | 2 | 3 | 3 | 5 | 3 | 0 | 0 | 0 | 0 | 0 |
60–64 | 2 | 0 | 1 | 1 | 5 | 1 | 0 | 0 | 0 | 0 |
≥ 65 | 1 | 3 | 0 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 2 | 4 | 3 | 5 | 4 | 0 | 0 | 0 | 0 | 0 |
Midwest | 10 | 13 | 8 | 9 | 19 | 3 | 4 | 1 | 5 | 6 |
South | 23 | 16 | 37 | 33 | 41 | 9 | 2 | 3 | 0 | 1 |
West | 73 | 71 | 65 | 70 | 76 | 6 | 13 | 10 | 15 | 8 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 108 | 103 | 113 | 117 | 141 | 18 | 19 | 14 | 21 | 16 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 25 | 23 | 19 | 17 | 21 | 0 | 0 | 0 | 0 | 0 |
20–24 | 147 | 105 | 94 | 58 | 82 | 2 | 0 | 2 | 1 | 1 |
25–29 | 151 | 164 | 129 | 120 | 123 | 4 | 5 | 4 | 4 | 4 |
30–34 | 113 | 119 | 94 | 89 | 113 | 6 | 2 | 6 | 3 | 4 |
35–39 | 89 | 71 | 74 | 49 | 72 | 1 | 3 | 1 | 0 | 4 |
40–44 | 74 | 62 | 41 | 45 | 47 | 0 | 1 | 1 | 2 | 1 |
45–49 | 64 | 57 | 51 | 40 | 39 | 2 | 0 | 1 | 0 | 1 |
50–54 | 34 | 22 | 35 | 22 | 39 | 0 | 0 | 0 | 0 | 0 |
55–59 | 21 | 21 | 16 | 13 | 23 | 0 | 0 | 0 | 0 | 1 |
60–64 | 10 | 11 | 8 | 11 | 8 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 7 | 10 | 8 | 9 | 6 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 127 | 121 | 99 | 71 | 109 | 2 | 1 | 2 | 0 | 2 |
Midwest | 73 | 65 | 53 | 53 | 56 | 0 | 0 | 1 | 1 | 3 |
South | 153 | 169 | 140 | 100 | 151 | 1 | 2 | 4 | 1 | 4 |
West | 380 | 307 | 270 | 247 | 256 | 12 | 9 | 7 | 10 | 8 |
U.S. dependent areas | 3 | 4 | 5 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
Total | 736 | 665 | 568 | 472 | 574 | 15 | 12 | 15 | 12 | 17 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 4 | 7 | 7 | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
15–19 | 853 | 808 | 793 | 606 | 685 | 12 | 10 | 10 | 12 | 9 |
20–24 | 2,512 | 2,410 | 2,379 | 2,072 | 2,344 | 45 | 52 | 41 | 41 | 30 |
25–29 | 2,459 | 2,488 | 2,336 | 1,967 | 2,067 | 75 | 84 | 87 | 58 | 50 |
30–34 | 1,334 | 1,267 | 1,424 | 1,447 | 1,637 | 51 | 50 | 65 | 53 | 62 |
35–39 | 752 | 742 | 741 | 655 | 778 | 37 | 29 | 39 | 26 | 37 |
40–44 | 435 | 447 | 456 | 384 | 423 | 21 | 18 | 21 | 16 | 24 |
45–49 | 351 | 352 | 333 | 266 | 288 | 14 | 12 | 17 | 8 | 14 |
50–54 | 324 | 311 | 283 | 237 | 232 | 25 | 17 | 18 | 6 | 6 |
55–59 | 205 | 203 | 204 | 194 | 229 | 11 | 9 | 9 | 7 | 6 |
60–64 | 111 | 99 | 111 | 93 | 122 | 5 | 6 | 6 | 3 | 3 |
≥ 65 | 66 | 76 | 81 | 54 | 75 | 5 | 4 | 2 | 2 | 2 |
Region of residencea | ||||||||||
Northeast | 1,140 | 1,073 | 1,112 | 923 | 1,007 | 38 | 53 | 38 | 34 | 36 |
Midwest | 1,500 | 1,458 | 1,408 | 1,304 | 1,393 | 50 | 54 | 44 | 37 | 41 |
South | 5,955 | 5,853 | 5,835 | 5,033 | 5,659 | 161 | 142 | 178 | 119 | 131 |
West | 811 | 820 | 790 | 714 | 820 | 54 | 43 | 55 | 41 | 36 |
U.S. dependent areas | 2 | 4 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
Total | 9,407 | 9,209 | 9,147 | 7,976 | 8,883 | 303 | 292 | 314 | 232 | 244 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 5 | 0 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
15–19 | 347 | 339 | 369 | 265 | 314 | 11 | 12 | 8 | 7 | 8 |
20–24 | 1,451 | 1,437 | 1,453 | 1,103 | 1,316 | 70 | 76 | 73 | 39 | 46 |
25–29 | 1,811 | 1,841 | 1,790 | 1,474 | 1,812 | 103 | 117 | 102 | 90 | 79 |
30–34 | 1,382 | 1,353 | 1,336 | 1,231 | 1,609 | 75 | 64 | 73 | 61 | 71 |
35–39 | 948 | 926 | 923 | 763 | 1,055 | 55 | 49 | 64 | 37 | 46 |
40–44 | 609 | 578 | 601 | 533 | 677 | 24 | 28 | 38 | 21 | 32 |
45–49 | 534 | 516 | 462 | 352 | 453 | 22 | 20 | 26 | 20 | 15 |
50–54 | 365 | 346 | 366 | 304 | 349 | 17 | 17 | 22 | 11 | 16 |
55–59 | 183 | 199 | 191 | 193 | 213 | 8 | 4 | 12 | 5 | 8 |
60–64 | 75 | 96 | 100 | 88 | 123 | 4 | 6 | 4 | 7 | 5 |
≥ 65 | 80 | 71 | 74 | 56 | 77 | 2 | 4 | 4 | 2 | 2 |
Region of residencea | ||||||||||
Northeast | 1,300 | 1,177 | 1,172 | 939 | 1,124 | 44 | 59 | 62 | 31 | 34 |
Midwest | 519 | 523 | 532 | 413 | 587 | 30 | 33 | 34 | 19 | 16 |
South | 3,224 | 3,151 | 3,135 | 2,560 | 3,438 | 132 | 121 | 156 | 112 | 116 |
West | 2,514 | 2,587 | 2,601 | 2,258 | 2,608 | 174 | 172 | 162 | 133 | 160 |
U.S. dependent areas | 232 | 263 | 226 | 195 | 243 | 12 | 11 | 11 | 5 | 2 |
Total | 7,788 | 7,701 | 7,666 | 6,366 | 8,000 | 391 | 397 | 425 | 299 | 327 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 1 | 3 | 1 | 2 | 5 | 0 | 0 | 0 | 1 | 0 |
20–24 | 7 | 5 | 6 | 6 | 3 | 0 | 2 | 0 | 0 | 1 |
25–29 | 7 | 9 | 16 | 10 | 15 | 1 | 2 | 1 | 1 | 0 |
30–34 | 7 | 10 | 9 | 8 | 9 | 0 | 1 | 1 | 1 | 2 |
35–39 | 2 | 9 | 7 | 6 | 10 | 1 | 0 | 1 | 1 | 0 |
40–44 | 5 | 2 | 5 | 6 | 7 | 0 | 0 | 0 | 0 | 0 |
45–49 | 1 | 2 | 0 | 1 | 3 | 0 | 0 | 0 | 1 | 0 |
50–54 | 2 | 1 | 4 | 2 | 4 | 0 | 0 | 0 | 0 | 0 |
55–59 | 1 | 4 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
≥ 65 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 2 | 2 | 1 | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
Midwest | 3 | 1 | 4 | 3 | 6 | 0 | 0 | 0 | 1 | 0 |
South | 6 | 8 | 10 | 6 | 16 | 0 | 0 | 0 | 0 | 0 |
West | 21 | 34 | 33 | 28 | 35 | 2 | 5 | 2 | 4 | 3 |
U.S. dependent areas | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
Total | 33 | 46 | 50 | 42 | 59 | 2 | 5 | 3 | 5 | 4 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 160 | 166 | 129 | 119 | 106 | 12 | 11 | 13 | 3 | 3 |
20–24 | 905 | 782 | 707 | 583 | 603 | 91 | 71 | 81 | 54 | 52 |
25–29 | 1,181 | 1,099 | 1,076 | 896 | 1,007 | 175 | 188 | 167 | 126 | 119 |
30–34 | 865 | 942 | 865 | 826 | 1,009 | 128 | 147 | 147 | 112 | 173 |
35–39 | 720 | 651 | 648 | 525 | 719 | 100 | 122 | 116 | 108 | 120 |
40–44 | 489 | 510 | 448 | 434 | 547 | 64 | 59 | 67 | 52 | 100 |
45–49 | 606 | 547 | 461 | 396 | 427 | 62 | 51 | 55 | 46 | 55 |
50–54 | 670 | 532 | 500 | 435 | 465 | 38 | 44 | 38 | 32 | 42 |
55–59 | 436 | 430 | 459 | 404 | 435 | 24 | 27 | 33 | 24 | 21 |
60–64 | 243 | 248 | 237 | 202 | 264 | 17 | 6 | 14 | 10 | 19 |
≥ 65 | 181 | 213 | 185 | 181 | 180 | 11 | 7 | 10 | 4 | 11 |
Region of residencea | ||||||||||
Northeast | 825 | 745 | 687 | 560 | 668 | 79 | 80 | 65 | 72 | 82 |
Midwest | 1,202 | 1,082 | 959 | 923 | 1,081 | 107 | 136 | 150 | 100 | 142 |
South | 2,795 | 2,741 | 2,605 | 2,201 | 2,620 | 319 | 302 | 309 | 225 | 284 |
West | 1,632 | 1,545 | 1,459 | 1,318 | 1,389 | 217 | 217 | 220 | 174 | 207 |
U.S. dependent areas | 3 | 6 | 4 | 1 | 5 | 0 | 0 | 0 | 0 | 0 |
Total | 6,457 | 6,119 | 5,714 | 5,002 | 5,762 | 721 | 734 | 742 | 570 | 714 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 64 | 48 | 51 | 44 | 54 | 3 | 2 | 2 | 0 | 0 |
20–24 | 245 | 221 | 189 | 138 | 149 | 13 | 12 | 6 | 9 | 6 |
25–29 | 272 | 218 | 218 | 168 | 145 | 15 | 30 | 22 | 13 | 14 |
30–34 | 162 | 138 | 136 | 102 | 125 | 14 | 14 | 27 | 6 | 16 |
35–39 | 94 | 95 | 83 | 74 | 65 | 14 | 13 | 8 | 7 | 8 |
40–44 | 59 | 55 | 58 | 51 | 46 | 5 | 2 | 11 | 8 | 1 |
45–49 | 59 | 47 | 40 | 43 | 31 | 5 | 5 | 1 | 5 | 4 |
50–54 | 59 | 36 | 20 | 31 | 32 | 6 | 4 | 2 | 2 | 1 |
55–59 | 24 | 18 | 39 | 16 | 23 | 4 | 0 | 1 | 0 | 2 |
60–64 | 13 | 12 | 11 | 8 | 6 | 0 | 0 | 1 | 1 | 0 |
≥ 65 | 7 | 11 | 8 | 11 | 13 | 0 | 1 | 1 | 0 | 1 |
Region of residencea | ||||||||||
Northeast | 177 | 151 | 150 | 108 | 111 | 12 | 11 | 8 | 5 | 6 |
Midwest | 167 | 124 | 101 | 100 | 103 | 11 | 16 | 14 | 11 | 16 |
South | 504 | 452 | 436 | 354 | 360 | 40 | 30 | 43 | 23 | 20 |
West | 209 | 172 | 164 | 124 | 115 | 17 | 28 | 16 | 12 | 12 |
U.S. dependent areas | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1,058 | 898 | 852 | 685 | 688 | 79 | 84 | 81 | 51 | 54 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 10 | 8 | 10 | 4 | 5 | 0 | 1 | 0 | 0 | 1 |
15–19 | 1,452 | 1,392 | 1,368 | 1,057 | 1,195 | 39 | 37 | 34 | 23 | 20 |
20–24 | 5,286 | 4,983 | 4,852 | 3,980 | 4,515 | 224 | 215 | 206 | 148 | 137 |
25–29 | 5,910 | 5,840 | 5,590 | 4,658 | 5,201 | 376 | 433 | 387 | 297 | 268 |
30–34 | 3,877 | 3,846 | 3,878 | 3,721 | 4,529 | 279 | 283 | 320 | 240 | 334 |
35–39 | 2,619 | 2,503 | 2,493 | 2,086 | 2,719 | 208 | 218 | 232 | 183 | 218 |
40–44 | 1,682 | 1,661 | 1,615 | 1,466 | 1,757 | 116 | 109 | 138 | 102 | 159 |
45–49 | 1,622 | 1,529 | 1,354 | 1,103 | 1,246 | 107 | 91 | 100 | 81 | 91 |
50–54 | 1,461 | 1,255 | 1,214 | 1,042 | 1,129 | 85 | 82 | 80 | 53 | 67 |
55–59 | 872 | 878 | 913 | 827 | 925 | 47 | 41 | 55 | 36 | 38 |
60–64 | 454 | 466 | 469 | 403 | 530 | 28 | 19 | 25 | 20 | 28 |
≥ 65 | 343 | 383 | 356 | 313 | 355 | 19 | 15 | 18 | 8 | 16 |
Region of residencea | ||||||||||
Northeast | 3,572 | 3,273 | 3,225 | 2,609 | 3,025 | 175 | 204 | 175 | 142 | 160 |
Midwest | 3,474 | 3,266 | 3,064 | 2,805 | 3,244 | 201 | 243 | 244 | 176 | 225 |
South | 12,660 | 12,389 | 12,199 | 10,288 | 12,286 | 661 | 598 | 691 | 480 | 555 |
West | 5,639 | 5,536 | 5,382 | 4,758 | 5,300 | 480 | 487 | 472 | 387 | 434 |
U.S. dependent areas | 242 | 278 | 240 | 200 | 252 | 12 | 11 | 13 | 5 | 2 |
Total | 25,587 | 24,742 | 24,110 | 20,660 | 24,107 | 1,529 | 1,542 | 1,594 | 1,190 | 1,375 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender and additional gender identity persons.
a Data are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
Male sex at birth | Female sex at birth | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
20–24 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | 0 | 1 |
25–29 | 6 | 1 | 0 | 0 | 3 | 2 | 3 | 1 | 5 | 5 |
30–34 | 3 | 3 | 2 | 4 | 1 | 2 | 2 | 2 | 4 | 4 |
35–39 | 0 | 0 | 3 | 1 | 0 | 2 | 4 | 6 | 4 | 2 |
40–44 | 1 | 0 | 3 | 0 | 2 | 2 | 1 | 2 | 1 | 0 |
45–49 | 0 | 1 | 1 | 0 | 2 | 2 | 2 | 1 | 2 | 2 |
50–54 | 3 | 2 | 1 | 2 | 0 | 3 | 2 | 2 | 0 | 3 |
55–59 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
60–64 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
≥ 65 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Midwest | 2 | 3 | 3 | 2 | 3 | 1 | 3 | 5 | 8 | 6 |
South | 2 | 1 | 3 | 4 | 3 | 4 | 6 | 6 | 1 | 1 |
West | 11 | 6 | 8 | 2 | 4 | 9 | 6 | 7 | 8 | 10 |
Total | 17 | 9 | 14 | 9 | 10 | 16 | 15 | 18 | 17 | 17 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25–29 | 1 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 2 |
30–34 | 1 | 3 | 0 | 2 | 2 | 0 | 2 | 2 | 2 | 0 |
35–39 | 1 | 0 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 0 |
40–44 | 3 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 |
45–49 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 |
50–54 | 1 | 1 | 3 | 2 | 2 | 1 | 0 | 0 | 1 | 1 |
55–59 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
60–64 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 |
≥ 65 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 4 | 5 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
Midwest | 0 | 1 | 3 | 2 | 4 | 0 | 0 | 0 | 0 | 1 |
South | 2 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
West | 4 | 1 | 6 | 8 | 6 | 3 | 2 | 3 | 2 | 2 |
Total | 10 | 11 | 14 | 13 | 14 | 5 | 5 | 6 | 5 | 6 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 5 | 4 | 3 | 2 | 2 | 12 | 9 | 7 | 8 | 5 |
20–24 | 19 | 22 | 20 | 18 | 25 | 35 | 23 | 32 | 18 | 24 |
25–29 | 34 | 45 | 50 | 33 | 33 | 36 | 30 | 45 | 37 | 36 |
30–34 | 49 | 43 | 58 | 42 | 50 | 39 | 42 | 42 | 36 | 38 |
35–39 | 44 | 53 | 42 | 33 | 48 | 39 | 36 | 42 | 31 | 37 |
40–44 | 30 | 35 | 39 | 28 | 43 | 42 | 29 | 39 | 20 | 33 |
45–49 | 42 | 41 | 31 | 30 | 30 | 41 | 32 | 37 | 29 | 29 |
50–54 | 42 | 49 | 37 | 29 | 33 | 40 | 40 | 34 | 25 | 29 |
55–59 | 55 | 50 | 39 | 37 | 43 | 33 | 38 | 33 | 30 | 31 |
60–64 | 32 | 36 | 41 | 23 | 34 | 25 | 24 | 27 | 18 | 19 |
≥ 65 | 33 | 35 | 32 | 28 | 31 | 19 | 16 | 20 | 10 | 19 |
Region of residencea | ||||||||||
Northeast | 120 | 118 | 107 | 85 | 94 | 95 | 76 | 97 | 52 | 68 |
Midwest | 61 | 57 | 52 | 43 | 47 | 60 | 48 | 50 | 43 | 53 |
South | 173 | 195 | 190 | 149 | 191 | 172 | 158 | 171 | 132 | 147 |
West | 30 | 43 | 41 | 24 | 39 | 35 | 35 | 40 | 34 | 32 |
Total | 385 | 413 | 389 | 301 | 371 | 361 | 318 | 358 | 260 | 300 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
15–19 | 4 | 3 | 1 | 2 | 1 | 5 | 2 | 6 | 3 | 3 |
20–24 | 22 | 24 | 17 | 14 | 21 | 20 | 24 | 19 | 11 | 12 |
25–29 | 40 | 30 | 46 | 39 | 38 | 21 | 21 | 23 | 19 | 25 |
30–34 | 59 | 64 | 46 | 34 | 60 | 35 | 27 | 22 | 30 | 26 |
35–39 | 45 | 49 | 48 | 39 | 46 | 24 | 29 | 34 | 26 | 26 |
40–44 | 42 | 35 | 35 | 40 | 33 | 18 | 16 | 13 | 14 | 18 |
45–49 | 38 | 35 | 23 | 26 | 30 | 15 | 20 | 17 | 11 | 13 |
50–54 | 40 | 38 | 28 | 24 | 26 | 13 | 15 | 18 | 9 | 14 |
55–59 | 23 | 26 | 25 | 14 | 20 | 9 | 10 | 10 | 10 | 12 |
60–64 | 12 | 15 | 13 | 14 | 12 | 7 | 9 | 7 | 9 | 6 |
≥ 65 | 12 | 8 | 13 | 13 | 11 | 4 | 5 | 5 | 4 | 6 |
Region of residencea | ||||||||||
Northeast | 115 | 103 | 89 | 69 | 69 | 50 | 57 | 47 | 38 | 38 |
Midwest | 16 | 14 | 11 | 14 | 26 | 10 | 10 | 14 | 7 | 7 |
South | 95 | 96 | 82 | 77 | 86 | 53 | 52 | 53 | 38 | 50 |
West | 112 | 114 | 112 | 99 | 119 | 58 | 58 | 60 | 62 | 65 |
Total | 338 | 327 | 294 | 260 | 299 | 171 | 177 | 173 | 146 | 161 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25–29 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30–34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
35–39 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
40–44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45–49 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
50–54 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
55–59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Midwest | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
South | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
West | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
Total | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 3 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 3 | 4 | 0 | 3 | 2 | 10 | 8 | 6 | 2 | 7 |
20–24 | 35 | 34 | 42 | 19 | 28 | 49 | 48 | 44 | 18 | 32 |
25–29 | 82 | 96 | 104 | 80 | 103 | 90 | 85 | 90 | 76 | 81 |
30–34 | 90 | 106 | 112 | 119 | 139 | 100 | 98 | 107 | 86 | 112 |
35–39 | 75 | 109 | 99 | 115 | 139 | 81 | 96 | 98 | 71 | 109 |
40–44 | 46 | 63 | 71 | 66 | 91 | 52 | 73 | 78 | 46 | 59 |
45–49 | 57 | 50 | 69 | 51 | 56 | 39 | 46 | 56 | 39 | 50 |
50–54 | 37 | 50 | 43 | 33 | 54 | 44 | 44 | 41 | 38 | 49 |
55–59 | 37 | 32 | 45 | 34 | 31 | 32 | 28 | 36 | 34 | 27 |
60–64 | 18 | 22 | 16 | 14 | 20 | 10 | 11 | 14 | 16 | 17 |
≥ 65 | 18 | 8 | 9 | 10 | 15 | 6 | 7 | 6 | 8 | 10 |
Region of residencea | ||||||||||
Northeast | 94 | 110 | 93 | 102 | 113 | 90 | 92 | 82 | 56 | 72 |
Midwest | 93 | 117 | 106 | 91 | 122 | 93 | 111 | 100 | 64 | 110 |
South | 195 | 214 | 272 | 247 | 316 | 236 | 228 | 282 | 230 | 277 |
West | 115 | 132 | 138 | 104 | 128 | 93 | 113 | 110 | 85 | 93 |
Total | 497 | 574 | 610 | 543 | 679 | 513 | 543 | 574 | 434 | 553 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 1 | 0 | 2 |
20–24 | 2 | 5 | 4 | 6 | 3 | 6 | 10 | 3 | 2 | 3 |
25–29 | 8 | 5 | 4 | 5 | 5 | 8 | 11 | 11 | 6 | 5 |
30–34 | 6 | 5 | 13 | 10 | 11 | 4 | 7 | 5 | 4 | 5 |
35–39 | 4 | 3 | 3 | 10 | 5 | 6 | 6 | 12 | 4 | 5 |
40–44 | 5 | 4 | 3 | 1 | 7 | 5 | 5 | 7 | 5 | 4 |
45–49 | 7 | 3 | 3 | 4 | 1 | 4 | 8 | 6 | 5 | 3 |
50–54 | 5 | 7 | 5 | 2 | 4 | 4 | 5 | 4 | 1 | 4 |
55–59 | 3 | 4 | 2 | 3 | 4 | 3 | 2 | 2 | 1 | 2 |
60–64 | 3 | 3 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 |
≥ 65 | 2 | 1 | 3 | 0 | 0 | 0 | 2 | 2 | 1 | 0 |
Region of residencea | ||||||||||
Northeast | 13 | 7 | 17 | 5 | 6 | 12 | 11 | 10 | 4 | 5 |
Midwest | 11 | 7 | 8 | 9 | 6 | 6 | 9 | 11 | 7 | 5 |
South | 12 | 16 | 12 | 22 | 20 | 18 | 28 | 25 | 14 | 18 |
West | 8 | 11 | 5 | 8 | 9 | 7 | 13 | 8 | 5 | 6 |
Total | 44 | 41 | 42 | 43 | 41 | 44 | 60 | 54 | 30 | 35 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
15–19 | 13 | 12 | 4 | 7 | 7 | 29 | 21 | 20 | 13 | 17 |
20–24 | 77 | 87 | 84 | 58 | 77 | 112 | 104 | 100 | 50 | 73 |
25–29 | 171 | 177 | 207 | 159 | 183 | 159 | 150 | 170 | 143 | 155 |
30–34 | 208 | 224 | 231 | 211 | 264 | 179 | 178 | 180 | 162 | 185 |
35–39 | 170 | 215 | 198 | 201 | 240 | 153 | 171 | 193 | 136 | 180 |
40–44 | 126 | 139 | 153 | 137 | 178 | 119 | 124 | 139 | 86 | 115 |
45–49 | 146 | 132 | 129 | 113 | 121 | 102 | 107 | 117 | 87 | 97 |
50–54 | 128 | 147 | 117 | 92 | 119 | 105 | 106 | 99 | 73 | 101 |
55–59 | 118 | 113 | 111 | 87 | 98 | 77 | 78 | 82 | 75 | 74 |
60–64 | 67 | 76 | 72 | 54 | 69 | 44 | 47 | 49 | 45 | 43 |
≥ 65 | 65 | 54 | 57 | 52 | 60 | 30 | 30 | 34 | 22 | 35 |
Region of residencea | ||||||||||
Northeast | 346 | 343 | 308 | 263 | 283 | 249 | 238 | 237 | 151 | 185 |
Midwest | 184 | 199 | 184 | 162 | 209 | 170 | 180 | 180 | 129 | 183 |
South | 479 | 527 | 560 | 499 | 617 | 485 | 473 | 538 | 417 | 496 |
West | 282 | 307 | 310 | 245 | 307 | 205 | 226 | 228 | 197 | 211 |
Total | 1,291 | 1,376 | 1,362 | 1,169 | 1,415 | 1,109 | 1,117 | 1,182 | 895 | 1,075 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use include transgender and additional gender identity persons.
aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
Male sex at birth | Female sex at birth | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
20–24 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 2 | 0 | 1 |
25–29 | 6 | 1 | 0 | 0 | 3 | 2 | 3 | 1 | 5 | 5 |
30–34 | 3 | 3 | 2 | 4 | 1 | 2 | 2 | 2 | 4 | 4 |
35–39 | 0 | 0 | 3 | 1 | 0 | 2 | 4 | 6 | 4 | 2 |
40–44 | 1 | 0 | 3 | 0 | 2 | 2 | 1 | 2 | 1 | 0 |
45–49 | 0 | 1 | 1 | 0 | 2 | 2 | 2 | 1 | 2 | 2 |
50–54 | 3 | 2 | 1 | 2 | 0 | 3 | 2 | 2 | 0 | 3 |
55–59 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
60–64 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
≥ 65 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Midwest | 2 | 3 | 3 | 2 | 3 | 1 | 3 | 5 | 8 | 6 |
South | 2 | 1 | 3 | 4 | 3 | 4 | 6 | 6 | 1 | 1 |
West | 11 | 6 | 8 | 2 | 4 | 9 | 6 | 7 | 8 | 10 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 9 | 14 | 9 | 10 | 16 | 15 | 18 | 17 | 17 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25–29 | 1 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 2 |
30–34 | 1 | 3 | 0 | 2 | 2 | 0 | 2 | 2 | 2 | 0 |
35–39 | 1 | 0 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 0 |
40–44 | 3 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 |
45–49 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 |
50–54 | 1 | 1 | 3 | 2 | 2 | 1 | 0 | 0 | 1 | 1 |
55–59 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
60–64 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 |
≥ 65 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 4 | 5 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
Midwest | 0 | 1 | 3 | 2 | 4 | 0 | 0 | 0 | 0 | 1 |
South | 2 | 4 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
West | 4 | 1 | 6 | 8 | 6 | 3 | 2 | 3 | 2 | 2 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 11 | 14 | 13 | 14 | 5 | 5 | 6 | 5 | 6 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 5 | 4 | 3 | 2 | 2 | 12 | 9 | 7 | 8 | 5 |
20–24 | 19 | 22 | 20 | 18 | 25 | 35 | 23 | 32 | 18 | 24 |
25–29 | 34 | 45 | 50 | 33 | 33 | 36 | 30 | 45 | 37 | 36 |
30–34 | 49 | 43 | 58 | 42 | 50 | 39 | 42 | 42 | 36 | 38 |
35–39 | 44 | 53 | 42 | 33 | 48 | 39 | 36 | 42 | 31 | 37 |
40–44 | 30 | 35 | 39 | 28 | 43 | 42 | 29 | 39 | 21 | 33 |
45–49 | 42 | 41 | 31 | 30 | 30 | 41 | 32 | 37 | 29 | 29 |
50–54 | 42 | 49 | 37 | 29 | 33 | 40 | 40 | 34 | 25 | 29 |
55–59 | 55 | 51 | 40 | 37 | 43 | 33 | 38 | 33 | 30 | 31 |
60–64 | 32 | 36 | 42 | 23 | 34 | 25 | 24 | 27 | 18 | 19 |
≥ 65 | 33 | 36 | 32 | 28 | 31 | 19 | 16 | 20 | 10 | 19 |
Region of residencea | ||||||||||
Northeast | 120 | 118 | 107 | 85 | 94 | 95 | 76 | 97 | 52 | 68 |
Midwest | 61 | 57 | 52 | 43 | 47 | 60 | 48 | 50 | 43 | 53 |
South | 173 | 195 | 190 | 149 | 191 | 172 | 158 | 171 | 132 | 147 |
West | 30 | 43 | 41 | 24 | 39 | 35 | 35 | 40 | 34 | 32 |
U.S. dependent areas | 0 | 2 | 3 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Total | 385 | 415 | 391 | 301 | 373 | 362 | 318 | 358 | 261 | 300 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
15–19 | 5 | 3 | 1 | 2 | 1 | 5 | 2 | 6 | 3 | 3 |
20–24 | 23 | 24 | 17 | 14 | 21 | 20 | 25 | 19 | 11 | 12 |
25–29 | 43 | 32 | 46 | 39 | 40 | 21 | 21 | 23 | 19 | 25 |
30–34 | 64 | 67 | 47 | 37 | 61 | 35 | 28 | 22 | 30 | 27 |
35–39 | 46 | 50 | 52 | 42 | 49 | 26 | 29 | 35 | 26 | 26 |
40–44 | 44 | 39 | 39 | 45 | 38 | 18 | 16 | 13 | 15 | 18 |
45–49 | 41 | 38 | 24 | 28 | 32 | 18 | 20 | 19 | 11 | 13 |
50–54 | 48 | 43 | 30 | 26 | 28 | 14 | 15 | 19 | 10 | 14 |
55–59 | 27 | 27 | 26 | 16 | 21 | 10 | 10 | 11 | 10 | 12 |
60–64 | 16 | 17 | 15 | 15 | 15 | 8 | 9 | 7 | 9 | 6 |
≥ 65 | 15 | 10 | 17 | 14 | 13 | 4 | 5 | 5 | 5 | 6 |
Region of residencea | ||||||||||
Northeast | 115 | 103 | 89 | 69 | 69 | 50 | 57 | 47 | 38 | 38 |
Midwest | 16 | 14 | 11 | 14 | 26 | 10 | 10 | 14 | 7 | 7 |
South | 95 | 96 | 82 | 77 | 86 | 53 | 52 | 53 | 38 | 50 |
West | 112 | 114 | 112 | 99 | 119 | 58 | 58 | 60 | 62 | 65 |
U.S. dependent areas | 35 | 23 | 19 | 19 | 19 | 9 | 3 | 5 | 3 | 2 |
Total | 372 | 350 | 313 | 278 | 318 | 179 | 179 | 178 | 149 | 162 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25–29 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30–34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
35–39 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
40–44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45–49 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
50–54 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
55–59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Midwest | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
South | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
West | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 3 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 3 | 4 | 0 | 3 | 2 | 10 | 8 | 6 | 2 | 7 |
20–24 | 35 | 34 | 42 | 19 | 28 | 49 | 48 | 44 | 18 | 32 |
25–29 | 82 | 96 | 104 | 80 | 103 | 90 | 85 | 90 | 76 | 81 |
30–34 | 90 | 106 | 112 | 119 | 139 | 100 | 98 | 107 | 86 | 112 |
35–39 | 75 | 109 | 99 | 115 | 139 | 81 | 96 | 98 | 71 | 109 |
40–44 | 46 | 63 | 71 | 66 | 91 | 52 | 73 | 78 | 46 | 59 |
45–49 | 57 | 50 | 69 | 52 | 57 | 39 | 46 | 56 | 39 | 50 |
50–54 | 37 | 50 | 43 | 33 | 54 | 44 | 44 | 41 | 38 | 49 |
55–59 | 37 | 32 | 45 | 34 | 31 | 32 | 28 | 36 | 34 | 27 |
60–64 | 18 | 22 | 16 | 14 | 20 | 10 | 11 | 14 | 16 | 17 |
≥ 65 | 18 | 8 | 9 | 10 | 15 | 6 | 7 | 6 | 8 | 10 |
Region of residencea | ||||||||||
Northeast | 94 | 110 | 93 | 102 | 113 | 90 | 92 | 82 | 56 | 72 |
Midwest | 93 | 117 | 106 | 91 | 122 | 93 | 111 | 100 | 64 | 110 |
South | 195 | 214 | 272 | 247 | 316 | 236 | 228 | 282 | 230 | 277 |
West | 115 | 132 | 138 | 104 | 128 | 93 | 113 | 110 | 85 | 93 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 497 | 574 | 610 | 543 | 679 | 513 | 543 | 574 | 434 | 553 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 1 | 0 | 2 |
20–24 | 2 | 5 | 4 | 6 | 3 | 6 | 10 | 3 | 2 | 3 |
25–29 | 8 | 5 | 4 | 5 | 5 | 8 | 11 | 11 | 6 | 5 |
30–34 | 6 | 5 | 13 | 10 | 11 | 4 | 7 | 5 | 4 | 5 |
35–39 | 5 | 3 | 3 | 10 | 5 | 6 | 6 | 12 | 4 | 5 |
40–44 | 5 | 4 | 3 | 1 | 7 | 5 | 5 | 7 | 5 | 4 |
45–49 | 7 | 3 | 3 | 4 | 1 | 4 | 8 | 6 | 5 | 3 |
50–54 | 5 | 7 | 5 | 2 | 4 | 4 | 5 | 4 | 1 | 4 |
55–59 | 3 | 4 | 2 | 3 | 4 | 3 | 2 | 2 | 1 | 2 |
60–64 | 3 | 3 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 |
≥ 65 | 2 | 1 | 3 | 0 | 0 | 0 | 2 | 2 | 1 | 0 |
Region of residencea | ||||||||||
Northeast | 13 | 7 | 17 | 5 | 6 | 12 | 11 | 10 | 4 | 5 |
Midwest | 11 | 7 | 8 | 9 | 6 | 6 | 9 | 11 | 7 | 5 |
South | 12 | 16 | 12 | 22 | 20 | 18 | 28 | 25 | 14 | 18 |
West | 8 | 11 | 5 | 8 | 9 | 7 | 13 | 8 | 5 | 6 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 44 | 41 | 42 | 43 | 41 | 44 | 60 | 54 | 30 | 35 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
15–19 | 14 | 12 | 4 | 7 | 7 | 29 | 21 | 20 | 13 | 17 |
20–24 | 78 | 87 | 84 | 58 | 77 | 112 | 105 | 100 | 50 | 73 |
25–29 | 173 | 179 | 207 | 159 | 184 | 159 | 150 | 170 | 143 | 155 |
30–34 | 213 | 227 | 232 | 214 | 264 | 180 | 179 | 180 | 162 | 186 |
35–39 | 171 | 216 | 202 | 203 | 242 | 155 | 171 | 194 | 136 | 180 |
40–44 | 129 | 143 | 157 | 142 | 182 | 119 | 124 | 139 | 87 | 115 |
45–49 | 149 | 135 | 130 | 115 | 123 | 106 | 108 | 119 | 88 | 97 |
50–54 | 137 | 152 | 119 | 93 | 122 | 106 | 106 | 100 | 74 | 102 |
55–59 | 123 | 115 | 113 | 90 | 100 | 78 | 78 | 83 | 76 | 74 |
60–64 | 71 | 78 | 75 | 56 | 72 | 45 | 48 | 50 | 45 | 43 |
≥ 65 | 69 | 56 | 61 | 53 | 61 | 30 | 30 | 34 | 23 | 36 |
Region of residencea | ||||||||||
Northeast | 346 | 343 | 308 | 263 | 283 | 249 | 238 | 237 | 151 | 185 |
Midwest | 184 | 199 | 184 | 162 | 209 | 170 | 180 | 180 | 129 | 183 |
South | 479 | 527 | 560 | 499 | 617 | 485 | 473 | 538 | 417 | 496 |
West | 282 | 307 | 310 | 245 | 307 | 205 | 226 | 228 | 197 | 211 |
U.S. dependent areas | 35 | 25 | 22 | 20 | 20 | 9 | 3 | 5 | 4 | 2 |
Total | 1,325 | 1,401 | 1,385 | 1,189 | 1,436 | 1,118 | 1,120 | 1,188 | 898 | 1,076 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use include transgender and additional gender identity persons.
aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
Male sex at birth | Female sex at birth | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) |
2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) |
2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
20–24 | 0 | 1 | 2 | 0 | 0 | 3 | 1 | 2 | 0 | 0 |
25–29 | 0 | 1 | 0 | 0 | 4 | 5 | 1 | 2 | 1 | 5 |
30–34 | 2 | 1 | 1 | 0 | 1 | 2 | 1 | 3 | 5 | 5 |
35–39 | 3 | 1 | 1 | 0 | 1 | 4 | 2 | 6 | 6 | 5 |
40–44 | 0 | 0 | 2 | 0 | 1 | 3 | 3 | 5 | 5 | 2 |
45–49 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 3 | 1 | 5 |
50–54 | 0 | 0 | 1 | 2 | 2 | 4 | 2 | 2 | 1 | 6 |
55–59 | 1 | 2 | 1 | 0 | 1 | 1 | 3 | 1 | 2 | 1 |
60–64 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Region of residencea | ||||||||||
Northeast | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
Midwest | 0 | 2 | 2 | 0 | 2 | 3 | 1 | 9 | 4 | 10 |
South | 3 | 3 | 6 | 1 | 3 | 5 | 7 | 5 | 7 | 7 |
West | 4 | 3 | 1 | 1 | 5 | 20 | 7 | 11 | 11 | 12 |
Total | 7 | 8 | 9 | 3 | 11 | 27 | 15 | 25 | 23 | 29 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 1 | 1 | 1 |
20–24 | 2 | 5 | 0 | 1 | 3 | 5 | 7 | 6 | 2 | 8 |
25–29 | 3 | 2 | 3 | 1 | 4 | 17 | 15 | 10 | 12 | 9 |
30–34 | 4 | 7 | 2 | 2 | 2 | 8 | 16 | 16 | 13 | 11 |
35–39 | 10 | 7 | 2 | 4 | 7 | 23 | 10 | 16 | 14 | 12 |
40–44 | 3 | 10 | 5 | 3 | 6 | 11 | 13 | 7 | 3 | 18 |
45–49 | 5 | 6 | 4 | 3 | 3 | 12 | 8 | 15 | 8 | 3 |
50–54 | 2 | 6 | 6 | 4 | 6 | 12 | 8 | 4 | 8 | 11 |
55–59 | 2 | 3 | 3 | 4 | 4 | 8 | 8 | 8 | 6 | 3 |
60–64 | 4 | 5 | 3 | 2 | 3 | 6 | 5 | 7 | 7 | 5 |
≥ 65 | 3 | 6 | 3 | 6 | 4 | 4 | 7 | 3 | 3 | 6 |
Region of residencea | ||||||||||
Northeast | 8 | 13 | 13 | 4 | 12 | 15 | 26 | 13 | 11 | 14 |
Midwest | 6 | 2 | 1 | 3 | 3 | 19 | 5 | 11 | 10 | 11 |
South | 11 | 22 | 11 | 13 | 18 | 30 | 27 | 29 | 21 | 32 |
West | 13 | 18 | 7 | 9 | 7 | 45 | 38 | 38 | 35 | 28 |
Total | 38 | 55 | 32 | 29 | 40 | 108 | 96 | 92 | 77 | 85 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 | 3 | 5 |
15–19 | 23 | 32 | 26 | 18 | 18 | 137 | 131 | 95 | 75 | 97 |
20–24 | 123 | 108 | 112 | 85 | 95 | 401 | 391 | 375 | 281 | 333 |
25–29 | 197 | 225 | 170 | 151 | 167 | 516 | 473 | 440 | 364 | 413 |
30–34 | 197 | 229 | 184 | 156 | 201 | 533 | 461 | 458 | 390 | 451 |
35–39 | 219 | 207 | 180 | 142 | 185 | 469 | 452 | 424 | 317 | 428 |
40–44 | 185 | 165 | 164 | 139 | 162 | 405 | 424 | 374 | 278 | 366 |
45–49 | 187 | 169 | 193 | 120 | 138 | 393 | 360 | 328 | 268 | 323 |
50–54 | 199 | 196 | 169 | 110 | 135 | 345 | 325 | 318 | 215 | 267 |
55–59 | 187 | 159 | 158 | 126 | 144 | 293 | 300 | 272 | 196 | 254 |
60–64 | 124 | 100 | 131 | 88 | 123 | 196 | 172 | 190 | 137 | 154 |
≥ 65 | 112 | 106 | 119 | 88 | 102 | 165 | 129 | 155 | 88 | 118 |
Region of residencea | ||||||||||
Northeast | 310 | 251 | 243 | 185 | 249 | 633 | 555 | 521 | 391 | 486 |
Midwest | 191 | 202 | 187 | 135 | 141 | 499 | 478 | 475 | 362 | 409 |
South | 1,186 | 1,164 | 1,108 | 852 | 1,012 | 2,485 | 2,317 | 2,187 | 1,666 | 2,085 |
West | 65 | 79 | 68 | 52 | 68 | 237 | 271 | 250 | 193 | 228 |
Total | 1,752 | 1,695 | 1,606 | 1,225 | 1,470 | 3,853 | 3,621 | 3,433 | 2,612 | 3,207 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 1 | 1 | 5 | 4 | 0 | 1 |
15–19 | 8 | 6 | 10 | 2 | 4 | 38 | 32 | 33 | 30 | 36 |
20–24 | 27 | 29 | 25 | 30 | 30 | 114 | 94 | 112 | 97 | 95 |
25–29 | 68 | 58 | 75 | 49 | 61 | 141 | 131 | 142 | 98 | 137 |
30–34 | 74 | 91 | 65 | 44 | 64 | 128 | 129 | 147 | 100 | 131 |
35–39 | 78 | 83 | 72 | 63 | 74 | 127 | 143 | 113 | 109 | 145 |
40–44 | 80 | 70 | 70 | 41 | 73 | 104 | 106 | 113 | 91 | 119 |
45–49 | 54 | 75 | 57 | 38 | 49 | 119 | 107 | 96 | 70 | 111 |
50–54 | 53 | 59 | 51 | 52 | 54 | 84 | 107 | 89 | 71 | 83 |
55–59 | 37 | 46 | 39 | 27 | 40 | 71 | 68 | 63 | 51 | 71 |
60–64 | 31 | 22 | 33 | 23 | 28 | 40 | 46 | 46 | 33 | 36 |
≥ 65 | 27 | 33 | 21 | 19 | 28 | 38 | 44 | 39 | 22 | 33 |
Region of residencea | ||||||||||
Northeast | 140 | 139 | 106 | 83 | 133 | 262 | 246 | 228 | 195 | 223 |
Midwest | 31 | 33 | 33 | 18 | 27 | 63 | 55 | 70 | 45 | 60 |
South | 272 | 314 | 293 | 221 | 257 | 454 | 469 | 455 | 353 | 468 |
West | 93 | 86 | 83 | 65 | 89 | 226 | 240 | 245 | 178 | 246 |
Total | 536 | 572 | 516 | 387 | 506 | 1,005 | 1,010 | 997 | 771 | 997 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
20–24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
25–29 | 1 | 0 | 1 | 0 | 0 | 2 | 0 | 1 | 2 | 0 |
30–34 | 1 | 1 | 0 | 1 | 0 | 3 | 2 | 1 | 1 | 1 |
35–39 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 1 |
40–44 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
45–49 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
50–54 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
55–59 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
≥ 65 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 |
Midwest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 |
South | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 1 | 4 | 1 |
West | 2 | 0 | 1 | 2 | 1 | 4 | 3 | 2 | 8 | 4 |
Total | 5 | 2 | 1 | 2 | 3 | 7 | 4 | 7 | 12 | 7 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
15–19 | 5 | 3 | 3 | 1 | 3 | 26 | 30 | 31 | 21 | 33 |
20–24 | 15 | 19 | 20 | 15 | 20 | 93 | 89 | 90 | 96 | 78 |
25–29 | 48 | 47 | 50 | 31 | 44 | 110 | 121 | 127 | 115 | 92 |
30–34 | 50 | 58 | 39 | 40 | 41 | 124 | 123 | 123 | 113 | 142 |
35–39 | 45 | 51 | 43 | 37 | 49 | 105 | 111 | 120 | 105 | 128 |
40–44 | 51 | 42 | 46 | 31 | 45 | 83 | 102 | 95 | 89 | 133 |
45–49 | 52 | 54 | 53 | 41 | 35 | 106 | 106 | 105 | 103 | 98 |
50–54 | 63 | 44 | 49 | 38 | 45 | 95 | 92 | 91 | 69 | 90 |
55–59 | 49 | 51 | 45 | 35 | 38 | 93 | 71 | 81 | 77 | 89 |
60–64 | 37 | 38 | 30 | 27 | 27 | 38 | 37 | 47 | 30 | 42 |
≥ 65 | 34 | 31 | 25 | 27 | 32 | 25 | 25 | 22 | 30 | 37 |
Region of residencea | ||||||||||
Northeast | 82 | 79 | 62 | 65 | 63 | 115 | 104 | 107 | 98 | 95 |
Midwest | 49 | 54 | 60 | 52 | 51 | 147 | 160 | 177 | 147 | 189 |
South | 240 | 240 | 214 | 167 | 213 | 485 | 486 | 481 | 421 | 503 |
West | 76 | 65 | 67 | 40 | 53 | 151 | 160 | 167 | 181 | 174 |
Total | 447 | 438 | 404 | 324 | 379 | 898 | 909 | 932 | 847 | 962 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
15–19 | 1 | 1 | 1 | 1 | 1 | 9 | 13 | 12 | 10 | 3 |
20–24 | 5 | 5 | 4 | 4 | 2 | 29 | 26 | 27 | 23 | 18 |
25–29 | 12 | 11 | 8 | 1 | 5 | 24 | 44 | 38 | 29 | 27 |
30–34 | 14 | 14 | 11 | 5 | 7 | 31 | 38 | 25 | 20 | 26 |
35–39 | 13 | 5 | 7 | 4 | 7 | 32 | 30 | 23 | 16 | 27 |
40–44 | 14 | 5 | 10 | 5 | 8 | 15 | 17 | 22 | 11 | 17 |
45–49 | 10 | 8 | 8 | 6 | 6 | 25 | 28 | 22 | 12 | 13 |
50–54 | 6 | 10 | 8 | 5 | 6 | 16 | 14 | 19 | 10 | 14 |
55–59 | 8 | 4 | 8 | 3 | 4 | 15 | 9 | 7 | 9 | 11 |
60–64 | 9 | 3 | 3 | 2 | 3 | 4 | 12 | 8 | 10 | 6 |
≥ 65 | 6 | 4 | 8 | 1 | 3 | 7 | 8 | 7 | 3 | 7 |
Region of residencea | ||||||||||
Northeast | 22 | 24 | 23 | 8 | 11 | 43 | 43 | 41 | 24 | 31 |
Midwest | 12 | 9 | 14 | 5 | 12 | 31 | 34 | 33 | 30 | 21 |
South | 56 | 34 | 34 | 20 | 26 | 106 | 127 | 108 | 86 | 96 |
West | 8 | 3 | 5 | 3 | 2 | 27 | 33 | 29 | 13 | 21 |
Total | 97 | 69 | 76 | 36 | 52 | 207 | 237 | 210 | 153 | 169 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 1 | 6 | 8 | 8 | 3 | 6 |
15–19 | 38 | 44 | 41 | 24 | 27 | 211 | 208 | 174 | 137 | 171 |
20–24 | 171 | 167 | 163 | 136 | 150 | 646 | 607 | 611 | 499 | 532 |
25–29 | 327 | 344 | 307 | 233 | 285 | 815 | 784 | 760 | 620 | 682 |
30–34 | 342 | 401 | 302 | 249 | 316 | 828 | 770 | 773 | 643 | 766 |
35–39 | 368 | 354 | 304 | 251 | 321 | 761 | 749 | 704 | 569 | 745 |
40–44 | 333 | 292 | 296 | 219 | 294 | 621 | 665 | 617 | 477 | 656 |
45–49 | 308 | 312 | 315 | 208 | 231 | 658 | 611 | 569 | 463 | 552 |
50–54 | 323 | 314 | 284 | 210 | 247 | 555 | 548 | 523 | 375 | 472 |
55–59 | 284 | 264 | 254 | 195 | 232 | 480 | 459 | 432 | 343 | 428 |
60–64 | 205 | 168 | 200 | 141 | 185 | 287 | 271 | 297 | 219 | 243 |
≥ 65 | 183 | 179 | 176 | 140 | 170 | 238 | 213 | 227 | 148 | 202 |
Region of residencea | ||||||||||
Northeast | 564 | 506 | 448 | 344 | 469 | 1,068 | 974 | 910 | 721 | 851 |
Midwest | 289 | 301 | 297 | 214 | 237 | 761 | 733 | 778 | 598 | 700 |
South | 1,768 | 1,778 | 1,666 | 1,275 | 1,529 | 3,567 | 3,433 | 3,266 | 2,556 | 3,192 |
West | 261 | 253 | 232 | 173 | 224 | 710 | 751 | 742 | 619 | 713 |
Total | 2,882 | 2,839 | 2,643 | 2,006 | 2,460 | 6,106 | 5,892 | 5,695 | 4,494 | 5,456 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified heterosexual contact include transgender and additional gender identity persons. Includes persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). Excludes men who have ever had sexual contact with both men and women.
aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
Male sex at birth | Female sex at birth | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) |
2021 | 2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) |
2021 | |
No. | No. | No. | No. | No. | No. | No. | No. | No. | No. | |
American Indian/Alaska Native | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
20–24 | 0 | 1 | 2 | 0 | 0 | 3 | 1 | 2 | 0 | 0 |
25–29 | 0 | 1 | 0 | 0 | 4 | 5 | 1 | 2 | 1 | 5 |
30–34 | 2 | 1 | 1 | 0 | 1 | 2 | 1 | 3 | 5 | 5 |
35–39 | 3 | 1 | 1 | 0 | 1 | 4 | 2 | 6 | 6 | 5 |
40–44 | 0 | 0 | 2 | 0 | 1 | 3 | 3 | 5 | 5 | 2 |
45–49 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 3 | 1 | 5 |
50–54 | 0 | 0 | 1 | 2 | 2 | 4 | 2 | 2 | 1 | 6 |
55–59 | 1 | 2 | 1 | 0 | 1 | 1 | 3 | 1 | 2 | 1 |
60–64 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 |
≥ 65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Region of residencea | ||||||||||
Northeast | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
Midwest | 0 | 2 | 2 | 0 | 2 | 3 | 1 | 9 | 4 | 10 |
South | 3 | 3 | 6 | 1 | 3 | 5 | 7 | 5 | 7 | 7 |
West | 4 | 3 | 1 | 1 | 5 | 20 | 7 | 11 | 11 | 12 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 8 | 9 | 3 | 11 | 27 | 15 | 25 | 23 | 29 |
Asian | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 1 | 1 | 1 |
20–24 | 2 | 5 | 0 | 1 | 3 | 5 | 7 | 6 | 2 | 8 |
25–29 | 3 | 2 | 3 | 1 | 4 | 17 | 15 | 10 | 12 | 9 |
30–34 | 4 | 7 | 2 | 2 | 2 | 8 | 16 | 16 | 13 | 11 |
35–39 | 10 | 7 | 2 | 4 | 7 | 23 | 10 | 16 | 14 | 12 |
40–44 | 3 | 10 | 5 | 3 | 6 | 11 | 13 | 7 | 3 | 18 |
45–49 | 5 | 6 | 4 | 3 | 3 | 12 | 8 | 15 | 8 | 3 |
50–54 | 2 | 6 | 6 | 4 | 6 | 12 | 8 | 4 | 8 | 11 |
55–59 | 2 | 3 | 3 | 4 | 4 | 8 | 8 | 8 | 6 | 3 |
60–64 | 4 | 5 | 3 | 2 | 3 | 6 | 5 | 7 | 7 | 5 |
≥ 65 | 3 | 6 | 3 | 6 | 4 | 4 | 7 | 3 | 3 | 6 |
Region of residencea | ||||||||||
Northeast | 8 | 13 | 13 | 4 | 12 | 15 | 26 | 13 | 11 | 14 |
Midwest | 6 | 2 | 1 | 3 | 3 | 19 | 5 | 11 | 10 | 11 |
South | 11 | 22 | 11 | 13 | 18 | 30 | 27 | 29 | 21 | 32 |
West | 13 | 18 | 7 | 9 | 7 | 45 | 38 | 38 | 35 | 28 |
U.S. dependent areas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 38 | 55 | 32 | 29 | 40 | 108 | 96 | 92 | 77 | 85 |
Black/African American | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 | 3 | 5 |
15–19 | 23 | 32 | 26 | 18 | 18 | 137 | 131 | 95 | 75 | 97 |
20–24 | 123 | 108 | 112 | 85 | 95 | 401 | 391 | 375 | 281 | 333 |
25–29 | 197 | 226 | 170 | 151 | 167 | 516 | 473 | 440 | 364 | 413 |
30–34 | 197 | 229 | 184 | 157 | 201 | 534 | 461 | 458 | 390 | 451 |
35–39 | 219 | 207 | 180 | 142 | 185 | 469 | 452 | 425 | 317 | 428 |
40–44 | 185 | 165 | 164 | 139 | 162 | 405 | 424 | 374 | 278 | 366 |
45–49 | 187 | 170 | 193 | 120 | 138 | 393 | 360 | 328 | 268 | 323 |
50–54 | 199 | 196 | 169 | 110 | 135 | 345 | 325 | 319 | 215 | 268 |
55–59 | 187 | 161 | 158 | 126 | 144 | 294 | 300 | 272 | 197 | 254 |
60–64 | 124 | 100 | 131 | 88 | 124 | 196 | 172 | 191 | 137 | 154 |
≥ 65 | 112 | 107 | 119 | 89 | 102 | 165 | 130 | 155 | 88 | 118 |
Region of residencea | ||||||||||
Northeast | 310 | 251 | 243 | 185 | 249 | 633 | 555 | 521 | 391 | 486 |
Midwest | 191 | 202 | 187 | 135 | 141 | 499 | 478 | 475 | 362 | 409 |
South | 1,186 | 1,164 | 1,108 | 852 | 1,012 | 2,485 | 2,317 | 2,187 | 1,666 | 2,085 |
West | 65 | 79 | 68 | 52 | 68 | 237 | 271 | 250 | 193 | 228 |
U.S. dependent areas | 0 | 5 | 0 | 2 | 0 | 3 | 1 | 3 | 2 | 1 |
Total | 1,753 | 1,700 | 1,607 | 1,226 | 1,470 | 3,856 | 3,622 | 3,436 | 2,613 | 3,208 |
Hispanic/Latinob | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 1 | 1 | 5 | 4 | 0 | 1 |
15–19 | 9 | 7 | 10 | 2 | 7 | 40 | 34 | 33 | 30 | 38 |
20–24 | 35 | 31 | 28 | 32 | 31 | 119 | 102 | 116 | 102 | 104 |
25–29 | 72 | 66 | 77 | 52 | 63 | 152 | 138 | 147 | 102 | 140 |
30–34 | 82 | 99 | 71 | 45 | 69 | 134 | 134 | 156 | 101 | 135 |
35–39 | 88 | 88 | 76 | 67 | 78 | 137 | 147 | 117 | 112 | 158 |
40–44 | 89 | 72 | 77 | 45 | 80 | 111 | 114 | 125 | 96 | 132 |
45–49 | 59 | 79 | 68 | 41 | 59 | 130 | 120 | 105 | 74 | 118 |
50–54 | 59 | 72 | 55 | 57 | 65 | 94 | 118 | 94 | 75 | 93 |
55–59 | 45 | 50 | 49 | 35 | 44 | 82 | 76 | 75 | 58 | 74 |
60–64 | 41 | 27 | 40 | 28 | 33 | 44 | 50 | 51 | 36 | 43 |
≥ 65 | 36 | 42 | 32 | 22 | 40 | 42 | 50 | 48 | 26 | 42 |
Region of residencea | ||||||||||
Northeast | 140 | 139 | 106 | 83 | 133 | 262 | 246 | 228 | 195 | 223 |
Midwest | 31 | 33 | 33 | 18 | 27 | 63 | 55 | 70 | 45 | 60 |
South | 272 | 314 | 293 | 221 | 257 | 454 | 469 | 455 | 353 | 468 |
West | 93 | 86 | 83 | 65 | 89 | 226 | 240 | 245 | 178 | 246 |
U.S. dependent areas | 79 | 61 | 64 | 38 | 63 | 80 | 77 | 74 | 41 | 80 |
Total | 615 | 633 | 580 | 426 | 569 | 1,085 | 1,088 | 1,071 | 812 | 1,077 |
Native Hawaiian/other Pacific Islander | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
20–24 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
25–29 | 1 | 0 | 1 | 0 | 0 | 2 | 0 | 1 | 2 | 0 |
30–34 | 1 | 1 | 0 | 1 | 0 | 3 | 2 | 1 | 1 | 1 |
35–39 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 2 | 1 | 1 |
40–44 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
45–49 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
50–54 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
55–59 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
60–64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
≥ 65 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Region of residencea | ||||||||||
Northeast | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 |
Midwest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 |
South | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 1 | 4 | 1 |
West | 2 | 0 | 1 | 2 | 1 | 4 | 3 | 2 | 8 | 4 |
U.S. dependent areas | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Total | 6 | 2 | 1 | 2 | 3 | 7 | 4 | 8 | 12 | 7 |
White | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
15–19 | 5 | 3 | 3 | 1 | 3 | 26 | 30 | 31 | 21 | 33 |
20–24 | 15 | 19 | 20 | 15 | 20 | 93 | 89 | 90 | 96 | 78 |
25–29 | 48 | 47 | 50 | 31 | 44 | 110 | 121 | 127 | 115 | 92 |
30–34 | 50 | 58 | 39 | 40 | 41 | 124 | 123 | 123 | 113 | 142 |
35–39 | 45 | 51 | 43 | 37 | 49 | 105 | 111 | 120 | 105 | 128 |
40–44 | 51 | 42 | 46 | 31 | 45 | 83 | 102 | 95 | 89 | 133 |
45–49 | 52 | 55 | 54 | 41 | 35 | 106 | 106 | 105 | 103 | 98 |
50–54 | 63 | 44 | 49 | 38 | 45 | 96 | 92 | 91 | 69 | 90 |
55–59 | 49 | 51 | 45 | 35 | 38 | 93 | 71 | 81 | 77 | 89 |
60–64 | 37 | 38 | 30 | 27 | 27 | 38 | 37 | 47 | 30 | 42 |
≥ 65 | 34 | 31 | 25 | 27 | 32 | 25 | 25 | 22 | 30 | 37 |
Region of residencea | ||||||||||
Northeast | 82 | 79 | 62 | 65 | 63 | 115 | 104 | 107 | 98 | 95 |
Midwest | 49 | 54 | 60 | 52 | 51 | 147 | 160 | 177 | 147 | 189 |
South | 240 | 240 | 214 | 167 | 213 | 485 | 486 | 481 | 421 | 503 |
West | 76 | 65 | 67 | 40 | 53 | 151 | 160 | 167 | 181 | 174 |
U.S. dependent areas | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Total | 447 | 438 | 405 | 324 | 379 | 899 | 909 | 932 | 847 | 962 |
Multiracial | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
15–19 | 1 | 1 | 1 | 1 | 1 | 9 | 13 | 12 | 10 | 3 |
20–24 | 5 | 5 | 4 | 4 | 2 | 29 | 26 | 27 | 23 | 18 |
25–29 | 12 | 11 | 8 | 1 | 5 | 24 | 44 | 38 | 29 | 27 |
30–34 | 14 | 14 | 11 | 5 | 7 | 31 | 38 | 25 | 20 | 26 |
35–39 | 13 | 6 | 7 | 4 | 7 | 32 | 30 | 23 | 16 | 27 |
40–44 | 14 | 5 | 10 | 5 | 8 | 15 | 17 | 22 | 11 | 17 |
45–49 | 10 | 8 | 8 | 6 | 6 | 25 | 28 | 22 | 12 | 13 |
50–54 | 6 | 10 | 8 | 5 | 6 | 16 | 14 | 19 | 10 | 14 |
55–59 | 8 | 4 | 8 | 3 | 4 | 15 | 9 | 7 | 9 | 11 |
60–64 | 9 | 3 | 3 | 2 | 3 | 4 | 12 | 8 | 10 | 6 |
≥ 65 | 6 | 4 | 8 | 1 | 3 | 7 | 8 | 7 | 3 | 7 |
Region of residencea | ||||||||||
Northeast | 22 | 24 | 23 | 8 | 11 | 43 | 43 | 41 | 24 | 31 |
Midwest | 12 | 9 | 14 | 5 | 12 | 31 | 34 | 33 | 30 | 21 |
South | 56 | 34 | 34 | 20 | 26 | 106 | 127 | 108 | 86 | 96 |
West | 8 | 3 | 5 | 3 | 2 | 27 | 33 | 29 | 13 | 21 |
U.S. dependent areas | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Total | 97 | 70 | 76 | 36 | 52 | 208 | 237 | 210 | 153 | 169 |
Total | ||||||||||
Age at diagnosis (yr) | ||||||||||
13–14 | 0 | 0 | 0 | 0 | 1 | 6 | 8 | 8 | 3 | 6 |
15–19 | 39 | 45 | 41 | 24 | 30 | 214 | 210 | 174 | 137 | 173 |
20–24 | 180 | 169 | 166 | 138 | 151 | 651 | 615 | 616 | 504 | 541 |
25–29 | 331 | 353 | 309 | 236 | 288 | 826 | 791 | 765 | 624 | 685 |
30–34 | 351 | 409 | 308 | 251 | 321 | 834 | 775 | 782 | 644 | 770 |
35–39 | 378 | 360 | 308 | 255 | 326 | 771 | 753 | 709 | 572 | 758 |
40–44 | 342 | 295 | 303 | 222 | 301 | 628 | 673 | 629 | 482 | 669 |
45–49 | 313 | 317 | 327 | 211 | 241 | 670 | 625 | 578 | 467 | 559 |
50–54 | 329 | 328 | 289 | 215 | 258 | 566 | 559 | 529 | 379 | 482 |
55–59 | 292 | 270 | 264 | 203 | 236 | 492 | 467 | 444 | 350 | 431 |
60–64 | 215 | 173 | 207 | 147 | 190 | 291 | 276 | 303 | 222 | 250 |
≥ 65 | 192 | 188 | 187 | 144 | 181 | 242 | 220 | 236 | 152 | 211 |
Region of residencea | ||||||||||
Northeast | 564 | 506 | 448 | 344 | 469 | 1,068 | 974 | 910 | 721 | 851 |
Midwest | 289 | 301 | 297 | 214 | 237 | 761 | 733 | 778 | 598 | 700 |
South | 1,768 | 1,778 | 1,666 | 1,275 | 1,529 | 3,567 | 3,433 | 3,266 | 2,556 | 3,192 |
West | 261 | 253 | 232 | 173 | 224 | 710 | 751 | 742 | 619 | 713 |
U.S. dependent areas | 81 | 68 | 66 | 40 | 63 | 84 | 78 | 78 | 42 | 80 |
Total | 2,962 | 2,906 | 2,709 | 2,046 | 2,523 | 6,190 | 5,970 | 5,773 | 4,536 | 5,536 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified heterosexual contact include transgender and additional gender identity persons. Includes persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). Excludes men who have ever had sexual contact with both men and women.
aData are based on residence at time of diagnosis of HIV infection.
bHispanic/Latino persons can be of any race.
13–14 years | 15–17 years | 18–19 years | 20–22 years | 23–24 years | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Sex at birth | ||||||||||||
Male | 8 | 0.2 | 260 | 3.9 | 990 | 22.6 | 2,788 | 42.1 | 2,052 | 47.1 | 6,098 | 23.0 |
Female | 7 | 0.2 | 63 | 1.0 | 139 | 3.3 | 349 | 5.5 | 271 | 6.5 | 829 | 3.3 |
Race/Ethnicity | ||||||||||||
American Indian/Alaska Native | 0 | 0.0 | 2 | 1.8 | 10 | 14.1 | 14 | 12.8 | 7 | 9.8 | 33 | 7.6 |
Asian | 0 | 0.0 | 2 | 0.3 | 21 | 4.6 | 43 | 6.0 | 51 | 10.1 | 117 | 4.2 |
Black/African American | 8 | 0.7 | 194 | 11.0 | 631 | 54.1 | 1,720 | 94.6 | 1,144 | 95.0 | 3,697 | 51.5 |
Hispanic/Latinob | 6 | 0.3 | 81 | 2.5 | 287 | 13.8 | 783 | 25.8 | 697 | 36.1 | 1,854 | 14.7 |
Native Hawaiian/Other Pacific Islander | 0 | 0.0 | 2 | 7.6 | 4 | 23.5 | 3 | 11.8 | 2 | 11.6 | 11 | 10.6 |
White | 1 | 0.0 | 28 | 0.4 | 128 | 2.9 | 468 | 6.8 | 346 | 7.6 | 971 | 3.6 |
Multiracial | 0 | 0.0 | 14 | 2.7 | 48 | 15.6 | 106 | 24.1 | 76 | 28.0 | 244 | 12.8 |
Transmission categoryc | ||||||||||||
Male sex at birthd | ||||||||||||
Male-to-male sexual contacte | 5 | — | 246 | — | 947 | — | 2,599 | — | 1,874 | — | 5,671 | — |
Injection drug usef | 0 | — | 1 | — | 5 | — | 36 | — | 41 | — | 84 | — |
Male-to-male sexual contacte and injection drug usef | 1 | — | 3 | — | 16 | — | 67 | — | 70 | — | 156 | — |
Heterosexual contactg | 1 | — | 6 | — | 21 | — | 84 | — | 66 | — | 178 | — |
Perinatalh | 1 | — | 3 | — | 1 | — | 2 | — | 1 | — | 8 | — |
Otheri | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — |
Subtotal | 8 | 0.2 | 260 | 3.9 | 990 | 22.6 | 2,788 | 42.1 | 2,052 | 47.1 | 6,098 | 23.0 |
Female sex at birthd | ||||||||||||
Injection drug usef | 1 | — | 4 | — | 13 | — | 36 | — | 37 | — | 91 | — |
Heterosexual contactg | 6 | — | 51 | — | 121 | — | 304 | — | 229 | — | 710 | — |
Perinatalh | 0 | — | 8 | — | 5 | — | 10 | — | 5 | — | 28 | — |
Otheri | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — |
Subtotal | 7 | 0.2 | 63 | 1.0 | 139 | 3.3 | 349 | 5.5 | 271 | 6.5 | 829 | 3.3 |
Region of residencej | ||||||||||||
Northeast | 2 | 0.1 | 54 | 2.6 | 120 | 8.1 | 378 | 17.3 | 322 | 23.0 | 876 | 10.2 |
Midwest | 5 | 0.3 | 45 | 1.6 | 156 | 8.7 | 475 | 17.1 | 304 | 17.1 | 985 | 9.0 |
South | 5 | 0.1 | 163 | 3.2 | 675 | 20.6 | 1,793 | 36.0 | 1,275 | 38.9 | 3,911 | 19.5 |
West | 3 | 0.1 | 61 | 2.0 | 178 | 8.9 | 491 | 16.2 | 422 | 20.2 | 1,155 | 9.3 |
Total | 15 | 0.2 | 323 | 2.5 | 1,129 | 13.2 | 3,137 | 24.2 | 2,323 | 27.2 | 6,927 | 13.3 |
Note: Numbers less than 12 should be interpreted with caution.
a Hispanic/Latino persons can be of any race.
b Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
c Data include transgender and additional gender identity persons.
d Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
e Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
f Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
g Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
h Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
i Data are based on residence at time of diagnosis of HIV infection.
13–14 years | 15–17 years | 18–19 years | 20–22 years | 23–24 years | Total | |
---|---|---|---|---|---|---|
No. | No. | No. | No. | No. | No. | |
Sex at birth | ||||||
Male | 8 | 260 | 996 | 2,814 | 2,069 | 6,147 |
Female | 7 | 64 | 140 | 353 | 276 | 840 |
Race/Ethnicity | ||||||
American Indian/Alaska Native | 0 | 2 | 10 | 14 | 7 | 33 |
Asian | 0 | 2 | 21 | 43 | 51 | 117 |
Black/African American | 8 | 194 | 631 | 1,721 | 1,144 | 3,698 |
Hispanic/Latinoa | 6 | 82 | 294 | 812 | 719 | 1,913 |
Native Hawaiian/Other Pacific Islander | 0 | 2 | 4 | 3 | 2 | 11 |
White | 1 | 28 | 128 | 468 | 346 | 971 |
Multiracial | 0 | 14 | 48 | 106 | 76 | 244 |
Transmission categoryb | ||||||
Male sex at birthc | ||||||
Male-to-male sexual contactd | 5 | 246 | 949 | 2,625 | 1,890 | 5,715 |
Injection drug usee | 0 | 1 | 5 | 36 | 41 | 84 |
Male-to-male sexual contactd and injection drug usee | 1 | 3 | 17 | 67 | 70 | 157 |
Heterosexual contactf | 1 | 6 | 24 | 84 | 67 | 182 |
Perinatalg | 1 | 3 | 1 | 2 | 1 | 8 |
Otherh | 0 | 0 | 0 | 0 | 0 | 0 |
Subtotal | 8 | 260 | 996 | 2,814 | 2,069 | 6,147 |
Female sex at birthc | ||||||
Injection drug usee | 1 | 4 | 13 | 36 | 37 | 91 |
Heterosexual contactf | 6 | 52 | 122 | 308 | 234 | 721 |
Perinatalg | 0 | 8 | 5 | 10 | 5 | 28 |
Otherh | 0 | 0 | 0 | 0 | 0 | 0 |
Subtotal | 7 | 64 | 140 | 353 | 276 | 840 |
Region of residencei | ||||||
Northeast | 2 | 54 | 120 | 378 | 322 | 876 |
Midwest | 5 | 45 | 156 | 475 | 304 | 985 |
South | 5 | 163 | 675 | 1,793 | 1,275 | 3,911 |
West | 3 | 61 | 178 | 491 | 422 | 1,155 |
U.S. dependent areas | 0 | 1 | 7 | 30 | 22 | 60 |
Total | 15 | 324 | 1,136 | 3,167 | 2,345 | 6,987 |
Note: Numbers less than 12 should be interpreted with caution.
a Hispanic/Latino persons can be of any race.
b Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
c Data include transgender and additional gender identity persons.
d Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
e Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
f Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
g Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
h Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
i Data are based on residence at time of diagnosis of HIV infection.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
American Indian/Alaska Native | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 1 | 0.2 | 0 | 0.0 |
Asian | 8 | 0.3 | 6 | 0.2 | 6 | 0.2 | 2 | 0.1 | 2 | 0.1 |
Black/African American | 56 | 0.8 | 49 | 0.7 | 31 | 0.4 | 35 | 0.5 | 33 | 0.5 |
Hispanic/Latinob | 15 | 0.1 | 10 | 0.1 | 7 | 0.1 | 9 | 0.1 | 11 | 0.1 |
Native Hawaiian/other Pacific Islander | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 0 | 0.0 |
White | 15 | 0.1 | 15 | 0.1 | 7 | 0.0 | 12 | 0.0 | 5 | 0.0 |
Multiracial | 10 | 0.4 | 6 | 0.2 | 5 | 0.2 | 0 | 0.0 | 2 | 0.1 |
Total | 105 | 0.2 | 86 | 0.2 | 57 | 0.1 | 60 | 0.1 | 53 | 0.1 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population.
b Hispanic/Latino persons can be of any race.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
American Indian/Alaska Native | 0 | 0 | 1 | 1 | 0 |
Asian | 8 | 6 | 6 | 2 | 2 |
Black/African American | 56 | 49 | 31 | 35 | 33 |
Hispanic/Latinoa | 15 | 10 | 7 | 9 | 11 |
Native Hawaiian/other Pacific Islander | 1 | 0 | 0 | 1 | 0 |
White | 15 | 15 | 7 | 12 | 5 |
Multiracial | 10 | 6 | 5 | 0 | 2 |
Total | 105 | 86 | 57 | 60 | 53 |
Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a Hispanic/Latino persons can be of any race.
Caribbeana | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States | South Americab | Central Americac | Mexico | Puerto Rico | Cuba | Other | Total | |||||||||
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No.d | % | |
Transmission categorye | ||||||||||||||||
Male sex at birthf | ||||||||||||||||
Male-to-male sexual contactg | 2,472 | 85.4 | 646 | 92.2 | 442 | 90.1 | 827 | 86.8 | 325 | 77.7 | 302 | 90.6 | 117.0 | 72.9 | 8,000 | 86.8 |
Injection drug useh | 105 | 3.6 | 8 | 1.1 | 8 | 1.6 | 24 | 2.5 | 26 | 6.1 | 2 | 0.5 | 5.0 | 3.3 | 318 | 3.4 |
Male-to-male sexual contactg and injection drug useh |
159 | 5.5 | 7 | 1 | 6 | 1.1 | 25 | 2.6 | 7 | 1.6 | 2 | 0.5 | 3.0 | 2.0 | 327 | 3.5 |
Heterosexual contacti | 157 | 5.4 | 39 | 5.6 | 33 | 6.7 | 77 | 8.0 | 61 | 14.5 | 28 | 8.4 | 35.0 | 21.7 | 569 | 6.2 |
Perinatalj | 0 | 0.0 | 1 | 0.2 | 2 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 3 | 0.0 |
Otherk | 1 | 0.0 | 0 | 0.0 | 0 | 0 | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0.0 | 0.1 | 4 | 0.0 |
Subtotal | 2,894 | 100 | 701 | 100 | 491 | 100 | 953 | 100 | 418 | 100 | 333 | 100 | 161 | 100 | 9,222 | 100 |
Female sex at birthf | ||||||||||||||||
Injection drug useh | 71 | 18.3 | 3 | 4 | 5 | 4.3 | 6 | 9.1 | 6 | 6.0 | 1 | 1.1 | 5.0 | 6.8 | 162 | 13.0 |
Heterosexual contacti | 315 | 81.5 | 69 | 94.7 | 99 | 92.9 | 62 | 90.3 | 93 | 94.0 | 46 | 98.5 | 64.0 | 93.0 | 1,077 | 86.5 |
Perinatalj | 1 | 0.2 | 1 | 1.4 | 3 | 2.7 | 0 | 0.6 | 0 | 0.0 | 0 | 0.4 | 0.0 | 0.1 | 6 | 0.5 |
Otherk | 0 | 0.0 | 0 | 0 | 0 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
Subtotal | 387 | 100 | 73 | 100 | 107 | 100 | 69 | 100 | 99 | 100 | 47 | 100 | 69 | 100 | 1,245 | 100 |
Total | 3,281 | 100 | 774 | 100 | 598 | 100 | 1,022 | 100 | 517 | 100 | 380 | 100 | 230 | 100 | 10,467 | 100 |
Note. Numbers less than 12, and percentages based on these numbers, should be interpreted with caution. Hispanic/Latino persons can be of any race.
a Countries include Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Montserrat, Puerto Rico, Saint Barthelemy, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Turks and Caicos Islands, Virgin Islands (British), and Virgin Islands (U.S.).
b Countries include Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, and Venezuela.
c Countries include Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama.
d Total includes persons whose place of birth is not among those listed and persons whose place of birth is unknown.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Data include transgender and additional gender identity persons.
g Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
h Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
i Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
j Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
k Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
Caribbeana | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States | South Americab | Central Americac | Mexico | Puerto Rico | Cuba | Other | Total | |||||||||
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No.d | % | |
Exposure categorye | ||||||||||||||||
Transgender womanf | ||||||||||||||||
Sexual contactg | 74 | 88.1 | 8 | 100 | 23 | 100 | 33 | 97.1 | 6 | 85.7 | 7 | 100 | 5 | 100 | 237 | 91.9 |
Injection drug useh | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.4 |
Sexual contactg and injection drug useh |
8 | 9.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 14.3 | 0 | 0.0 | 0 | 0.0 | 13 | 5.0 |
Otheri | 2 | 2.4 | 0 | 0.0 | 0 | 0.0 | 1 | 2.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 7 | 2.7 |
Subtotal | 84 | 100 | 8 | 100 | 23 | 100 | 34 | 100 | 7 | 100 | 7 | 100 | 5 | 100 | 258 | 100 |
Transgender manf | ||||||||||||||||
Sexual contactg | 9 | 90.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 12 | 85.7 |
Injection drug useh | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sexual contactg and injection drug useh |
0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Otheri | 1 | 10.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 14.3 |
Subtotal | 10 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 14 | 100 |
Additional gender identityj | ||||||||||||||||
Sexual contactg | 7 | 77.8 | 0 | 0.0 | 1 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100 | 11 | 78.6 |
Injection drug useh | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Sexual contactg and injection drug useh |
1 | 11.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 14.3 |
Otheri | 1 | 11.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 7.1 |
Subtotal | 9 | 100 | 0 | 0.0 | 1 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100 | 14 | 100 |
Total | 103 | 100 | 8 | 100 | 24 | 100 | 34 | 100 | 7 | 100 | 7 | 100 | 6 | 100 | 286 | 100 |
Note. Numbers less than 12, and percentages based on these numbers, should be interpreted with caution. Hispanic/Latino persons can be of any race.
a Countries include Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Montserrat, Puerto Rico, Saint Barthelemy, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Turks and Caicos Islands, Virgin Islands (British), and Virgin Islands (U.S.).
b Countries include Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, and Venezuela.
c Countries include Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama.
d Total includes persons whose place of birth is not among those listed and persons whose place of birth is unknown.
e Risk factor data for transgender and additional gender identity persons aged ≥ 13 years are presented using the exposure category classification which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
f “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
g For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
h Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
i Other risk factors, including perinatal, hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
j Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 12,240 | — | 12,102 | — | 12,309 | — | 14,210 | — | 14,663 | — |
Female | 3,989 | — | 3,986 | — | 3,841 | — | 4,630 | — | 4,743 | — |
Transgender woman/girlb | 108 | — | 118 | — | 145 | — | 207 | — | 215 | — |
Transgender man/boyb | 5 | — | 5 | — | 5 | — | 10 | — | 2 | — |
Additional gender identityc | 3 | — | 1 | — | 2 | — | 0 | — | 1 | — |
Age at death (yr) | ||||||||||
< 13 | 2 | 0.0 | 1 | 0.0 | 2 | 0.0 | 5 | 0.0 | 1 | 0.0 |
13–14 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 7 | 0.0 | 9 | 0.0 | 11 | 0.1 | 13 | 0.1 | 4 | 0.0 |
20–24 | 145 | 0.7 | 121 | 0.6 | 123 | 0.6 | 140 | 0.7 | 105 | 0.5 |
25–29 | 445 | 1.9 | 420 | 1.8 | 436 | 1.9 | 461 | 2.0 | 459 | 2.0 |
30–34 | 602 | 2.7 | 614 | 2.8 | 664 | 3.0 | 797 | 3.5 | 901 | 3.9 |
35–39 | 863 | 4.1 | 814 | 3.8 | 858 | 3.9 | 940 | 4.2 | 1,070 | 4.8 |
40–44 | 970 | 5.0 | 960 | 4.9 | 937 | 4.7 | 1,134 | 5.5 | 1,177 | 5.6 |
45–49 | 1,742 | 8.3 | 1,603 | 7.7 | 1,402 | 6.9 | 1,511 | 7.4 | 1,522 | 7.7 |
50–54 | 2,727 | 12.8 | 2,580 | 12.4 | 2,246 | 11.0 | 2,347 | 11.3 | 2,261 | 10.8 |
55–59 | 2,967 | 13.5 | 2,930 | 13.4 | 2,921 | 13.4 | 3,299 | 15.0 | 3,370 | 15.6 |
60–64 | 2,487 | 12.5 | 2,525 | 12.4 | 2,669 | 13.0 | 3,177 | 15.1 | 3,269 | 15.4 |
≥ 65 | 3,388 | 6.7 | 3,635 | 6.9 | 4,032 | 7.5 | 5,233 | 9.6 | 5,485 | 9.8 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 47 | 2.0 | 49 | 2.0 | 57 | 2.4 | 82 | 3.4 | 80 | 3.3 |
Asiand | 88 | 0.5 | 83 | 0.4 | 100 | 0.5 | 103 | 0.5 | 125 | 0.6 |
Black/African American | 7,194 | 17.7 | 6,982 | 17.1 | 7,009 | 17.0 | 8,330 | 20.0 | 8,402 | 20.1 |
Hispanic/Latinoe | 2,693 | 4.6 | 2,838 | 4.8 | 2,771 | 4.6 | 3,452 | 5.6 | 3,499 | 5.6 |
Native Hawaiian/other Pacific Islander | 9 | 1.5 | 13 | 2.2 | 14 | 2.3 | 11 | 1.8 | 14 | 2.2 |
White | 5,235 | 2.6 | 5,150 | 2.6 | 5,256 | 2.7 | 5,756 | 2.9 | 6,025 | 3.1 |
Multiracial | 1,077 | 15.4 | 1,097 | 15.3 | 1,091 | 14.8 | 1,322 | 17.3 | 1,478 | 19.0 |
Transmission categoryf | ||||||||||
Male sex at birth (≥ 13 yrs at death)g | ||||||||||
Male-to-male sexual contacth | 7,010 | — | 6,888 | — | 7,184 | — | 8,237 | — | 8,672 | — |
Injection drug usei | 2,154 | — | 2,169 | — | 2,087 | — | 2,427 | — | 2,335 | — |
Male-to-male sexual contacth and injection drug usei |
1,383 | — | 1,453 | — | 1,395 | — | 1,665 | — | 1,687 | — |
Heterosexual contactj | 1,694 | — | 1,600 | — | 1,688 | — | 1,961 | — | 2,071 | — |
Perinatalk | 41 | — | 51 | — | 41 | — | 57 | — | 54 | — |
Otherl | 67 | — | 58 | — | 59 | — | 67 | — | 60 | — |
Subtotal | 12,350 | 9.3 | 12,220 | 9.1 | 12,454 | 9.2 | 14,415 | 10.5 | 14,879 | 10.8 |
Female sex at birth (≥ 13 yrs at death)g | ||||||||||
Injection drug usei | 1,373 | — | 1,335 | — | 1,316 | — | 1,494 | — | 1,466 | — |
Heterosexual contactj | 2,548 | — | 2,594 | — | 2,470 | — | 3,060 | — | 3,191 | — |
Perinatalk | 43 | — | 37 | — | 37 | — | 45 | — | 52 | — |
Otherl | 29 | — | 26 | — | 24 | — | 38 | — | 36 | — |
Subtotal | 3,993 | 2.9 | 3,991 | 2.8 | 3,846 | 2.7 | 4,637 | 3.3 | 4,744 | 3.3 |
Child (< 13 yrs at death) | ||||||||||
Perinatal | 2 | — | 1 | — | 1 | — | 4 | — | 1 | — |
Otherl | 0 | — | 0 | — | 1 | — | 1 | — | 0 | — |
Subtotal | 2 | 0.0 | 1 | 0.0 | 2 | 0.0 | 5 | 0.0 | 1 | 0.0 |
Region of residencem | ||||||||||
Northeast | 3,693 | 6.6 | 3,523 | 6.3 | 3,653 | 6.5 | 4,524 | 7.9 | 4,324 | 7.6 |
Midwest | 1,915 | 2.8 | 2,003 | 2.9 | 1,961 | 2.9 | 2,316 | 3.4 | 2,284 | 3.3 |
South | 7,997 | 6.5 | 7,880 | 6.3 | 7,917 | 6.3 | 9,078 | 7.2 | 9,540 | 7.5 |
West | 2,740 | 3.5 | 2,806 | 3.6 | 2,771 | 3.5 | 3,139 | 4.0 | 3,476 | 4.4 |
Totaln | 16,345 | 5.0 | 16,212 | 5.0 | 16,302 | 5.0 | 19,057 | 5.7 | 19,624 | 5.9 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanic/Latino persons can be of any race.
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
n Includes persons whose race/ethnicity is unknown.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 12,541 | — | 12,392 | — | 12,585 | — | 14,484 | — | 14,942 | — |
Female | 4,097 | — | 4,062 | — | 3,920 | — | 4,716 | — | 4,825 | — |
Transgender woman/girlb | 110 | — | 119 | — | 147 | — | 208 | — | 216 | — |
Transgender man/boyb | 5 | — | 5 | — | 5 | — | 10 | — | 2 | — |
Additional gender identityc | 3 | — | 1 | — | 2 | — | 0 | — | 1 | — |
Age at death (yr) | ||||||||||
< 13 | 2 | 0.0 | 1 | 0.0 | 2 | 0.0 | 5 | 0.0 | 1 | 0.0 |
13–14 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 7 | 0.0 | 9 | 0.0 | 11 | 0.1 | 13 | 0.1 | 4 | 0.0 |
20–24 | 147 | 0.7 | 125 | 0.6 | 125 | 0.6 | 142 | 0.7 | 106 | 0.5 |
25–29 | 451 | 1.9 | 428 | 1.8 | 442 | 1.9 | 463 | 2.0 | 467 | 2.1 |
30–34 | 617 | 2.8 | 626 | 2.8 | 676 | 3.0 | 803 | 3.5 | 906 | 3.9 |
35–39 | 878 | 4.1 | 833 | 3.8 | 875 | 4.0 | 963 | 4.3 | 1,084 | 4.8 |
40–44 | 1,005 | 5.1 | 989 | 5.0 | 976 | 4.8 | 1,165 | 5.6 | 1,206 | 5.7 |
45–49 | 1,794 | 8.5 | 1,641 | 7.8 | 1,438 | 7.0 | 1,546 | 7.5 | 1,552 | 7.8 |
50–54 | 2,804 | 13.0 | 2,631 | 12.5 | 2,319 | 11.2 | 2,393 | 11.4 | 2,302 | 10.9 |
55–59 | 3,049 | 13.7 | 3,000 | 13.5 | 2,973 | 13.4 | 3,374 | 15.1 | 3,429 | 15.7 |
60–64 | 2,529 | 12.5 | 2,574 | 12.5 | 2,722 | 13.1 | 3,227 | 15.2 | 3,325 | 15.5 |
≥ 65 | 3,473 | 6.7 | 3,722 | 7.0 | 4,099 | 7.5 | 5,324 | 9.6 | 5,604 | 9.9 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 47 | — | 49 | — | 57 | — | 82 | — | 80 | — |
Asiand | 88 | — | 83 | — | 100 | — | 104 | — | 125 | — |
Black/African American | 7,199 | — | 6,982 | — | 7,010 | — | 8,333 | — | 8,405 | — |
Hispanic/Latinoe | 3,098 | — | 3,200 | — | 3,120 | — | 3,807 | — | 3,858 | — |
Native Hawaiian/other Pacific Islander | 9 | — | 16 | — | 16 | — | 11 | — | 14 | — |
White | 5,236 | — | 5,151 | — | 5,258 | — | 5,758 | — | 6,025 | — |
Multiracial | 1,077 | — | 1,098 | — | 1,094 | — | 1,322 | — | 1,478 | — |
Transmission categoryf | ||||||||||
Male sex at birth (≥ 13 yrs at death)g | ||||||||||
Male-to-male sexual contacth | 7,081 | — | 6,967 | — | 7,257 | — | 8,319 | — | 8,730 | — |
Injection drug usei | 2,286 | — | 2,290 | — | 2,209 | — | 2,534 | — | 2,451 | — |
Male-to-male sexual contacth and injection drug usei |
1,408 | — | 1,475 | — | 1,420 | — | 1,695 | — | 1,714 | — |
Heterosexual contactj | 1,768 | — | 1,663 | — | 1,744 | — | 2,015 | — | 2,149 | — |
Perinatalk | 42 | — | 57 | — | 43 | — | 60 | — | 55 | — |
Otherl | 67 | — | 59 | — | 59 | — | 67 | — | 60 | — |
Subtotal | 12,653 | 9.4 | 12,511 | 9.2 | 12,732 | 9.3 | 14,690 | 10.6 | 15,159 | 10.9 |
Female sex at birth (≥ 13 yrs at death)g | ||||||||||
Injection drug usei | 1,409 | — | 1,368 | — | 1,345 | — | 1,521 | — | 1,486 | — |
Heterosexual contactj | 2,620 | — | 2,635 | — | 2,517 | — | 3,119 | — | 3,253 | — |
Perinatalk | 44 | — | 39 | — | 38 | — | 45 | — | 52 | — |
Otherl | 29 | — | 26 | — | 25 | — | 38 | — | 36 | — |
Subtotal | 4,101 | 2.9 | 4,067 | 2.9 | 3,925 | 2.8 | 4,723 | 3.3 | 4,826 | 3.4 |
Child (< 13 yrs at death) | ||||||||||
Perinatal | 2 | — | 1 | — | 1 | — | 4 | — | 1 | — |
Otherl | 0 | — | 0 | — | 1 | — | 1 | — | 0 | — |
Subtotal | 2 | 0.0 | 1 | 0.0 | 2 | 0.0 | 5 | 0.0 | 1 | 0.0 |
Region of residencem | ||||||||||
Northeast | 3,693 | 6.6 | 3,523 | 6.3 | 3,653 | 6.5 | 4,524 | 7.9 | 4,324 | 7.6 |
Midwest | 1,915 | 2.8 | 2,003 | 2.9 | 1,961 | 2.9 | 2,316 | 3.4 | 2,284 | 3.3 |
South | 7,997 | 6.5 | 7,880 | 6.3 | 7,917 | 6.3 | 9,078 | 7.2 | 9,540 | 7.5 |
West | 2,740 | 3.5 | 2,806 | 3.6 | 2,771 | 3.5 | 3,139 | 4.0 | 3,476 | 4.4 |
U.S. dependent areas | 411 | 11.0 | 367 | 10.2 | 357 | 9.9 | 361 | 9.8 | 362 | 9.9 |
Totaln | 16,756 | 5.1 | 16,579 | 5.0 | 16,659 | 5.0 | 19,418 | 5.8 | 19,986 | 6.0 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanic/Latino persons can be of any race.
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
n Includes persons whose race/ethnicity is unknown.
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | |
Gender | ||||||||||||||||
Male | 53 | — | 100 | — | 5,599 | — | 2,720 | — | 14 | — | 5,076 | — | 1,101 | — | 14,663 | — |
Female | 22 | — | 23 | — | 2,703 | — | 720 | — | 0 | — | 923 | — | 351 | — | 4,743 | — |
Transgender woman/girle | 5 | — | 2 | — | 99 | — | 58 | — | 0 | — | 26 | — | 25 | — | 215 | — |
Transgender man/boye | 0 | — | 0 | — | 1 | — | 1 | — | 0 | — | 0 | — | 0 | — | 2 | — |
Additional gender identityf | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 1 | — | 1 | — |
Age at death (yr) | ||||||||||||||||
< 13 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
13–14 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 0 | 0.0 | 0 | 0.0 | 3 | 0.1 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 0.0 |
20–24 | 0 | 0.0 | 0 | 0.0 | 50 | 1.7 | 29 | 0.6 | 0 | 0.0 | 18 | 0.2 | 8 | 1.1 | 105 | 0.5 |
25–29 | 2 | 1.1 | 4 | 0.3 | 239 | 7.3 | 95 | 2.0 | 0 | 0.0 | 85 | 0.7 | 34 | 5.5 | 459 | 2.0 |
30–34 | 10 | 5.3 | 8 | 0.5 | 423 | 12.9 | 202 | 4.3 | 0 | 0.0 | 193 | 1.5 | 65 | 13.1 | 901 | 3.9 |
35–39 | 8 | 4.9 | 9 | 0.5 | 491 | 17.1 | 233 | 5.1 | 1 | 1.9 | 259 | 2.1 | 69 | 17.3 | 1,070 | 4.8 |
40–44 | 12 | 8.0 | 8 | 0.5 | 499 | 18.4 | 255 | 5.8 | 2 | 4.4 | 307 | 2.6 | 94 | 27.4 | 1,177 | 5.6 |
45–49 | 11 | 7.9 | 16 | 1.1 | 647 | 25.9 | 304 | 7.7 | 1 | 2.6 | 436 | 3.8 | 107 | 38.1 | 1,522 | 7.7 |
50–54 | 4 | 2.8 | 19 | 1.5 | 931 | 36.2 | 442 | 12.4 | 4 | 10.9 | 680 | 5.2 | 181 | 70.4 | 2,261 | 10.8 |
55–59 | 9 | 5.9 | 19 | 1.6 | 1,351 | 51.6 | 591 | 19.2 | 3 | 8.4 | 1,114 | 7.8 | 283 | 119.9 | 3,370 | 15.6 |
60–64 | 10 | 6.8 | 14 | 1.3 | 1,412 | 57.7 | 511 | 20.8 | 2 | 6.3 | 1,078 | 7.2 | 242 | 110.9 | 3,269 | 15.4 |
≥ 65 | 14 | 4.3 | 28 | 1.0 | 2,356 | 44.6 | 835 | 16.5 | 1 | 1.5 | 1,855 | 4.4 | 395 | 83.1 | 5,485 | 9.8 |
Transmission categoryg | ||||||||||||||||
Male sex at birth (≥ 13 yrs at death)h | ||||||||||||||||
Male-to-male sexual contacti | 34 | — | 82 | — | 2,746 | — | 1,561 | — | 12 | — | 3,603 | — | 634 | — | 8,672 | — |
Injection drug usej | 8 | — | 4 | — | 1,085 | — | 544 | — | 0 | — | 521 | — | 173 | — | 2,335 | — |
Male-to-male sexual contacti and injection drug usej |
11 | — | 3 | — | 483 | — | 354 | — | 1 | — | 653 | — | 184 | — | 1,687 | — |
Heterosexual contactk | 5 | — | 12 | — | 1,344 | — | 291 | — | 1 | — | 295 | — | 123 | — | 2,071 | — |
Perinatall | 0 | — | 0 | — | 28 | — | 15 | — | 0 | — | 5 | — | 5 | — | 54 | — |
Otherm | 0 | — | 1 | — | 13 | — | 13 | — | 0 | — | 25 | — | 8 | — | 60 | — |
Subtotal | 58 | 5.8 | 102 | 1.3 | 5,698 | 34.5 | 2,778 | 11.2 | 14 | 5.4 | 5,102 | 6.0 | 1,127 | 44.1 | 14,879 | 10.8 |
Female sex at birth (≥ 13 yrs at death)h | ||||||||||||||||
Injection drug usej | 10 | — | 5 | — | 687 | — | 256 | — | 0 | — | 383 | — | 125 | — | 1,466 | — |
Heterosexual contactk | 13 | — | 18 | — | 1,976 | — | 447 | — | 0 | — | 521 | — | 217 | — | 3,191 | — |
Perinatall | 0 | — | 0 | — | 31 | — | 12 | — | 0 | — | 6 | — | 2 | — | 52 | — |
Otherm | 0 | — | 0 | — | 10 | — | 6 | — | 0 | — | 12 | — | 7 | — | 36 | — |
Subtotal | 22 | 2.1 | 23 | 0.3 | 2,704 | 14.8 | 720 | 3.0 | 0 | 0.0 | 923 | 1.1 | 351 | 13.1 | 4,744 | 3.3 |
Child (< 13 yrs at death) | ||||||||||||||||
Perinatal | 0 | — | 0 | — | 0 | — | 1 | — | 0 | — | 0 | — | 0 | — | 1 | — |
Otherm | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — |
Subtotal | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
Region of residencen | ||||||||||||||||
Northeast | 1 | 0.8 | 23 | 0.6 | 1,653 | 25.4 | 1,225 | 14.0 | 0 | 0.0 | 993 | 2.7 | 429 | 40.5 | 4,324 | 7.6 |
Midwest | 6 | 1.4 | 12 | 0.5 | 944 | 12.9 | 188 | 3.2 | 2 | 4.9 | 930 | 1.8 | 202 | 13.5 | 2,284 | 3.3 |
South | 9 | 1.1 | 28 | 0.6 | 5,208 | 21.3 | 1,155 | 4.8 | 1 | 1.0 | 2,554 | 3.6 | 585 | 22.4 | 9,540 | 7.5 |
West | 64 | 6.0 | 62 | 0.7 | 597 | 16.4 | 931 | 3.9 | 11 | 2.4 | 1,548 | 4.0 | 262 | 10.0 | 3,476 | 4.4 |
Total | 80 | 3.3 | 125 | 0.6 | 8,402 | 20.1 | 3,499 | 5.6 | 14 | 2.2 | 6,025 | 3.1 | 1,478 | 19.0 | 19,624 | 5.9 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for the year 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12 should be interpreted with caution.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
e “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
f Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
g Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
h Data include transgender and additional gender identity persons.
i Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
j Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
k Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
l Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
m Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
n Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |
---|---|---|---|---|---|---|---|---|
No. | No. | No. | No. | No. | No. | No. | No. | |
Gender | ||||||||
Male | 53 | 100 | 5,601 | 2,997 | 14 | 5,076 | 1,101 | 14,942 |
Female | 22 | 23 | 2,704 | 801 | 0 | 923 | 351 | 4,825 |
Transgender woman/girld | 5 | 2 | 99 | 59 | 0 | 26 | 25 | 216 |
Transgender man/boyd | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 |
Additional gender identitye | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Age at death (yr) | ||||||||
< 13 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
13–14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 4 |
20–24 | 0 | 0 | 50 | 30 | 0 | 18 | 8 | 106 |
25–29 | 2 | 4 | 240 | 102 | 0 | 85 | 34 | 467 |
30–34 | 10 | 8 | 423 | 207 | 0 | 193 | 65 | 906 |
35–39 | 8 | 9 | 491 | 247 | 1 | 259 | 69 | 1,084 |
40–44 | 12 | 8 | 499 | 284 | 2 | 307 | 94 | 1,206 |
45–49 | 11 | 16 | 647 | 334 | 1 | 436 | 107 | 1,552 |
50–54 | 4 | 19 | 931 | 483 | 4 | 680 | 181 | 2,302 |
55–59 | 9 | 19 | 1,351 | 650 | 3 | 1,114 | 283 | 3,429 |
60–64 | 10 | 14 | 1,412 | 567 | 2 | 1,078 | 242 | 3,325 |
≥ 65 | 14 | 28 | 2,358 | 952 | 1 | 1,855 | 395 | 5,604 |
Transmission categoryf | ||||||||
Male sex at birth (≥ 13 yrs at death)g | ||||||||
Male-to-male sexual contacth | 34 | 82 | 2,748 | 1,617 | 12 | 3,603 | 634 | 8,730 |
Injection drug usei | 8 | 4 | 1,085 | 660 | 0 | 521 | 173 | 2,451 |
Male-to-male sexual contacth and injection drug usei |
11 | 3 | 483 | 380 | 1 | 653 | 184 | 1,714 |
Heterosexual contactj | 5 | 12 | 1,344 | 370 | 1 | 295 | 123 | 2,149 |
Perinatalk | 0 | 0 | 28 | 16 | 0 | 5 | 5 | 55 |
Otherl | 0 | 1 | 13 | 13 | 0 | 25 | 8 | 60 |
Subtotal | 58 | 102 | 5,700 | 3,056 | 14 | 5,102 | 1,127 | 15,159 |
Female sex at birth (≥ 13 yrs at death)g | ||||||||
Injection drug usei | 10 | 5 | 687 | 276 | 0 | 383 | 125 | 1,486 |
Heterosexual contactj | 13 | 18 | 1,977 | 507 | 0 | 521 | 217 | 3,253 |
Perinatalk | 0 | 0 | 31 | 12 | 0 | 6 | 2 | 52 |
Otherl | 0 | 0 | 10 | 6 | 0 | 12 | 7 | 36 |
Subtotal | 22 | 23 | 2,705 | 801 | 0 | 923 | 351 | 4,826 |
Child (< 13 yrs at death) | ||||||||
Perinatal | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
Otherl | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subtotal | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
Region of residencem | ||||||||
Northeast | 1 | 23 | 1,653 | 1,225 | 0 | 993 | 429 | 4,324 |
Midwest | 6 | 12 | 944 | 188 | 2 | 930 | 202 | 2,284 |
South | 9 | 28 | 5,208 | 1,155 | 1 | 2,554 | 585 | 9,540 |
West | 64 | 62 | 597 | 931 | 11 | 1,548 | 262 | 3,476 |
U.S. dependent areas | 0 | 0 | 3 | 359 | 0 | 0 | 0 | 362 |
Total | 80 | 125 | 8,405 | 3,858 | 14 | 6,025 | 1,478 | 19,986 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for the year 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12 should be interpreted with caution.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
e Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at death (yr) | ||||||||||
13–14 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 5 | 0.0 | 5 | 0.0 | 9 | 0.1 | 9 | 0.1 | 4 | 0.0 |
20–24 | 113 | 1.0 | 95 | 0.9 | 95 | 0.9 | 110 | 1.0 | 81 | 0.7 |
25–29 | 347 | 2.9 | 346 | 2.9 | 370 | 3.1 | 361 | 3.1 | 366 | 3.2 |
30–34 | 447 | 4.0 | 464 | 4.1 | 510 | 4.5 | 603 | 5.2 | 746 | 6.4 |
35–39 | 624 | 5.9 | 577 | 5.4 | 618 | 5.7 | 696 | 6.2 | 837 | 7.4 |
40–44 | 659 | 6.8 | 633 | 6.5 | 643 | 6.5 | 806 | 7.8 | 842 | 7.9 |
45–49 | 1,226 | 11.8 | 1,130 | 11.0 | 983 | 9.7 | 1,046 | 10.3 | 1,067 | 10.8 |
50–54 | 2,035 | 19.4 | 1,901 | 18.5 | 1,668 | 16.5 | 1,749 | 16.9 | 1,628 | 15.6 |
55–59 | 2,246 | 21.0 | 2,255 | 21.2 | 2,277 | 21.4 | 2,544 | 23.4 | 2,526 | 23.8 |
60–64 | 1,934 | 20.3 | 1,908 | 19.6 | 2,062 | 20.9 | 2,445 | 23.9 | 2,479 | 24.0 |
≥ 65 | 2,714 | 12.1 | 2,906 | 12.5 | 3,218 | 13.4 | 4,046 | 16.5 | 4,303 | 17.1 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 33 | 3.4 | 33 | 3.4 | 38 | 3.9 | 49 | 4.9 | 58 | 5.8 |
Asianc | 73 | 1.0 | 72 | 1.0 | 92 | 1.2 | 88 | 1.1 | 102 | 1.3 |
Black/African American | 4,910 | 31.2 | 4,707 | 29.6 | 4,800 | 29.9 | 5,714 | 34.9 | 5,698 | 34.5 |
Hispanic/Latinod | 2,109 | 9.3 | 2,254 | 9.7 | 2,201 | 9.3 | 2,715 | 11.1 | 2,778 | 11.2 |
Native Hawaiian/other Pacific Islander | 5 | 2.1 | 12 | 5.0 | 9 | 3.6 | 10 | 3.9 | 14 | 5.4 |
White | 4,409 | 5.2 | 4,319 | 5.1 | 4,486 | 5.3 | 4,895 | 5.8 | 5,102 | 6.0 |
Multiracial | 810 | 36.8 | 823 | 36.1 | 825 | 34.9 | 943 | 38.2 | 1,127 | 44.1 |
Transmission categorye | ||||||||||
Male-to-male sexual contactf | 7,010 | — | 6,888 | — | 7,184 | — | 8,237 | — | 8,672 | — |
Injection drug useg | 2,154 | — | 2,169 | — | 2,087 | — | 2,427 | — | 2,335 | — |
Male-to-male sexual contactf and injection drug useg |
1,383 | — | 1,453 | — | 1,395 | — | 1,665 | — | 1,687 | — |
Heterosexual contacth | 1,694 | — | 1,600 | — | 1,688 | — | 1,961 | — | 2,071 | — |
Perinatali | 41 | — | 51 | — | 41 | — | 57 | — | 54 | — |
Otherj | 67 | — | 58 | — | 59 | — | 67 | — | 60 | — |
Region of residencek | ||||||||||
Northeast | 2,620 | 11.3 | 2,486 | 10.7 | 2,604 | 11.3 | 3,224 | 13.5 | 3,103 | 13.0 |
Midwest | 1,513 | 5.4 | 1,597 | 5.7 | 1,574 | 5.6 | 1,866 | 6.5 | 1,819 | 6.3 |
South | 5,822 | 11.6 | 5,713 | 11.3 | 5,880 | 11.5 | 6,600 | 12.7 | 6,936 | 13.3 |
West | 2,395 | 7.5 | 2,424 | 7.5 | 2,396 | 7.4 | 2,725 | 8.3 | 3,021 | 9.1 |
Subtotal | 12,350 | 9.3 | 12,220 | 9.1 | 12,454 | 9.2 | 14,415 | 10.5 | 14,879 | 10.8 |
Female sex at birthb | ||||||||||
Age at death (yr) | ||||||||||
13–14 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 2 | 0.0 | 4 | 0.0 | 2 | 0.0 | 4 | 0.0 | 0 | 0.0 |
20–24 | 32 | 0.3 | 26 | 0.2 | 28 | 0.3 | 30 | 0.3 | 24 | 0.2 |
25–29 | 98 | 0.9 | 74 | 0.6 | 66 | 0.6 | 100 | 0.9 | 93 | 0.8 |
30–34 | 155 | 1.4 | 150 | 1.4 | 154 | 1.4 | 194 | 1.7 | 155 | 1.4 |
35–39 | 239 | 2.3 | 237 | 2.2 | 240 | 2.2 | 244 | 2.2 | 233 | 2.1 |
40–44 | 311 | 3.2 | 327 | 3.3 | 294 | 2.9 | 328 | 3.2 | 335 | 3.2 |
45–49 | 516 | 4.9 | 473 | 4.5 | 419 | 4.1 | 465 | 4.6 | 455 | 4.6 |
50–54 | 692 | 6.4 | 679 | 6.4 | 578 | 5.6 | 598 | 5.7 | 633 | 6.0 |
55–59 | 721 | 6.4 | 675 | 6.0 | 644 | 5.7 | 755 | 6.8 | 844 | 7.7 |
60–64 | 553 | 5.3 | 617 | 5.8 | 607 | 5.7 | 732 | 6.8 | 790 | 7.2 |
≥ 65 | 674 | 2.4 | 729 | 2.5 | 814 | 2.7 | 1,187 | 4.0 | 1,182 | 3.9 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 14 | 1.4 | 16 | 1.6 | 19 | 1.9 | 33 | 3.2 | 22 | 2.1 |
Asianc | 15 | 0.2 | 11 | 0.1 | 8 | 0.1 | 15 | 0.2 | 23 | 0.3 |
Black/African American | 2,283 | 13.0 | 2,274 | 12.8 | 2,208 | 12.3 | 2,613 | 14.4 | 2,704 | 14.8 |
Hispanic/Latinod | 584 | 2.6 | 584 | 2.6 | 569 | 2.4 | 737 | 3.1 | 720 | 3.0 |
Native Hawaiian/other Pacific Islander | 4 | 1.7 | 1 | 0.4 | 5 | 2.0 | 1 | 0.4 | 0 | 0.0 |
White | 825 | 0.9 | 831 | 1.0 | 770 | 0.9 | 859 | 1.0 | 923 | 1.1 |
Multiracial | 267 | 11.4 | 274 | 11.3 | 266 | 10.6 | 379 | 14.6 | 351 | 13.1 |
Transmission categorye | ||||||||||
Injection drug useg | 1,373 | — | 1,335 | — | 1,316 | — | 1,494 | — | 1,466 | — |
Heterosexual contacth | 2,548 | — | 2,593 | — | 2,470 | — | 3,060 | — | 3,191 | — |
Perinatali | 43 | — | 37 | — | 37 | — | 45 | — | 52 | — |
Otherj | 29 | — | 26 | — | 24 | — | 38 | — | 36 | — |
Region of residencek | ||||||||||
Northeast | 1,073 | 4.3 | 1,036 | 4.2 | 1,049 | 4.2 | 1,298 | 5.2 | 1,221 | 4.9 |
Midwest | 401 | 1.4 | 406 | 1.4 | 386 | 1.3 | 450 | 1.5 | 465 | 1.6 |
South | 2,174 | 4.1 | 2,167 | 4.0 | 2,036 | 3.8 | 2,476 | 4.6 | 2,603 | 4.8 |
West | 345 | 1.1 | 382 | 1.2 | 375 | 1.1 | 413 | 1.3 | 455 | 1.4 |
Subtotal | 3,993 | 2.9 | 3,991 | 2.8 | 3,846 | 2.7 | 4,637 | 3.3 | 4,744 | 3.3 |
Total | 16,343 | 6.0 | 16,211 | 5.9 | 16,300 | 5.9 | 19,052 | 6.8 | 19,623 | 7.0 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Data include transgender and additional gender identity persons.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at death (yr) | ||||||||||
13–14 | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 5 | 0.0 | 5 | 0.0 | 9 | 0.1 | 9 | 0.1 | 4 | 0.0 |
20–24 | 114 | 1.0 | 99 | 0.9 | 97 | 0.9 | 112 | 1.0 | 82 | 0.7 |
25–29 | 351 | 2.9 | 353 | 2.9 | 374 | 3.1 | 363 | 3.1 | 373 | 3.2 |
30–34 | 457 | 4.1 | 472 | 4.2 | 516 | 4.5 | 607 | 5.2 | 750 | 6.4 |
35–39 | 635 | 5.9 | 590 | 5.4 | 629 | 5.7 | 715 | 6.3 | 847 | 7.5 |
40–44 | 687 | 7.0 | 656 | 6.6 | 671 | 6.7 | 831 | 7.9 | 867 | 8.1 |
45–49 | 1,267 | 12.1 | 1,157 | 11.2 | 1,010 | 9.9 | 1,067 | 10.4 | 1,091 | 10.9 |
50–54 | 2,094 | 19.7 | 1,939 | 18.7 | 1,728 | 16.9 | 1,784 | 17.0 | 1,664 | 15.8 |
55–59 | 2,304 | 21.4 | 2,310 | 21.4 | 2,317 | 21.5 | 2,602 | 23.7 | 2,569 | 23.9 |
60–64 | 1,963 | 20.4 | 1,950 | 19.9 | 2,104 | 21.1 | 2,481 | 24.0 | 2,522 | 24.1 |
≥ 65 | 2,776 | 12.2 | 2,980 | 12.6 | 3,276 | 13.4 | 4,119 | 16.6 | 4,390 | 17.2 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 33 | — | 33 | — | 38 | — | 49 | — | 58 | — |
Asianc | 73 | — | 72 | — | 92 | — | 89 | — | 102 | — |
Black/African American | 4,914 | — | 4,707 | — | 4,801 | — | 5,715 | — | 5,700 | — |
Hispanic/Latinod | 2,407 | — | 2,542 | — | 2,472 | — | 2,986 | — | 3,056 | — |
Native Hawaiian/other Pacific Islander | 5 | — | 13 | — | 11 | — | 10 | — | 14 | — |
White | 4,410 | — | 4,320 | — | 4,488 | — | 4,897 | — | 5,102 | — |
Multiracial | 810 | — | 824 | — | 827 | — | 943 | — | 1,127 | — |
Transmission categorye | ||||||||||
Male-to-male sexual contactf | 7,082 | — | 6,967 | — | 7,257 | — | 8,320 | — | 8,730 | — |
Injection drug useg | 2,286 | — | 2,290 | — | 2,209 | — | 2,534 | — | 2,451 | — |
Male-to-male sexual contactf and injection drug useg |
1,408 | — | 1,475 | — | 1,420 | — | 1,695 | — | 1,714 | — |
Heterosexual contacth | 1,768 | — | 1,663 | — | 1,744 | — | 2,015 | — | 2,149 | — |
Perinatali | 42 | — | 57 | — | 43 | — | 60 | — | 55 | — |
Otherj | 67 | — | 59 | — | 59 | — | 67 | — | 60 | — |
Region of residencek | ||||||||||
Northeast | 2,620 | 11.3 | 2,486 | 10.7 | 2,604 | 11.3 | 3,224 | 13.5 | 3,103 | 13.0 |
Midwest | 1,513 | 5.4 | 1,597 | 5.7 | 1,574 | 5.6 | 1,866 | 6.5 | 1,819 | 6.3 |
South | 5,822 | 11.6 | 5,713 | 11.3 | 5,880 | 11.5 | 6,600 | 12.7 | 6,936 | 13.3 |
West | 2,395 | 7.5 | 2,424 | 7.5 | 2,396 | 7.4 | 2,725 | 8.3 | 3,021 | 9.1 |
US dependent areas | 303 | 20.0 | 291 | 19.8 | 278 | 18.8 | 275 | 18.1 | 280 | 18.4 |
Subtotal | 12,653 | 9.4 | 12,511 | 9.2 | 12,732 | 9.3 | 14,690 | 10.6 | 15,159 | 10.9 |
Female sex at birthb | ||||||||||
Age at death (yr) | ||||||||||
13–14 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
15–19 | 2 | 0.0 | 4 | 0.0 | 2 | 0.0 | 4 | 0.0 | 0 | 0.0 |
20–24 | 33 | 0.3 | 26 | 0.2 | 28 | 0.3 | 30 | 0.3 | 24 | 0.2 |
25–29 | 100 | 0.9 | 75 | 0.6 | 68 | 0.6 | 100 | 0.9 | 94 | 0.8 |
30–34 | 160 | 1.5 | 154 | 1.4 | 160 | 1.4 | 196 | 1.7 | 156 | 1.4 |
35–39 | 243 | 2.3 | 243 | 2.2 | 246 | 2.2 | 248 | 2.2 | 237 | 2.1 |
40–44 | 318 | 3.2 | 333 | 3.3 | 305 | 3.0 | 334 | 3.2 | 339 | 3.2 |
45–49 | 527 | 4.9 | 484 | 4.6 | 428 | 4.1 | 479 | 4.7 | 461 | 4.6 |
50–54 | 710 | 6.5 | 692 | 6.5 | 591 | 5.6 | 609 | 5.8 | 638 | 6.0 |
55–59 | 745 | 6.5 | 690 | 6.1 | 656 | 5.8 | 772 | 6.8 | 860 | 7.8 |
60–64 | 566 | 5.4 | 624 | 5.8 | 618 | 5.7 | 746 | 6.8 | 803 | 7.3 |
≥ 65 | 697 | 2.4 | 742 | 2.5 | 823 | 2.7 | 1,205 | 4.0 | 1,214 | 3.9 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 14 | — | 16 | — | 19 | — | 33 | — | 22 | — |
Asianc | 15 | — | 11 | — | 8 | — | 15 | — | 23 | — |
Black/African American | 2,284 | — | 2,274 | — | 2,208 | — | 2,615 | — | 2,705 | — |
Hispanic/Latinod | 691 | — | 658 | — | 647 | — | 821 | — | 801 | — |
Native Hawaiian/other Pacific Islander | 4 | — | 3 | — | 5 | — | 1 | — | 0 | — |
White | 825 | — | 831 | — | 770 | — | 859 | — | 923 | — |
Multiracial | 267 | — | 274 | — | 267 | — | 379 | — | 351 | — |
Transmission categorye | ||||||||||
Injection drug useg | 1,408 | — | 1,368 | — | 1,346 | — | 1,521 | — | 1,486 | — |
Heterosexual contacth | 2,620 | — | 2,634 | — | 2,517 | — | 3,119 | — | 3,253 | — |
Perinatali | 44 | — | 39 | — | 38 | — | 45 | — | 52 | — |
Otherj | 29 | — | 26 | — | 25 | — | 38 | — | 36 | — |
Region of residencek | ||||||||||
Northeast | 1,073 | 4.3 | 1,036 | 4.2 | 1,049 | 4.2 | 1,298 | 5.2 | 1,221 | 4.9 |
Midwest | 401 | 1.4 | 406 | 1.4 | 386 | 1.3 | 450 | 1.5 | 465 | 1.6 |
South | 2,174 | 4.1 | 2,167 | 4.0 | 2,036 | 3.8 | 2,476 | 4.6 | 2,603 | 4.8 |
West | 345 | 1.1 | 382 | 1.2 | 375 | 1.1 | 413 | 1.3 | 455 | 1.4 |
US dependent areas | 108 | 6.4 | 76 | 4.6 | 79 | 4.8 | 86 | 5.1 | 82 | 4.8 |
Subtotal | 4,101 | 2.9 | 4,067 | 2.9 | 3,925 | 2.8 | 4,723 | 3.3 | 4,826 | 3.4 |
Total | 16,754 | 6.1 | 16,578 | 6.0 | 16,657 | 6.0 | 19,413 | 6.9 | 19,985 | 7.1 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Data include transgender and additional gender identity persons.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 2 | 1 | 5 | 7 | 5 |
25–29 | 8 | 12 | 17 | 17 | 12 |
30–34 | 9 | 9 | 19 | 30 | 41 |
35–39 | 15 | 13 | 17 | 29 | 29 |
40–44 | 12 | 12 | 17 | 23 | 27 |
45–49 | 19 | 12 | 17 | 26 | 15 |
50–54 | 11 | 19 | 17 | 21 | 20 |
55–59 | 19 | 18 | 17 | 25 | 30 |
60–64 | 7 | 11 | 12 | 14 | 20 |
≥ 65 | 6 | 11 | 7 | 15 | 16 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 2 | 1 | 4 | 5 |
Asianb | 0 | 2 | 1 | 3 | 2 |
Black/African American | 45 | 46 | 69 | 106 | 99 |
Hispanic/Latinoc | 36 | 34 | 33 | 52 | 58 |
Native Hawaiian/other Pacific Islander | 1 | 0 | 0 | 1 | 0 |
White | 18 | 21 | 24 | 23 | 26 |
Multiracial | 8 | 13 | 17 | 18 | 25 |
Exposure categoryd | |||||
Sexual contacte | 79 | 78 | 99 | 144 | 159 |
Injection drug usef | 0 | 0 | 1 | 2 | 0 |
Sexual contacte and injection drug usef |
26 | 38 | 39 | 56 | 49 |
Otherg | 3 | 2 | 6 | 5 | 7 |
Region of residenceh | |||||
Northeast | 26 | 32 | 39 | 61 | 56 |
Midwest | 11 | 11 | 22 | 22 | 27 |
South | 41 | 43 | 55 | 72 | 75 |
West | 30 | 32 | 29 | 52 | 57 |
Subtotal | 108 | 118 | 145 | 207 | 215 |
Transgender mana | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 1 | 0 |
25–29 | 0 | 0 | 1 | 1 | 0 |
30–34 | 1 | 0 | 0 | 1 | 0 |
35–39 | 0 | 0 | 0 | 1 | 0 |
40–44 | 0 | 0 | 0 | 2 | 0 |
45–49 | 1 | 2 | 0 | 1 | 0 |
50–54 | 0 | 1 | 1 | 0 | 0 |
55–59 | 2 | 1 | 1 | 1 | 1 |
60–64 | 0 | 0 | 2 | 1 | 1 |
≥ 65 | 1 | 1 | 0 | 1 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asianb | 0 | 0 | 0 | 0 | 0 |
Black/African American | 3 | 0 | 1 | 3 | 1 |
Hispanic/Latinoc | 1 | 2 | 2 | 2 | 1 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 0 | 2 | 1 | 2 | 0 |
Multiracial | 1 | 1 | 1 | 3 | 0 |
Exposure categoryd | |||||
Sexual contacte | 3 | 0 | 3 | 6 | 0 |
Injection drug usef | 0 | 0 | 0 | 0 | 0 |
Sexual contacte and injection drug usef |
2 | 5 | 1 | 4 | 2 |
Otherg | 0 | 0 | 1 | 0 | 0 |
Region of residenceh | |||||
Northeast | 1 | 0 | 1 | 2 | 1 |
Midwest | 0 | 1 | 1 | 1 | 0 |
South | 3 | 3 | 3 | 4 | 1 |
West | 1 | 1 | 0 | 3 | 0 |
Subtotal | 5 | 5 | 5 | 10 | 2 |
Additional gender identityi | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 0 | 0 |
25–29 | 0 | 0 | 0 | 0 | 0 |
30–34 | 2 | 0 | 0 | 0 | 0 |
35–39 | 0 | 0 | 0 | 0 | 0 |
40–44 | 0 | 0 | 1 | 0 | 0 |
45–49 | 0 | 0 | 0 | 0 | 0 |
50–54 | 0 | 0 | 0 | 0 | 0 |
55–59 | 1 | 1 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 1 |
≥ 65 | 0 | 0 | 1 | 0 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asianb | 0 | 0 | 0 | 0 | 0 |
Black/African American | 1 | 0 | 2 | 0 | 0 |
Hispanic/Latinoc | 1 | 1 | 0 | 0 | 0 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 1 | 0 | 0 | 0 | 0 |
Multiracial | 0 | 0 | 0 | 0 | 1 |
Exposure categoryd | |||||
Sexual contacte | 2 | 0 | 1 | 0 | 1 |
Injection drug usef | 0 | 0 | 0 | 0 | 0 |
Sexual contacte and injection drug usef |
1 | 1 | 1 | 0 | 0 |
Otherg | 0 | 0 | 0 | 0 | 0 |
Region of residenceh | |||||
Northeast | 1 | 0 | 1 | 0 | 1 |
Midwest | 1 | 0 | 1 | 0 | 0 |
South | 1 | 0 | 0 | 0 | 0 |
West | 0 | 1 | 0 | 0 | 0 |
Subtotal | 3 | 1 | 2 | 0 | 1 |
Total | 116 | 124 | 152 | 217 | 218 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanic/Latino persons can be of any race.
d Risk factor data for transgender and additional gender identity persons aged ≥13 years are presented using the exposure category classification, which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
e For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
f Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
g Other risk factors, including perinatal, hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
h Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
i Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 2 | 1 | 5 | 7 | 5 |
25–29 | 8 | 12 | 17 | 17 | 12 |
30–34 | 9 | 9 | 19 | 30 | 41 |
35–39 | 16 | 13 | 17 | 29 | 30 |
40–44 | 12 | 12 | 17 | 23 | 27 |
45–49 | 19 | 12 | 18 | 26 | 15 |
50–54 | 12 | 19 | 17 | 22 | 20 |
55–59 | 19 | 18 | 17 | 25 | 30 |
60–64 | 7 | 11 | 12 | 14 | 20 |
≥ 65 | 6 | 12 | 8 | 15 | 16 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 2 | 1 | 4 | 5 |
Asianb | 0 | 2 | 1 | 3 | 2 |
Black/African American | 45 | 46 | 69 | 106 | 99 |
Hispanic/Latinoc | 38 | 35 | 35 | 53 | 59 |
Native Hawaiian/other Pacific Islander | 1 | 0 | 0 | 1 | 0 |
White | 18 | 21 | 24 | 23 | 26 |
Multiracial | 8 | 13 | 17 | 18 | 25 |
Exposure categoryd | |||||
Sexual contacte | 79 | 79 | 99 | 145 | 159 |
Injection drug usef | 0 | 0 | 1 | 2 | 0 |
Sexual contacte and injection drug usef |
28 | 38 | 41 | 56 | 50 |
Otherg | 3 | 2 | 6 | 5 | 7 |
Region of residenceh | |||||
Northeast | 26 | 32 | 39 | 61 | 56 |
Midwest | 11 | 11 | 22 | 22 | 27 |
South | 41 | 43 | 55 | 72 | 75 |
West | 30 | 32 | 29 | 52 | 57 |
US dependent areas | 2 | 1 | 2 | 1 | 1 |
Subtotal | 110 | 119 | 147 | 208 | 216 |
Transgender mana | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 1 | 0 |
25–29 | 0 | 0 | 1 | 1 | 0 |
30–34 | 1 | 0 | 0 | 1 | 0 |
35–39 | 0 | 0 | 0 | 1 | 0 |
40–44 | 0 | 0 | 0 | 2 | 0 |
45–49 | 1 | 2 | 0 | 1 | 0 |
50–54 | 0 | 1 | 1 | 0 | 0 |
55–59 | 2 | 1 | 1 | 1 | 1 |
60–64 | 0 | 0 | 2 | 1 | 1 |
≥ 65 | 1 | 1 | 0 | 1 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asianb | 0 | 0 | 0 | 0 | 0 |
Black/African American | 3 | 0 | 1 | 3 | 1 |
Hispanic/Latinoc | 1 | 2 | 2 | 2 | 1 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 0 | 2 | 1 | 2 | 0 |
Multiracial | 1 | 1 | 1 | 3 | 0 |
Exposure categoryd | |||||
Sexual contacte | 3 | 0 | 3 | 6 | 0 |
Injection drug usef | 0 | 0 | 0 | 0 | 0 |
Sexual contacte and injection drug usef |
2 | 5 | 1 | 4 | 2 |
Otherg | 0 | 0 | 1 | 0 | 0 |
Region of residenceh | |||||
Northeast | 1 | 0 | 1 | 2 | 1 |
Midwest | 0 | 1 | 1 | 1 | 0 |
South | 3 | 3 | 3 | 4 | 1 |
West | 1 | 1 | 0 | 3 | 0 |
US dependent areas | 0 | 0 | 0 | 0 | 0 |
Subtotal | 5 | 5 | 5 | 10 | 2 |
Additional gender identityi | |||||
Age at death (yr) | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 0 | 0 | 0 | 0 | 0 |
20–24 | 0 | 0 | 0 | 0 | 0 |
25–29 | 0 | 0 | 0 | 0 | 0 |
30–34 | 2 | 0 | 0 | 0 | 0 |
35–39 | 0 | 0 | 0 | 0 | 0 |
40–44 | 0 | 0 | 1 | 0 | 0 |
45–49 | 0 | 0 | 0 | 0 | 0 |
50–54 | 0 | 0 | 0 | 0 | 0 |
55–59 | 1 | 1 | 0 | 0 | 0 |
60–64 | 0 | 0 | 0 | 0 | 1 |
≥ 65 | 0 | 0 | 1 | 0 | 0 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 0 | 0 | 0 | 0 |
Asianb | 0 | 0 | 0 | 0 | 0 |
Black/African American | 1 | 0 | 2 | 0 | 0 |
Hispanic/Latinoc | 1 | 1 | 0 | 0 | 0 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 1 | 0 | 0 | 0 | 0 |
Multiracial | 0 | 0 | 0 | 0 | 1 |
Exposure categoryd | |||||
Sexual contacte | 2 | 0 | 1 | 0 | 1 |
Injection drug usef | 0 | 0 | 0 | 0 | 0 |
Sexual contacte and injection drug usef |
1 | 1 | 1 | 0 | 0 |
Otherg | 0 | 0 | 0 | 0 | 0 |
Region of residenceh | |||||
Northeast | 1 | 0 | 1 | 0 | 1 |
Midwest | 1 | 0 | 1 | 0 | 0 |
South | 1 | 0 | 0 | 0 | 0 |
West | 0 | 1 | 0 | 0 | 0 |
US dependent areas | 0 | 0 | 0 | 0 | 0 |
Subtotal | 3 | 1 | 2 | 0 | 1 |
Total | 118 | 125 | 154 | 218 | 219 |
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Death data for years 2020 and 2021 should be interpreted with caution due to excess deaths in the United States population attributed to the COVID-19 pandemic. For additional information, see https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanic/Latino persons can be of any race.
d Risk factor data for transgender and additional gender identity persons aged ≥13 years are presented using the exposure category classification, which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
e For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
f Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
g Other risk factors, including perinatal, hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
h Data are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used; when both residence at death and state where a person’s death occurred were not available, the most recent known address on or before the date of death is used.
i Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 749,255 | — | 767,894 | — | 785,712 | — | 796,670 | — | 812,192 | — |
Female | 235,211 | — | 238,870 | — | 242,488 | — | 243,646 | — | 246,029 | — |
Transgender woman/girlb | 10,775 | — | 11,347 | — | 11,937 | — | 12,447 | — | 13,111 | — |
Transgender man/boyb | 401 | — | 448 | — | 490 | — | 520 | — | 574 | — |
Additional gender identityc | 239 | — | 260 | — | 292 | — | 315 | — | 361 | — |
Age at end of year | ||||||||||
< 13 | 2,058 | 3.9 | 1,897 | 3.6 | 1,670 | 3.2 | 1,445 | 2.8 | 1,262 | 2.4 |
13–14 | 670 | 8.1 | 667 | 8.0 | 652 | 7.8 | 639 | 7.3 | 599 | 6.7 |
15–19 | 4,548 | 21.5 | 4,367 | 20.7 | 4,251 | 20.2 | 3,800 | 17.6 | 3,689 | 17.1 |
20–24 | 28,433 | 128.9 | 27,005 | 123.7 | 26,064 | 120.4 | 24,267 | 113.0 | 23,768 | 110.4 |
25–29 | 70,343 | 301.1 | 70,846 | 300.9 | 69,328 | 294.5 | 65,558 | 287.5 | 62,673 | 279.9 |
30–34 | 82,697 | 376.6 | 87,652 | 396.0 | 93,088 | 414.4 | 97,085 | 424.4 | 100,758 | 436.1 |
35–39 | 91,538 | 432.0 | 93,448 | 433.7 | 95,421 | 438.6 | 96,667 | 434.8 | 100,231 | 449.5 |
40–44 | 95,663 | 488.7 | 96,353 | 489.5 | 97,899 | 491.4 | 100,213 | 484.8 | 102,963 | 487.9 |
45–49 | 129,431 | 619.4 | 122,787 | 592.7 | 116,648 | 572.1 | 108,962 | 536.3 | 104,701 | 529.3 |
50–54 | 162,116 | 760.0 | 156,876 | 752.2 | 150,087 | 733.2 | 144,716 | 696.3 | 138,428 | 662.1 |
55–59 | 143,636 | 654.5 | 152,013 | 693.6 | 159,310 | 728.4 | 162,057 | 735.4 | 162,000 | 751.1 |
60–64 | 95,574 | 479.6 | 103,683 | 510.7 | 111,536 | 542.5 | 119,583 | 568.4 | 127,237 | 599.2 |
≥ 65 | 89,174 | 175.7 | 101,225 | 193.3 | 114,965 | 212.8 | 128,606 | 236.2 | 143,958 | 257.8 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 2,759 | 115.1 | 2,882 | 119.6 | 3,020 | 124.7 | 3,130 | 128.0 | 3,276 | 133.6 |
Asiand | 13,730 | 74.8 | 14,605 | 78.0 | 15,360 | 80.5 | 15,974 | 81.9 | 16,720 | 84.9 |
Black/African American | 403,102 | 993.1 | 412,368 | 1008.3 | 421,362 | 1022.9 | 426,145 | 1,021.3 | 432,958 | 1,034.3 |
Hispanic/Latinoe | 226,093 | 387.1 | 234,034 | 393.5 | 242,008 | 400.6 | 247,235 | 399.5 | 255,281 | 407.5 |
Native Hawaiian/other Pacific Islander | 745 | 127.9 | 790 | 133.1 | 836 | 138.4 | 889 | 143.7 | 955 | 152.5 |
White | 292,874 | 148.1 | 297,228 | 150.5 | 301,145 | 152.7 | 303,326 | 153.4 | 306,583 | 155.8 |
Multiracial | 55,893 | 798.0 | 56,227 | 781.8 | 56,507 | 766.1 | 56,219 | 737.5 | 55,816 | 716.4 |
Transmission categoryf | ||||||||||
Male sex at birth (≥ 13 yrs at end of year)g | ||||||||||
Male-to-male sexual contacth | 549,064 | — | 567,472 | — | 585,215 | — | 598,237 | — | 615,019 | — |
Injection drug usei | 67,773 | — | 67,101 | — | 66,494 | — | 65,327 | — | 64,530 | — |
Male-to-male sexual contacth and injection drug usei |
58,001 | — | 58,116 | — | 58,324 | — | 57,858 | — | 57,559 | — |
Heterosexual contactj | 76,847 | — | 78,210 | — | 79,292 | — | 79,440 | — | 79,991 | — |
Perinatalk | 4,814 | — | 4,912 | — | 5,037 | — | 5,120 | — | 5,217 | — |
Otherl | 2,767 | — | 2,753 | — | 2,755 | — | 2,737 | — | 2,733 | — |
Subtotal | 759,266 | 570.1 | 778,564 | 580.6 | 797,117 | 590.5 | 808,719 | 588.8 | 825,049 | 598.1 |
Female sex at birth (≥ 13 yrs at end of year)g | ||||||||||
Injection drug usei | 49,011 | — | 48,850 | — | 48,759 | — | 48,197 | — | 47,864 | — |
Heterosexual contactj | 178,387 | — | 182,152 | — | 185,832 | — | 187,561 | — | 190,265 | — |
Perinatalk | 5,518 | — | 5,697 | — | 5,858 | — | 5,979 | — | 6,120 | — |
Otherl | 1,641 | — | 1,659 | — | 1,684 | — | 1,697 | — | 1,707 | — |
Subtotal | 234,557 | 168.5 | 238,358 | 170.0 | 242,132 | 171.6 | 243,434 | 171.9 | 245,956 | 172.9 |
Child (< 13 yrs at end of year) | ||||||||||
Perinatal | 1,713 | — | 1,562 | — | 1,382 | — | 1,209 | — | 1,060 | — |
Otherl | 345 | — | 335 | — | 288 | — | 236 | — | 202 | — |
Subtotal | 2,058 | 3.9 | 1,897 | 3.6 | 1,670 | 3.2 | 1,445 | 2.8 | 1,262 | 2.4 |
Region of residencem | ||||||||||
Northeast | 231,318 | 412.5 | 233,355 | 416.1 | 234,829 | 419.3 | 234,339 | 407.4 | 235,158 | 411.4 |
Midwest | 118,715 | 174.2 | 121,808 | 178.4 | 124,536 | 182.2 | 126,494 | 183.5 | 129,138 | 187.6 |
South | 449,380 | 363.5 | 461,770 | 370.5 | 474,428 | 377.5 | 482,397 | 381.6 | 493,509 | 387.9 |
West | 196,468 | 254.3 | 201,886 | 259.4 | 207,126 | 264.5 | 210,368 | 267.5 | 214,462 | 272.6 |
Totaln | 995,881 | 306.3 | 1,018,819 | 311.7 | 1,040,919 | 317.0 | 1,053,598 | 317.8 | 1,072,267 | 323.1 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanic/Latino persons can be of any race.
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at the end of the specified year (i.e., most recent known address).
n Includes persons whose race/ethnicity is unknown.
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Gender | ||||||||||
Male | 760,803 | — | 779,369 | — | 797,263 | — | 808,207 | — | 823,824 | — |
Female | 240,162 | — | 243,758 | — | 247,371 | — | 248,484 | — | 250,857 | — |
Transgender woman/girlb | 10,814 | — | 11,385 | — | 11,978 | — | 12,491 | — | 13,150 | — |
Transgender man/boyb | 404 | — | 451 | — | 493 | — | 523 | — | 577 | — |
Additional gender identityc | 239 | — | 261 | — | 292 | — | 315 | — | 361 | — |
Age at end of year | ||||||||||
< 13 | 2,067 | 3.9 | 1,903 | 3.6 | 1,675 | 3.2 | 1,448 | 2.7 | 1,266 | 2.4 |
13–14 | 676 | 8.1 | 675 | 8.0 | 656 | 7.8 | 642 | 7.2 | 601 | 6.7 |
15–19 | 4,594 | 21.5 | 4,410 | 20.7 | 4,277 | 20.1 | 3,822 | 17.6 | 3,707 | 17.0 |
20–24 | 28,729 | 128.7 | 27,275 | 123.6 | 26,319 | 120.2 | 24,487 | 112.8 | 23,959 | 110.0 |
25–29 | 71,050 | 300.9 | 71,544 | 300.7 | 70,016 | 294.3 | 66,172 | 287.0 | 63,270 | 279.4 |
30–34 | 83,610 | 377.1 | 88,530 | 396.4 | 93,994 | 414.6 | 97,999 | 424.2 | 101,666 | 435.7 |
35–39 | 92,825 | 433.4 | 94,626 | 434.8 | 96,498 | 439.3 | 97,690 | 435.3 | 101,254 | 449.9 |
40–44 | 97,251 | 491.0 | 97,870 | 491.7 | 99,356 | 493.3 | 101,638 | 486.4 | 104,375 | 489.3 |
45–49 | 131,618 | 622.6 | 124,765 | 595.6 | 118,507 | 574.7 | 110,642 | 538.4 | 106,287 | 531.2 |
50–54 | 165,046 | 764.7 | 159,691 | 756.8 | 152,693 | 737.3 | 147,229 | 700.3 | 140,770 | 665.7 |
55–59 | 146,286 | 659.2 | 154,756 | 698.4 | 162,214 | 733.5 | 164,931 | 740.0 | 164,852 | 755.6 |
60–64 | 97,425 | 483.3 | 105,704 | 514.8 | 113,673 | 546.8 | 121,871 | 572.7 | 129,622 | 603.6 |
≥ 65 | 91,245 | 177.3 | 103,475 | 195.0 | 117,519 | 214.6 | 131,449 | 238.1 | 147,140 | 259.8 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 2,761 | — | 2,884 | — | 3,022 | — | 3,132 | — | 3,278 | — |
Asiand | 13,786 | — | 14,665 | — | 15,427 | — | 16,041 | — | 16,788 | — |
Black/African American | 403,402 | — | 412,682 | — | 421,683 | — | 426,472 | — | 433,293 | — |
Hispanic/Latinoe | 242,128 | — | 249,919 | — | 257,943 | — | 263,102 | — | 271,212 | — |
Native Hawaiian/other Pacific Islander | 778 | — | 822 | — | 869 | — | 923 | — | 989 | — |
White | 292,960 | — | 297,313 | — | 301,240 | — | 303,423 | — | 306,688 | — |
Multiracial | 55,919 | — | 56,251 | — | 56,529 | — | 56,244 | — | 55,839 | — |
Transmission categoryf | ||||||||||
Male sex at birth (≥ 13 yrs at end of year)g | ||||||||||
Male-to-male sexual contacth | 553,853 | — | 572,368 | — | 590,283 | — | 603,437 | — | 620,421 | — |
Injection drug usei | 71,241 | — | 70,441 | — | 69,734 | — | 68,468 | — | 67,586 | — |
Male-to-male sexual contacth and injection drug usei |
58,804 | — | 58,890 | — | 59,089 | — | 58,604 | — | 58,297 | — |
Heterosexual contactj | 79,212 | — | 80,556 | — | 81,654 | — | 81,781 | — | 82,317 | — |
Perinatalk | 4,943 | — | 5,040 | — | 5,166 | — | 5,245 | — | 5,337 | — |
Otherl | 2,795 | — | 2,780 | — | 2,782 | — | 2,763 | — | 2,759 | — |
Subtotal | 770,848 | 572.3 | 790,075 | 582.7 | 808,707 | 592.6 | 820,299 | 590.7 | 836,718 | 600.0 |
Female sex at birth (≥ 13 yrs at end of year)g | ||||||||||
Injection drug usei | 50,003 | — | 49,809 | — | 49,704 | — | 49,119 | — | 48,764 | — |
Heterosexual contactj | 182,209 | — | 185,953 | — | 189,650 | — | 191,356 | — | 194,074 | — |
Perinatalk | 5,641 | — | 5,813 | — | 5,966 | — | 6,090 | — | 6,227 | — |
Otherl | 1,654 | — | 1,671 | — | 1,694 | — | 1,708 | — | 1,720 | — |
Subtotal | 239,507 | 170.0 | 243,246 | 171.5 | 247,015 | 173.1 | 248,273 | 173.2 | 250,785 | 174.2 |
Child (< 13 yrs at end of year) | ||||||||||
Perinatal | 1,722 | — | 1,568 | — | 1,387 | — | 1,212 | — | 1,064 | — |
Otherl | 345 | — | 335 | — | 288 | — | 236 | — | 202 | — |
Subtotal | 2,067 | 3.9 | 1,903 | 3.6 | 1,675 | 3.2 | 1,448 | 2.7 | 1,266 | 2.4 |
Region of residencem | ||||||||||
Northeast | 231,318 | 412.5 | 233,355 | 416.1 | 234,829 | 419.3 | 234,339 | 407.4 | 235,158 | 411.4 |
Midwest | 118,715 | 174.2 | 121,808 | 178.4 | 124,536 | 182.2 | 126,494 | 183.5 | 129,138 | 187.6 |
South | 449,380 | 363.5 | 461,770 | 370.5 | 474,428 | 377.5 | 482,397 | 381.6 | 493,509 | 387.9 |
West | 196,468 | 254.3 | 201,886 | 259.4 | 207,126 | 264.5 | 210,368 | 267.5 | 214,462 | 272.6 |
U.S. dependent areas | 16,541 | 444.2 | 16,405 | 456.8 | 16,478 | 459.0 | 16,422 | 446.6 | 16,502 | 451.1 |
Totaln | 1,012,422 | 307.9 | 1,035,224 | 313.3 | 1,057,397 | 318.6 | 1,070,020 | 319.2 | 1,088,769 | 324.5 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
c Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanic/Latino persons can be of any race.
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at the end of the specified year (i.e., most recent known address).
n Includes persons whose race/ethnicity is unknown.
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | |
Gender | ||||||||||||||||
Male | 2,411 | — | 13,594 | — | 283,953 | — | 204,798 | — | 763 | — | 264,430 | — | 41,758 | — | 812,192 | — |
Female | 796 | — | 2,890 | — | 142,524 | — | 45,945 | — | 153 | — | 40,562 | — | 12,966 | — | 246,029 | — |
Transgender woman/girle | 64 | — | 219 | — | 6,106 | — | 4,311 | — | 39 | — | 1,370 | — | 1,002 | — | 13,111 | — |
Transgender man/boye | 4 | — | 11 | — | 234 | — | 130 | — | 0 | — | 142 | — | 53 | — | 574 | — |
Additional gender identityf | 1 | — | 6 | — | 141 | — | 97 | — | 0 | — | 79 | — | 37 | — | 361 | — |
Age at end of year | ||||||||||||||||
< 13 | 6 | 1.5 | 88 | 3.1 | 731 | 10.2 | 180 | 1.3 | 3 | 2.6 | 155 | 0.6 | 99 | 3.9 | 1,262 | 2.4 |
13–14 | 1 | 1.3 | 39 | 8.7 | 338 | 27.5 | 81 | 3.5 | 0 | 0.0 | 88 | 2.0 | 52 | 13.7 | 599 | 6.7 |
15–19 | 19 | 10.5 | 108 | 9.5 | 2,171 | 74.2 | 766 | 14.3 | 8 | 18.5 | 417 | 3.7 | 200 | 24.4 | 3,689 | 17.1 |
20–24 | 88 | 48.7 | 376 | 30.9 | 13,224 | 437.5 | 5,909 | 119.1 | 27 | 63.2 | 3,118 | 27.4 | 1,021 | 143.8 | 23,768 | 110.4 |
25–29 | 270 | 142.5 | 1,160 | 79.5 | 30,983 | 946.5 | 16,750 | 344.7 | 71 | 150.0 | 10,225 | 85.6 | 3,208 | 518.2 | 62,673 | 279.9 |
30–34 | 394 | 210.5 | 1,860 | 110.0 | 47,548 | 1450.8 | 25,990 | 549.9 | 126 | 234.5 | 19,220 | 151.7 | 5,614 | 1131.0 | 100,758 | 436.1 |
35–39 | 391 | 237.9 | 1,953 | 116.1 | 42,427 | 1480.5 | 27,860 | 604.2 | 124 | 239.0 | 21,900 | 174.9 | 5,569 | 1393.7 | 100,231 | 449.5 |
40–44 | 380 | 252.1 | 2,038 | 134.2 | 41,304 | 1525.0 | 29,189 | 665.9 | 129 | 284.9 | 24,185 | 202.3 | 5,723 | 1667.4 | 102,963 | 487.9 |
45–49 | 318 | 229.1 | 2,348 | 161.6 | 41,266 | 1652.8 | 29,001 | 730.0 | 101 | 262.6 | 26,078 | 228.7 | 5,562 | 1979.5 | 104,701 | 529.3 |
50–54 | 458 | 317.7 | 2,290 | 175.1 | 51,427 | 1998.0 | 34,138 | 960.3 | 110 | 298.8 | 42,454 | 325.8 | 7,465 | 2901.8 | 138,428 | 662.1 |
55–59 | 397 | 258.3 | 1,771 | 151.8 | 58,932 | 2251.4 | 34,884 | 1135.0 | 100 | 280.9 | 57,324 | 401.3 | 8,440 | 3574.7 | 162,000 | 751.1 |
60–64 | 281 | 190.0 | 1,133 | 108.5 | 48,019 | 1961.2 | 24,471 | 995.8 | 73 | 231.2 | 46,754 | 314.0 | 6,359 | 2914.3 | 127,237 | 599.2 |
≥ 65 | 273 | 83.2 | 1,556 | 57.7 | 54,588 | 1034.4 | 26,062 | 516.2 | 83 | 122.6 | 54,665 | 130.3 | 6,504 | 1368.1 | 143,958 | 257.8 |
Transmission categoryg | ||||||||||||||||
Male sex at birth (≥ 13 yrs at end of year)h | ||||||||||||||||
Male-to-male sexual contacti | 1,773 | — | 11,670 | — | 192,625 | — | 159,035 | — | 683 | — | 217,222 | — | 31,683 | — | 615,019 | — |
Injection drug usej | 225 | — | 463 | — | 29,182 | — | 18,423 | — | 24 | — | 13,440 | — | 2,699 | — | 64,530 | — |
Male-to-male sexual contacti and injection drug usej |
293 | — | 436 | — | 15,249 | — | 13,539 | — | 52 | — | 23,373 | — | 4,573 | — | 57,559 | — |
Heterosexual contactk | 164 | — | 1,078 | — | 49,028 | — | 16,450 | — | 37 | — | 9,915 | — | 3,292 | — | 79,991 | — |
Perinatall | 6 | — | 66 | — | 2,969 | — | 1,241 | — | 3 | — | 574 | — | 350 | — | 5,217 | — |
Otherm | 14 | — | 67 | — | 793 | — | 430 | — | 1 | — | 1,274 | — | 150 | — | 2,733 | — |
Subtotal | 2,474 | 247.3 | 13,780 | 172.7 | 289,847 | 1756.8 | 209,118 | 839.6 | 800 | 309.7 | 265,798 | 313.6 | 42,747 | 1673.0 | 825,049 | 598.1 |
Female sex at birth (≥ 13 yrs at end of year)h | ||||||||||||||||
Injection drug usej | 270 | — | 192 | — | 22,134 | — | 9,349 | — | 27 | — | 12,783 | — | 3,047 | — | 47,864 | — |
Heterosexual contactk | 509 | — | 2,511 | — | 115,867 | — | 34,984 | — | 125 | — | 26,736 | — | 9,416 | — | 190,265 | — |
Perinatall | 9 | — | 77 | — | 3,584 | — | 1,384 | — | 0 | — | 638 | — | 419 | — | 6,120 | — |
Otherm | 8 | — | 71 | — | 795 | — | 267 | — | 1 | — | 473 | — | 87 | — | 1,707 | — |
Subtotal | 796 | 76.5 | 2,852 | 32.3 | 142,380 | 781.6 | 45,983 | 188.6 | 152 | 59.9 | 40,630 | 46.8 | 12,970 | 483.6 | 245,956 | 172.9 |
Child (< 13 yrs at end of year) | ||||||||||||||||
Perinatal | 5 | — | 51 | — | 621 | — | 165 | — | 3 | — | 124 | — | 91 | — | 1,060 | — |
Otherm | 1 | — | 37 | — | 110 | — | 15 | — | 0 | — | 31 | — | 8 | — | 202 | — |
Subtotal | 6 | 1.5 | 88 | 3.1 | 731 | 10.2 | 180 | 1.3 | 3 | 2.6 | 155 | 0.6 | 99 | 3.9 | 1,262 | 2.4 |
Region of residencen | ||||||||||||||||
Northeast | 145 | 109.0 | 3,571 | 88.2 | 88,954 | 1,366.9 | 73,702 | 840.5 | 66 | 284.4 | 53,270 | 145.5 | 15,118 | 1,428.2 | 235,158 | 411.4 |
Midwest | 417 | 99.4 | 1,618 | 65.8 | 54,575 | 747.9 | 16,755 | 287.0 | 52 | 126.7 | 48,522 | 94.6 | 7,116 | 476.1 | 129,138 | 187.6 |
South | 803 | 97.3 | 3,600 | 75.3 | 255,815 | 1,047.8 | 89,718 | 375.2 | 167 | 161.2 | 119,022 | 168.7 | 24,228 | 926.4 | 493,509 | 387.9 |
West | 1,911 | 177.9 | 7,931 | 94.5 | 33,614 | 923.7 | 75,106 | 311.3 | 670 | 146.2 | 85,769 | 223.6 | 9,354 | 356.7 | 214,462 | 272.6 |
Total | 3,276 | 133.6 | 16,720 | 84.9 | 432,958 | 1034.3 | 255,281 | 407.5 | 955 | 152.5 | 306,583 | 155.8 | 55,816 | 716.4 | 1,072,267 | 323.1 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12, and rates based on these numbers, should be interpreted with caution.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
e “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
f Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
g Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
h Data include transgender and additional gender identity persons.
i Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
j Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
k Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
l Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
m Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
n Data are based on residence at the end of the specified year (i.e., most recent known address).
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |
---|---|---|---|---|---|---|---|---|
No. | No. | No. | No. | No. | No. | No. | No. | |
Gender | ||||||||
Male | 2,413 | 13,651 | 284,157 | 216,034 | 789 | 264,516 | 41,776 | 823,824 |
Female | 796 | 2,901 | 142,655 | 50,599 | 160 | 40,581 | 12,971 | 250,857 |
Transgender woman/girld | 64 | 219 | 6,106 | 4,349 | 40 | 1,370 | 1,002 | 13,150 |
Transgender man/boyd | 4 | 11 | 234 | 133 | 0 | 142 | 53 | 577 |
Additional gender identitye | 1 | 6 | 141 | 97 | 0 | 79 | 37 | 361 |
Age at end of year | ||||||||
< 13 | 6 | 88 | 732 | 182 | 4 | 155 | 99 | 1,266 |
13–14 | 1 | 39 | 338 | 83 | 0 | 88 | 52 | 601 |
15–19 | 19 | 108 | 2,173 | 781 | 8 | 417 | 201 | 3,707 |
20–24 | 88 | 376 | 13,230 | 6,092 | 28 | 3,118 | 1,022 | 23,959 |
25–29 | 270 | 1,160 | 30,988 | 17,338 | 73 | 10,226 | 3,209 | 63,270 |
30–34 | 394 | 1,867 | 47,563 | 26,864 | 132 | 19,226 | 5,614 | 101,666 |
35–39 | 391 | 1,960 | 42,444 | 28,844 | 128 | 21,911 | 5,569 | 101,254 |
40–44 | 380 | 2,046 | 41,326 | 30,555 | 135 | 24,191 | 5,727 | 104,375 |
45–49 | 318 | 2,356 | 41,303 | 30,531 | 102 | 26,086 | 5,563 | 106,287 |
50–54 | 459 | 2,296 | 51,485 | 36,388 | 114 | 42,471 | 7,470 | 140,770 |
55–59 | 397 | 1,781 | 58,982 | 37,651 | 103 | 57,343 | 8,443 | 164,852 |
60–64 | 282 | 1,147 | 48,064 | 26,772 | 77 | 46,773 | 6,360 | 129,622 |
≥ 65 | 273 | 1,564 | 54,665 | 29,131 | 85 | 54,683 | 6,510 | 147,140 |
Transmission categoryf | ||||||||
Male sex at birth (≥ 13 yrs at end of year)g | ||||||||
Male-to-male sexual contacth | 1,774 | 11,716 | 192,718 | 164,187 | 704 | 217,295 | 31,698 | 620,421 |
Injection drug usei | 225 | 469 | 29,219 | 21,432 | 24 | 13,444 | 2,700 | 67,586 |
Male-to-male sexual contacth and injection drug usei |
293 | 438 | 15,255 | 14,260 | 54 | 23,379 | 4,575 | 58,297 |
Heterosexual contactj | 165 | 1,082 | 49,093 | 18,700 | 40 | 9,919 | 3,293 | 82,317 |
Perinatalk | 6 | 66 | 2,971 | 1,358 | 3 | 574 | 350 | 5,337 |
Otherl | 14 | 67 | 793 | 455 | 1 | 1,274 | 150 | 2,759 |
Subtotal | 2,476 | 13,837 | 290,050 | 220,391 | 827 | 265,884 | 42,765 | 836,718 |
Female sex at birth (≥ 13 yrs at end of year)g | ||||||||
Injection drug usei | 270 | 194 | 22,149 | 10,225 | 27 | 12,789 | 3,048 | 48,764 |
Heterosexual contactj | 509 | 2,520 | 115,977 | 38,653 | 130 | 26,748 | 9,419 | 194,074 |
Perinatalk | 9 | 77 | 3,589 | 1,485 | 1 | 638 | 421 | 6,227 |
Otherl | 8 | 71 | 797 | 277 | 1 | 473 | 87 | 1,720 |
Subtotal | 796 | 2,863 | 142,511 | 50,639 | 158 | 40,649 | 12,975 | 250,785 |
Child (< 13 yrs at end of year) | ||||||||
Perinatal | 5 | 51 | 622 | 167 | 4 | 124 | 91 | 1,064 |
Otherl | 1 | 37 | 110 | 15 | 0 | 31 | 8 | 202 |
Subtotal | 6 | 88 | 732 | 182 | 4 | 155 | 99 | 1,266 |
Region of residencem | ||||||||
Northeast | 145 | 3,571 | 88,954 | 73,702 | 66 | 53,270 | 15,118 | 235,158 |
Midwest | 417 | 1,618 | 54,575 | 16,755 | 52 | 48,522 | 7,116 | 129,138 |
South | 803 | 3,600 | 255,815 | 89,718 | 167 | 119,022 | 24,228 | 493,509 |
West | 1,911 | 7,931 | 33,614 | 75,106 | 670 | 85,769 | 9,354 | 214,462 |
U.S. dependent areas | 2 | 68 | 335 | 15,931 | 34 | 105 | 23 | 16,502 |
Total | 3,278 | 16,788 | 433,293 | 271,212 | 989 | 306,688 | 55,839 | 1,088,769 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12 should be interpreted with caution.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
e Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
f Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
g Data include transgender and additional gender identity persons.
h Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
i Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
j Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
k Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
l Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
m Data are based on residence at the end of the specified year (i.e., most recent known address).
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at end of year | ||||||||||
13–14 | 301 | 7.1 | 298 | 7.0 | 308 | 7.2 | 311 | 6.9 | 300 | 6.6 |
15–19 | 2,983 | 27.7 | 2,883 | 26.8 | 2,858 | 26.6 | 2,500 | 22.7 | 2,415 | 21.9 |
20–24 | 23,174 | 204.8 | 22,111 | 197.9 | 21,436 | 193.7 | 20,106 | 183.7 | 19,861 | 181.0 |
25–29 | 58,974 | 495.7 | 59,659 | 496.7 | 58,647 | 487.9 | 55,563 | 479.8 | 53,173 | 467.3 |
30–34 | 66,180 | 597.2 | 71,477 | 639.0 | 76,816 | 675.6 | 80,964 | 699.6 | 84,810 | 726.5 |
35–39 | 67,930 | 641.0 | 70,429 | 653.2 | 73,075 | 670.9 | 75,449 | 672.1 | 79,475 | 705.6 |
40–44 | 67,581 | 695.4 | 68,345 | 698.7 | 70,274 | 709.4 | 72,880 | 702.9 | 75,872 | 716.2 |
45–49 | 94,975 | 917.6 | 89,349 | 871.8 | 83,910 | 832.2 | 77,639 | 764.4 | 74,209 | 751.4 |
50–54 | 124,484 | 1,187.2 | 119,594 | 1,165.3 | 113,494 | 1,125.7 | 108,467 | 1,046.0 | 102,890 | 985.9 |
55–59 | 110,421 | 1,034.8 | 117,086 | 1,098.5 | 122,778 | 1,154.0 | 124,826 | 1,149.7 | 124,456 | 1,170.8 |
60–64 | 73,334 | 769.6 | 79,273 | 815.8 | 85,115 | 864.0 | 91,286 | 892.2 | 97,331 | 941.9 |
≥ 65 | 68,929 | 306.1 | 78,060 | 335.4 | 88,406 | 367.4 | 98,728 | 402.4 | 110,257 | 437.3 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 2,031 | 212.1 | 2,139 | 221.4 | 2,252 | 231.0 | 2,353 | 237.2 | 2,474 | 247.3 |
Asianc | 11,210 | 153.0 | 11,965 | 159.7 | 12,605 | 164.8 | 13,127 | 166.7 | 13,780 | 172.7 |
Black/African American | 265,465 | 1,686.5 | 272,692 | 1,715.9 | 279,785 | 1,743.9 | 284,122 | 1,734.2 | 289,847 | 1,756.8 |
Hispanic/Latinod | 182,348 | 805.4 | 189,522 | 818.7 | 196,749 | 832.8 | 201,717 | 825.6 | 209,118 | 839.6 |
Native Hawaiian/other Pacific Islander | 619 | 261.2 | 662 | 273.6 | 706 | 286.0 | 744 | 292.6 | 800 | 309.7 |
White | 254,576 | 302.8 | 258,273 | 307.2 | 261,441 | 310.9 | 263,168 | 309.8 | 265,798 | 313.6 |
Multiracial | 42,527 | 1,929.5 | 42,821 | 1,877.2 | 43,092 | 1,824.8 | 43,002 | 1,742.0 | 42,747 | 1,673.0 |
Transmission categorye | ||||||||||
Male-to-male sexual contactf | 549,064 | — | 567,472 | — | 585,215 | — | 598,237 | — | 615,019 | — |
Injection drug useg | 67,773 | — | 67,101 | — | 66,494 | — | 65,327 | — | 64,530 | — |
Male-to-male sexual contactf and injection drug useg |
58,001 | — | 58,116 | — | 58,324 | — | 57,858 | — | 57,559 | — |
Heterosexual contacth | 76,847 | — | 78,210 | — | 79,292 | — | 79,440 | — | 79,991 | — |
Perinatali | 4,814 | — | 4,912 | — | 5,037 | — | 5,120 | — | 5,217 | — |
Otherj | 2,767 | — | 2,753 | — | 2,755 | — | 2,737 | — | 2,733 | — |
Region of residencek | ||||||||||
Northeast | 163,299 | 707.0 | 165,156 | 714.1 | 166,690 | 720.8 | 166,706 | 696.6 | 167,785 | 703.6 |
Midwest | 93,749 | 335.1 | 96,200 | 342.8 | 98,302 | 349.3 | 99,911 | 349.3 | 102,097 | 356.3 |
South | 330,995 | 660.0 | 341,278 | 673.9 | 351,614 | 687.4 | 358,763 | 692.2 | 368,312 | 704.1 |
West | 171,223 | 536.0 | 175,930 | 545.1 | 180,511 | 554.3 | 183,339 | 556.0 | 186,855 | 564.0 |
Subtotal | 759,266 | 570.1 | 778,564 | 580.6 | 797,117 | 590.5 | 808,719 | 588.8 | 825,049 | 598.1 |
Female sex at birthb | ||||||||||
Age at end of year | ||||||||||
13–14 | 369 | 9.1 | 369 | 9.1 | 344 | 8.4 | 328 | 7.7 | 299 | 6.9 |
15–19 | 1,565 | 15.2 | 1,484 | 14.4 | 1,393 | 13.5 | 1,300 | 12.3 | 1,274 | 12.1 |
20–24 | 5,259 | 48.9 | 4,894 | 45.9 | 4,628 | 43.8 | 4,161 | 39.5 | 3,907 | 37.0 |
25–29 | 11,369 | 99.2 | 11,187 | 97.0 | 10,681 | 92.7 | 9,995 | 89.0 | 9,500 | 86.3 |
30–34 | 16,517 | 151.9 | 16,175 | 147.8 | 16,272 | 146.7 | 16,121 | 142.6 | 15,948 | 139.5 |
35–39 | 23,608 | 222.8 | 23,019 | 213.8 | 22,346 | 205.7 | 21,218 | 192.8 | 20,756 | 188.1 |
40–44 | 28,082 | 284.9 | 28,008 | 282.9 | 27,625 | 275.9 | 27,333 | 265.3 | 27,091 | 257.7 |
45–49 | 34,456 | 326.7 | 33,438 | 319.5 | 32,738 | 317.6 | 31,323 | 308.3 | 30,492 | 307.8 |
50–54 | 37,632 | 347.0 | 37,282 | 351.9 | 36,593 | 352.3 | 36,249 | 348.1 | 35,538 | 339.4 |
55–59 | 33,215 | 294.6 | 34,927 | 310.2 | 36,532 | 325.2 | 37,231 | 333.1 | 37,544 | 343.3 |
60–64 | 22,240 | 213.9 | 24,410 | 230.6 | 26,421 | 246.7 | 28,297 | 261.8 | 29,906 | 274.3 |
≥ 65 | 20,245 | 71.7 | 23,165 | 79.7 | 26,559 | 88.6 | 29,878 | 99.9 | 33,701 | 110.0 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 722 | 72.1 | 737 | 72.9 | 762 | 74.6 | 770 | 74.7 | 796 | 76.5 |
Asianc | 2,406 | 29.2 | 2,531 | 30.0 | 2,646 | 30.8 | 2,747 | 31.5 | 2,852 | 32.3 |
Black/African American | 136,404 | 774.3 | 138,566 | 779.5 | 140,606 | 783.8 | 141,187 | 780.4 | 142,380 | 781.6 |
Hispanic/Latinod | 43,472 | 194.8 | 44,258 | 193.7 | 45,035 | 193.0 | 45,323 | 189.6 | 45,983 | 188.6 |
Native Hawaiian/other Pacific Islander | 123 | 52.4 | 126 | 52.6 | 128 | 52.4 | 142 | 56.9 | 152 | 59.9 |
White | 38,048 | 43.5 | 38,714 | 44.3 | 39,494 | 45.2 | 39,976 | 45.9 | 40,630 | 46.8 |
Multiracial | 13,187 | 561.8 | 13,231 | 546.0 | 13,267 | 530.3 | 13,095 | 504.2 | 12,970 | 483.6 |
Transmission categorye | ||||||||||
Injection drug useg | 49,011 | — | 48,850 | — | 48,759 | — | 48,198 | — | 47,864 | — |
Heterosexual contacth | 178,387 | — | 182,152 | — | 185,832 | — | 187,561 | — | 190,265 | — |
Perinatali | 5,518 | — | 5,697 | — | 5,858 | — | 5,979 | — | 6,120 | — |
Otherj | 1,641 | — | 1,659 | — | 1,684 | — | 1,697 | — | 1,707 | — |
Region of residencek | ||||||||||
Northeast | 67,699 | 274.2 | 67,927 | 275.0 | 67,894 | 275.0 | 67,428 | 267.8 | 67,192 | 268.0 |
Midwest | 24,497 | 84.2 | 25,146 | 86.2 | 25,835 | 88.3 | 26,233 | 89.5 | 26,742 | 91.1 |
South | 117,446 | 221.6 | 119,631 | 223.4 | 122,055 | 225.6 | 122,969 | 227.2 | 124,610 | 227.9 |
West | 24,915 | 76.8 | 25,654 | 78.3 | 26,348 | 79.7 | 26,804 | 81.2 | 27,412 | 82.6 |
Subtotal | 234,557 | 168.5 | 238,358 | 170.0 | 242,132 | 171.6 | 243,434 | 171.9 | 245,956 | 172.9 |
Total | 993,823 | 364.8 | 1,016,922 | 370.8 | 1,039,249 | 376.5 | 1,052,153 | 377.1 | 1,071,005 | 382.2 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Data include transgender and additional gender identity persons.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on residence at the end of the specified year (i.e., most recent known address).
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Male sex at birthb | ||||||||||
Age at end of year | ||||||||||
13–14 | 303 | 7.1 | 302 | 7.0 | 311 | 7.2 | 313 | 6.9 | 301 | 6.6 |
15–19 | 3,007 | 27.6 | 2,911 | 26.7 | 2,875 | 26.4 | 2,514 | 22.6 | 2,426 | 21.8 |
20–24 | 23,402 | 204.4 | 22,314 | 197.5 | 21,639 | 193.4 | 20,287 | 183.2 | 20,013 | 180.3 |
25–29 | 59,536 | 495.2 | 60,224 | 496.4 | 59,207 | 487.5 | 56,059 | 478.8 | 53,671 | 466.5 |
30–34 | 66,862 | 597.8 | 72,149 | 639.4 | 77,522 | 675.7 | 81,692 | 699.3 | 85,548 | 725.7 |
35–39 | 68,831 | 642.9 | 71,261 | 654.7 | 73,861 | 671.9 | 76,221 | 673.0 | 80,259 | 706.4 |
40–44 | 68,666 | 698.6 | 69,398 | 701.9 | 71,300 | 712.2 | 73,877 | 705.2 | 76,866 | 718.3 |
45–49 | 96,474 | 921.8 | 90,669 | 875.1 | 85,137 | 835.3 | 78,767 | 767.1 | 75,282 | 754.0 |
50–54 | 126,550 | 1,193.5 | 121,608 | 1,171.9 | 115,351 | 1,131.4 | 110,249 | 1,051.6 | 104,521 | 990.7 |
55–59 | 112,232 | 1,040.7 | 118,983 | 1,104.6 | 124,796 | 1,160.7 | 126,831 | 1,155.8 | 126,481 | 1,177.0 |
60–64 | 74,637 | 774.7 | 80,658 | 821.1 | 86,562 | 869.3 | 92,826 | 897.6 | 98,927 | 947.3 |
≥ 65 | 70,348 | 308.2 | 79,598 | 337.5 | 90,146 | 369.8 | 100,663 | 404.8 | 112,423 | 439.9 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 2,033 | — | 2,141 | — | 2,254 | — | 2,355 | — | 2,476 | — |
Asianc | 11,255 | — | 12,014 | — | 12,661 | — | 13,183 | — | 13,837 | — |
Black/African American | 265,638 | — | 272,879 | — | 279,975 | — | 284,317 | — | 290,050 | — |
Hispanic/Latinod | 193,594 | — | 200,681 | — | 207,968 | — | 212,915 | — | 220,391 | — |
Native Hawaiian/other Pacific Islander | 644 | — | 688 | — | 732 | — | 771 | — | 827 | — |
White | 254,644 | — | 258,341 | — | 261,518 | — | 263,248 | — | 265,884 | — |
Multiracial | 42,548 | — | 42,839 | — | 43,110 | — | 43,022 | — | 42,765 | — |
Transmission categorye | ||||||||||
Male-to-male sexual contactf | 553,853 | — | 572,368 | — | 590,282 | — | 603,437 | — | 620,421 | — |
Injection drug useg | 71,241 | — | 70,441 | — | 69,734 | — | 68,468 | — | 67,586 | — |
Male-to-male sexual contactf and injection drug useg |
58,805 | — | 58,890 | — | 59,089 | — | 58,605 | — | 58,297 | — |
Heterosexual contacth | 79,212 | — | 80,556 | — | 81,654 | — | 81,781 | — | 82,317 | — |
Perinatali | 4,943 | — | 5,040 | — | 5,166 | — | 5,245 | — | 5,337 | — |
Otherj | 2,795 | — | 2,780 | — | 2,782 | — | 2,763 | — | 2,759 | — |
Region of residencek | ||||||||||
Northeast | 163,299 | 707.0 | 165,156 | 714.1 | 166,690 | 720.8 | 166,706 | 696.6 | 167,785 | 703.6 |
Midwest | 93,749 | 335.1 | 96,200 | 342.8 | 98,302 | 349.3 | 99,911 | 349.3 | 102,097 | 356.3 |
South | 330,995 | 660.0 | 341,278 | 673.9 | 351,614 | 687.4 | 358,763 | 692.2 | 368,312 | 704.1 |
West | 171,223 | 536.0 | 175,930 | 545.1 | 180,511 | 554.3 | 183,339 | 556.0 | 186,855 | 564.0 |
U.S. dependent areas | 11,582 | 765.7 | 11,511 | 782.4 | 11,590 | 784.3 | 11,580 | 761.2 | 11,669 | 767.5 |
Subtotal | 770,848 | 572.3 | 790,075 | 582.7 | 808,707 | 592.6 | 820,299 | 590.7 | 836,718 | 600.0 |
Female sex at birthb | ||||||||||
Age at end of year | ||||||||||
13–14 | 373 | 9.1 | 373 | 9.1 | 345 | 8.4 | 329 | 7.6 | 300 | 6.9 |
15–19 | 1,587 | 15.2 | 1,499 | 14.4 | 1,402 | 13.4 | 1,308 | 12.3 | 1,281 | 12.0 |
20–24 | 5,327 | 49.0 | 4,961 | 46.0 | 4,680 | 43.7 | 4,200 | 39.5 | 3,946 | 37.0 |
25–29 | 11,514 | 99.3 | 11,320 | 97.1 | 10,809 | 92.8 | 10,113 | 89.1 | 9,599 | 86.2 |
30–34 | 16,748 | 152.4 | 16,381 | 148.2 | 16,472 | 147.1 | 16,307 | 142.8 | 16,118 | 139.6 |
35–39 | 23,994 | 223.9 | 23,365 | 214.7 | 22,637 | 206.3 | 21,469 | 193.1 | 20,995 | 188.4 |
40–44 | 28,585 | 286.5 | 28,472 | 284.2 | 28,056 | 277.0 | 27,761 | 266.4 | 27,509 | 258.8 |
45–49 | 35,144 | 329.3 | 34,096 | 322.0 | 33,370 | 320.0 | 31,875 | 310.0 | 31,005 | 309.3 |
50–54 | 38,496 | 350.6 | 38,083 | 355.2 | 37,342 | 355.2 | 36,980 | 350.8 | 36,249 | 342.1 |
55–59 | 34,054 | 298.6 | 35,773 | 314.1 | 37,418 | 329.3 | 38,100 | 336.7 | 38,371 | 346.6 |
60–64 | 22,788 | 216.5 | 25,046 | 233.9 | 27,111 | 250.3 | 29,045 | 265.5 | 30,695 | 278.2 |
≥ 65 | 20,897 | 73.0 | 23,877 | 81.0 | 27,373 | 90.1 | 30,786 | 101.5 | 34,717 | 111.7 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 722 | — | 737 | — | 762 | — | 770 | — | 796 | — |
Asianc | 2,417 | — | 2,542 | — | 2,657 | — | 2,758 | — | 2,863 | — |
Black/African American | 136,530 | — | 138,692 | — | 140,736 | — | 141,318 | — | 142,511 | — |
Hispanic/Latinod | 48,254 | — | 48,980 | — | 49,748 | — | 49,991 | — | 50,639 | — |
Native Hawaiian/other Pacific Islander | 130 | — | 131 | — | 134 | — | 148 | — | 158 | — |
White | 38,066 | — | 38,731 | — | 39,512 | — | 39,993 | — | 40,649 | — |
Multiracial | 13,192 | — | 13,237 | — | 13,271 | — | 13,100 | — | 12,975 | — |
Transmission categorye | ||||||||||
Injection drug useg | 50,003 | — | 49,809 | — | 49,704 | — | 49,119 | — | 48,764 | — |
Heterosexual contacth | 182,209 | — | 185,953 | — | 189,650 | — | 191,356 | — | 194,074 | — |
Perinatali | 5,641 | — | 5,813 | — | 5,966 | — | 6,090 | — | 6,227 | — |
Otherj | 1,654 | — | 1,671 | — | 1,694 | — | 1,708 | — | 1,720 | — |
Region of residencek | ||||||||||
Northeast | 67,699 | 274.2 | 67,927 | 275.0 | 67,894 | 275.0 | 67,428 | 267.8 | 67,192 | 268.0 |
Midwest | 24,497 | 84.2 | 25,146 | 86.2 | 25,835 | 88.3 | 26,233 | 89.5 | 26,742 | 91.1 |
South | 117,446 | 221.6 | 119,631 | 223.4 | 122,055 | 225.6 | 122,969 | 227.2 | 124,610 | 227.9 |
West | 24,915 | 76.8 | 25,654 | 78.3 | 26,348 | 79.7 | 26,804 | 81.2 | 27,412 | 82.6 |
U.S. dependent areas | 4,950 | 294.0 | 4,888 | 298.7 | 4,883 | 296.8 | 4,839 | 285.1 | 4,829 | 284.1 |
Subtotal | 239,507 | 170.0 | 243,246 | 171.5 | 247,015 | 173.1 | 248,273 | 173.2 | 250,785 | 174.2 |
Total | 1,010,355 | 366.6 | 1,033,321 | 372.5 | 1,055,722 | 378.1 | 1,068,572 | 378.7 | 1,087,503 | 383.7 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
a Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
b Data include transgender and additional gender identity persons.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanic/Latino persons can be of any race.
e Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on residence at the end of the specified year (i.e., most recent known address).
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at end of year | |||||
13–14 | 0 | 0 | 0 | 1 | 2 |
15–19 | 106 | 78 | 76 | 53 | 64 |
20–24 | 864 | 837 | 802 | 774 | 786 |
25–29 | 2,002 | 2,005 | 1,928 | 1,846 | 1,833 |
30–34 | 1,891 | 2,115 | 2,380 | 2,620 | 2,749 |
35–39 | 1,519 | 1,628 | 1,758 | 1,840 | 2,015 |
40–44 | 1,150 | 1,227 | 1,314 | 1,451 | 1,605 |
45–49 | 1,117 | 1,132 | 1,173 | 1,168 | 1,191 |
50–54 | 1,010 | 1,056 | 1,055 | 1,105 | 1,123 |
55–59 | 625 | 703 | 795 | 830 | 876 |
60–64 | 314 | 355 | 392 | 455 | 521 |
≥ 65 | 175 | 209 | 262 | 303 | 345 |
Race/ethnicity | |||||
American Indian/Alaska Native | 44 | 51 | 55 | 59 | 64 |
Asianb | 166 | 176 | 188 | 201 | 219 |
Black/African American | 5,029 | 5,305 | 5,581 | 5,816 | 6,106 |
Hispanic/Latinoc | 3,436 | 3,642 | 3,870 | 4,062 | 4,311 |
Native Hawaiian/other Pacific Islander | 24 | 27 | 31 | 33 | 39 |
White | 1,124 | 1,174 | 1,232 | 1,284 | 1,370 |
Multiracial | 950 | 970 | 978 | 991 | 1,001 |
Exposure categoryd | |||||
Sexual contacte | 8,923 | 9,467 | 10,027 | 10,529 | 11,151 |
Injection drug usef | 22 | 26 | 27 | 27 | 30 |
Sexual contacte and injection drug usef |
1,646 | 1,663 | 1,682 | 1,670 | 1,679 |
Perinatalg | 24 | 24 | 23 | 23 | 22 |
Otherh | 158 | 165 | 176 | 197 | 228 |
Region of residencei | |||||
Northeast | 2,786 | 2,928 | 3,039 | 3,126 | 3,256 |
Midwest | 1,497 | 1,601 | 1,655 | 1,741 | 1,862 |
South | 3,937 | 4,114 | 4,339 | 4,577 | 4,830 |
West | 2,553 | 2,702 | 2,902 | 3,002 | 3,162 |
Subtotal | 10,773 | 11,345 | 11,935 | 12,446 | 13,110 |
Transgender mana | |||||
Age at end of year | |||||
13–14 | 1 | 0 | 0 | 1 | 2 |
15–19 | 7 | 7 | 5 | 3 | 6 |
20–24 | 20 | 22 | 29 | 39 | 40 |
25–29 | 63 | 75 | 75 | 69 | 70 |
30–34 | 45 | 63 | 88 | 99 | 123 |
35–39 | 66 | 66 | 67 | 76 | 83 |
40–44 | 41 | 51 | 55 | 56 | 62 |
45–49 | 49 | 52 | 53 | 48 | 48 |
50–54 | 48 | 47 | 45 | 48 | 47 |
55–59 | 28 | 25 | 34 | 39 | 45 |
60–64 | 21 | 27 | 23 | 25 | 23 |
≥ 65 | 11 | 12 | 15 | 17 | 25 |
Race/ethnicity | |||||
American Indian/Alaska Native | 4 | 4 | 4 | 4 | 4 |
Asianb | 6 | 8 | 9 | 9 | 11 |
Black/African American | 175 | 194 | 210 | 217 | 234 |
Hispanic/Latinoc | 87 | 96 | 109 | 117 | 130 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 86 | 102 | 110 | 123 | 142 |
Multiracial | 42 | 43 | 47 | 50 | 53 |
Exposure categoryd | |||||
Sexual contacte | 291 | 334 | 367 | 390 | 437 |
Injection drug usef | 6 | 8 | 9 | 10 | 10 |
Sexual contacte and injection drug usef |
65 | 63 | 65 | 66 | 65 |
Perinatalg | 18 | 18 | 17 | 19 | 19 |
Otherh | 20 | 24 | 31 | 35 | 43 |
Region of residencei | |||||
Northeast | 77 | 80 | 89 | 94 | 101 |
Midwest | 112 | 122 | 127 | 129 | 136 |
South | 119 | 136 | 153 | 176 | 198 |
West | 92 | 109 | 120 | 121 | 139 |
Subtotal | 400 | 447 | 489 | 520 | 574 |
Additional gender identityj | |||||
Age at end of year | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 3 | 5 | 6 | 4 | 4 |
20–24 | 26 | 30 | 39 | 36 | 49 |
25–29 | 46 | 47 | 46 | 53 | 65 |
30–34 | 34 | 41 | 58 | 69 | 73 |
35–39 | 34 | 38 | 41 | 38 | 39 |
40–44 | 21 | 20 | 18 | 24 | 33 |
45–49 | 27 | 26 | 26 | 32 | 33 |
50–54 | 17 | 18 | 21 | 19 | 22 |
55–59 | 16 | 17 | 18 | 14 | 16 |
60–64 | 9 | 10 | 8 | 14 | 14 |
≥ 65 | 6 | 8 | 11 | 12 | 13 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 1 | 1 | 1 | 1 |
Asianb | 2 | 5 | 5 | 6 | 6 |
Black/African American | 102 | 109 | 118 | 128 | 141 |
Hispanic/Latinoc | 63 | 67 | 76 | 81 | 97 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 45 | 49 | 58 | 64 | 79 |
Multiracial | 27 | 29 | 34 | 35 | 37 |
Exposure categoryd | |||||
Sexual contacte | 203 | 225 | 255 | 275 | 314 |
Injection drug usef | 1 | 1 | 1 | 1 | 1 |
Sexual contacte and injection drug usef |
28 | 27 | 28 | 29 | 34 |
Perinatalg | 3 | 3 | 3 | 3 | 3 |
Otherh | 4 | 4 | 5 | 7 | 9 |
Region of residencei | |||||
Northeast | 110 | 129 | 138 | 143 | 155 |
Midwest | 37 | 40 | 52 | 59 | 67 |
South | 72 | 72 | 79 | 81 | 90 |
West | 20 | 19 | 23 | 32 | 49 |
Subtotal | 239 | 260 | 292 | 315 | 361 |
Total | 11,412 | 12,052 | 12,716 | 13,281 | 14,045 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanic/Latino persons can be of any race.
d Risk factor data for transgender and additional gender identity persons aged ≥ 13 years are presented using the exposure category classification which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
e For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
f Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
g Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
h Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
i Data are based on address of residence at the end of the specified year (i.e., most recent known address).
j Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
2017 | 2018 | 2019 | 2020 (COVID-19 Pandemic) | 2021 | |
---|---|---|---|---|---|
No. | No. | No. | No. | No. | |
Transgender womana | |||||
Age at end of year | |||||
13–14 | 0 | 0 | 0 | 1 | 2 |
15–19 | 106 | 78 | 76 | 53 | 64 |
20–24 | 867 | 841 | 807 | 780 | 789 |
25–29 | 2,005 | 2,008 | 1,931 | 1,848 | 1,838 |
30–34 | 1,900 | 2,124 | 2,388 | 2,627 | 2,754 |
35–39 | 1,524 | 1,631 | 1,761 | 1,846 | 2,018 |
40–44 | 1,153 | 1,234 | 1,322 | 1,460 | 1,614 |
45–49 | 1,120 | 1,132 | 1,174 | 1,170 | 1,193 |
50–54 | 1,014 | 1,058 | 1,059 | 1,107 | 1,124 |
55–59 | 631 | 710 | 801 | 836 | 881 |
60–64 | 315 | 356 | 394 | 458 | 525 |
≥ 65 | 177 | 211 | 263 | 304 | 347 |
Race/ethnicity | |||||
American Indian/Alaska Native | 44 | 51 | 55 | 59 | 64 |
Asianb | 166 | 176 | 188 | 201 | 219 |
Black/African American | 5,030 | 5,306 | 5,582 | 5,817 | 6,106 |
Hispanic/Latinoc | 3,474 | 3,679 | 3,908 | 4,104 | 4,349 |
Native Hawaiian/other Pacific Islander | 24 | 27 | 32 | 34 | 40 |
White | 1,124 | 1,174 | 1,233 | 1,284 | 1,370 |
Multiracial | 950 | 970 | 978 | 991 | 1,001 |
Exposure categoryd | |||||
Sexual contacte | 8,954 | 9,498 | 10,062 | 10,567 | 11,185 |
Injection drug usef | 22 | 26 | 27 | 27 | 30 |
Sexual contacte and injection drug usef |
1,654 | 1,670 | 1,688 | 1,676 | 1,684 |
Perinatalg | 24 | 24 | 23 | 23 | 22 |
Otherh | 158 | 165 | 176 | 197 | 228 |
Region of residencei | |||||
Northeast | 2,786 | 2,928 | 3,039 | 3,126 | 3,256 |
Midwest | 1,497 | 1,601 | 1,655 | 1,741 | 1,862 |
South | 3,937 | 4,114 | 4,339 | 4,577 | 4,830 |
West | 2,553 | 2,702 | 2,902 | 3,002 | 3,162 |
US dependent areas | 39 | 38 | 41 | 44 | 39 |
Subtotal | 10,812 | 11,383 | 11,976 | 12,490 | 13,149 |
Transgender mana | |||||
Age at end of year | |||||
13–14 | 1 | 0 | 0 | 1 | 2 |
15–19 | 8 | 8 | 5 | 3 | 6 |
20–24 | 20 | 22 | 30 | 40 | 41 |
25–29 | 64 | 76 | 76 | 69 | 70 |
30–34 | 45 | 63 | 88 | 100 | 124 |
35–39 | 66 | 66 | 67 | 76 | 83 |
40–44 | 41 | 51 | 55 | 56 | 62 |
45–49 | 49 | 52 | 53 | 48 | 48 |
50–54 | 48 | 47 | 45 | 48 | 47 |
55–59 | 28 | 25 | 34 | 39 | 45 |
60–64 | 21 | 27 | 23 | 25 | 23 |
≥ 65 | 12 | 13 | 16 | 18 | 26 |
Race/ethnicity | |||||
American Indian/Alaska Native | 4 | 4 | 4 | 4 | 4 |
Asianb | 6 | 8 | 9 | 9 | 11 |
Black/African American | 175 | 194 | 210 | 217 | 234 |
Hispanic/Latinoc | 90 | 99 | 112 | 120 | 133 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 86 | 102 | 110 | 123 | 142 |
Multiracial | 42 | 43 | 47 | 50 | 53 |
Exposure categoryd | |||||
Sexual contacte | 292 | 335 | 368 | 391 | 438 |
Injection drug usef | 6 | 8 | 9 | 10 | 10 |
Sexual contacte and injection drug usef |
66 | 64 | 66 | 67 | 66 |
Perinatalg | 19 | 19 | 18 | 20 | 20 |
Otherh | 20 | 24 | 31 | 35 | 43 |
Region of residencei | |||||
Northeast | 77 | 80 | 89 | 94 | 101 |
Midwest | 112 | 122 | 127 | 129 | 136 |
South | 119 | 136 | 153 | 176 | 198 |
West | 92 | 109 | 120 | 121 | 139 |
US dependent areas | 3 | 3 | 3 | 3 | 3 |
Subtotal | 403 | 450 | 492 | 523 | 577 |
Additional gender identityj | |||||
Age at end of year | |||||
13–14 | 0 | 0 | 0 | 0 | 0 |
15–19 | 3 | 5 | 6 | 4 | 4 |
20–24 | 26 | 30 | 39 | 36 | 49 |
25–29 | 46 | 47 | 46 | 53 | 65 |
30–34 | 34 | 42 | 58 | 69 | 73 |
35–39 | 34 | 38 | 41 | 38 | 39 |
40–44 | 21 | 20 | 18 | 24 | 33 |
45–49 | 27 | 26 | 26 | 32 | 33 |
50–54 | 17 | 18 | 21 | 19 | 22 |
55–59 | 16 | 17 | 18 | 14 | 16 |
60–64 | 9 | 10 | 8 | 14 | 14 |
≥ 65 | 6 | 8 | 11 | 12 | 13 |
Race/ethnicity | |||||
American Indian/Alaska Native | 0 | 1 | 1 | 1 | 1 |
Asianb | 2 | 5 | 5 | 6 | 6 |
Black/African American | 102 | 109 | 118 | 128 | 141 |
Hispanic/Latinoc | 63 | 68 | 76 | 81 | 97 |
Native Hawaiian/other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
White | 45 | 49 | 58 | 64 | 79 |
Multiracial | 27 | 29 | 34 | 35 | 37 |
Exposure categoryd | |||||
Sexual contacte | 203 | 226 | 255 | 275 | 314 |
Injection drug usef | 1 | 1 | 1 | 1 | 1 |
Sexual contacte and injection drug usef |
28 | 27 | 28 | 29 | 34 |
Perinatalg | 3 | 3 | 3 | 3 | 3 |
Otherh | 4 | 4 | 5 | 7 | 9 |
Region of residencei | |||||
Northeast | 110 | 129 | 138 | 143 | 155 |
Midwest | 37 | 40 | 52 | 59 | 67 |
South | 72 | 72 | 79 | 81 | 90 |
West | 20 | 19 | 23 | 32 | 49 |
US dependent areas | 0 | 1 | 0 | 0 | 0 |
Subtotal | 239 | 261 | 292 | 315 | 361 |
Total | 11,454 | 12,094 | 12,760 | 13,328 | 14,087 |
Note. Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
a “Transgender woman” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender man” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanic/Latino persons can be of any race.
d Risk factor data for transgender and additional gender identity persons aged ≥ 13 years are presented using the exposure category classification which is meant to convey all the known ways the person could have been exposed to HIV. Exposure categories are mutually exclusive and have no presumed hierarchical order of probability, except for rare circumstances where route of transmission has been confirmed through investigation. See Technical Notes for more information on exposure categories.
e For persons assigned “male” sex at birth, sexual contact with any person. For persons assigned “female” sex at birth, sexual contact with a person assigned “male” sex at birth.
f Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
g Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
h Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified. Data were not statistically adjusted to account for missing exposure category; therefore, case counts for “Other” might be high.
i Data are based on address of residence at the end of the specified year (i.e., most recent known address).
j Additional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
13–14 years | 15–17 years | 18–19 years | 20–22 years | 23–24 years | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea | |
Sex at birth | ||||||||||||
Male | 300 | 6.6 | 726 | 10.9 | 1,689 | 38.6 | 8,732 | 131.9 | 11,129 | 255.6 | 22,576 | 85.1 |
Female | 299 | 6.9 | 630 | 9.9 | 644 | 15.4 | 1,842 | 29.0 | 2,065 | 49.2 | 5,480 | 21.6 |
Race/Ethnicity | ||||||||||||
American Indian/Alaska Native | 1 | 1.3 | 3 | 2.7 | 16 | 22.5 | 42 | 38.5 | 46 | 64.3 | 108 | 24.8 |
Asianb | 39 | 8.7 | 56 | 8.3 | 52 | 11.3 | 166 | 23.3 | 210 | 41.5 | 523 | 18.7 |
Black/African American | 338 | 27.5 | 833 | 47.4 | 1,338 | 114.8 | 6,064 | 333.5 | 7,160 | 594.7 | 15,733 | 219.2 |
Hispanic/Latinoc | 81 | 3.5 | 229 | 7.0 | 537 | 25.9 | 2,549 | 84.1 | 3,360 | 174.1 | 6,756 | 53.6 |
Native Hawaiian/Other Pacific Islander | 0 | 0.0 | 3 | 11.4 | 5 | 29.4 | 14 | 54.8 | 13 | 75.7 | 35 | 33.7 |
White | 88 | 2.0 | 148 | 2.2 | 269 | 6.0 | 1,307 | 19.1 | 1,811 | 39.8 | 3,623 | 13.5 |
Multiracial | 52 | 13.7 | 84 | 16.4 | 116 | 37.6 | 431 | 98.1 | 590 | 217.7 | 1,273 | 66.6 |
Transmission Categoryd | ||||||||||||
Male sex at birthe | ||||||||||||
Male-to-male sexual contactf | 5 | — | 248 | — | 1,290 | — | 7,698 | — | 9,848 | — | 19,089 | — |
Injection drug useg | 0 | — | 2 | — | 5 | — | 71 | — | 126 | — | 204 | — |
Male-to-male sexual contactf and injection drug useg |
1 | — | 4 | — | 21 | — | 174 | — | 341 | — | 541 | — |
Heterosexual contacth | 1 | — | 11 | — | 28 | — | 219 | — | 308 | — | 566 | — |
Perinatali | 236 | — | 364 | — | 278 | — | 500 | — | 457 | — | 1,834 | — |
Otherj | 57 | — | 97 | — | 67 | — | 72 | — | 50 | — | 343 | — |
Subtotal | 300 | 6.6 | 726 | 10.9 | 1,689 | 38.6 | 8,732 | 131.9 | 11,129 | 255.6 | 22,576 | 85.1 |
Female sex at birthe | ||||||||||||
Injection drug useg | 1 | — | 6 | — | 27 | — | 108 | — | 156 | — | 296 | — |
Heterosexual contacth | 6 | — | 75 | — | 221 | — | 1,027 | — | 1,320 | — | 2,648 | — |
Perinatali | 224 | — | 456 | — | 304 | — | 633 | — | 552 | — | 2,169 | — |
Otherj | 69 | — | 93 | — | 92 | — | 74 | — | 38 | — | 366 | — |
Subtotal | 299 | 6.9 | 630 | 9.9 | 644 | 15.4 | 1,842 | 29.0 | 2,065 | 49.2 | 5,480 | 21.6 |
Region of residencek | ||||||||||||
Northeast | 94 | 6.7 | 242 | 11.5 | 345 | 23.1 | 1,557 | 71.1 | 1,980 | 141.1 | 4,218 | 49.2 |
Midwest | 140 | 7.5 | 236 | 8.6 | 356 | 19.8 | 1,569 | 56.5 | 1,936 | 108.9 | 4,237 | 38.6 |
South | 261 | 7.5 | 638 | 12.6 | 1,249 | 38.1 | 5,874 | 118.1 | 7,115 | 216.8 | 15,137 | 75.5 |
West | 104 | 4.9 | 240 | 7.7 | 383 | 19.2 | 1,574 | 51.9 | 2,163 | 103.5 | 4,464 | 36.1 |
Totall | 599 | 6.7 | 1,356 | 10.4 | 2,333 | 27.2 | 10,574 | 81.5 | 13,194 | 154.3 | 28,056 | 54.0 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12, and rates based on these numbers, should be interpreted with caution.
a Rates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanic/Latino persons can be of any race.
d Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
e Data include transgender and additional gender identity persons.
f Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
g Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
h Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
i Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
j Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
k Data are based on address of residence at the end of the specified year (i.e., most recent known address).
l Includes persons whose race/ethnicity is unknown.
13–14 years | 15–17 years | 18–19 years | 20–22 years | 23–24 years | Total | |
---|---|---|---|---|---|---|
No. | No. | No. | No. | No. | No. | |
Sex at birth | ||||||
Male | 301 | 731 | 1,695 | 8,795 | 11,218 | 22,740 |
Female | 300 | 635 | 646 | 1,859 | 2,087 | 5,527 |
Race/Ethnicity | ||||||
American Indian/Alaska Native | 1 | 3 | 16 | 42 | 46 | 108 |
Asiana | 39 | 56 | 52 | 166 | 210 | 523 |
Black/African American | 338 | 834 | 1,339 | 6,066 | 7,164 | 15,741 |
Hispanic/Latinob | 83 | 237 | 544 | 2,627 | 3,465 | 6,956 |
Native Hawaiian/Other Pacific Islander | 0 | 3 | 5 | 14 | 14 | 36 |
White | 88 | 148 | 269 | 1,307 | 1,811 | 3,623 |
Multiracial | 52 | 85 | 116 | 431 | 591 | 1,275 |
Transmission Categoryc | ||||||
Male sex at birthd | ||||||
Male-to-male sexual contacte | 5 | 248 | 1,294 | 7,745 | 9,921 | 19,213 |
Injection drug usef | 0 | 2 | 5 | 71 | 127 | 205 |
Male-to-male sexual contacte and injection drug usef | 1 | 4 | 21 | 177 | 343 | 546 |
Heterosexual contactg | 1 | 11 | 29 | 222 | 312 | 574 |
Perinatalh | 237 | 369 | 279 | 509 | 465 | 1,858 |
Otheri | 57 | 97 | 67 | 73 | 50 | 344 |
Subtotal | 301 | 731 | 1,695 | 8,795 | 11,218 | 22,740 |
Female sex at birthd | ||||||
Injection drug usef | 1 | 6 | 27 | 108 | 156 | 296 |
Heterosexual contactg | 6 | 76 | 222 | 1,036 | 1,335 | 2,675 |
Perinatalh | 225 | 460 | 305 | 641 | 556 | 2,187 |
Otheri | 69 | 93 | 92 | 74 | 40 | 368 |
Subtotal | 300 | 635 | 646 | 1,859 | 2,087 | 5,527 |
Region of residencej | ||||||
Northeast | 94 | 242 | 345 | 1,557 | 1,980 | 4,218 |
Midwest | 140 | 236 | 356 | 1,569 | 1,936 | 4,237 |
South | 261 | 638 | 1,249 | 5,874 | 7,115 | 15,137 |
West | 104 | 240 | 383 | 1,574 | 2,163 | 4,464 |
U.S. dependent areas | 2 | 10 | 8 | 80 | 111 | 211 |
Totalk | 601 | 1,366 | 2,341 | 10,654 | 13,305 | 28,267 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12 should be interpreted with caution.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Transmission category is classified based on a hierarchy of the risk factors most likely responsible for HIV transmission; classification is determined based on the person’s assigned sex at birth. Data have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
d Data include transgender and additional gender identity persons.
e Includes individuals assigned male sex at birth, regardless of current gender identity, who have had sexual contact with other males, and individuals assigned male sex at birth who have had sexual contact with both males and females (i.e., bisexual contact).
f Includes persons who injected nonprescription drugs or who injected prescription drugs for nonmedical purposes. Also includes injection of drugs prescribed to persons if there is evidence that injection equipment was shared (e.g., syringes, needles, cookers).
g Heterosexual contact with a person known to have, or with a risk factor for, HIV infection.
h Individuals were aged ≥ 13 years at time of diagnosis of HIV infection.
i Other risk factors, including hemophilia, blood transfusion, and risk factor not reported or not identified.
j Data are based on address of residence at the end of the specified year (i.e., most recent known address).
k Includes persons whose race/ethnicity is unknown.
Diagnosis, 2021a | Prevalence of diagnosed HIV infection, year-end 2021 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Persons aged ≥13 years | Children (<13 years) | Total | Persons aged ≥13 years | Children (<13 years) | Total | |||||||
Area of residence | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb | No. | Rateb |
Alabama | 625 | 14.7 | 2 | 0.3 | 627 | 12.4 | 14,436 | 339.7 | 23 | 2.9 | 14,459 | 286.9 |
Alaska | 30 | 5.0 | 0 | 0.0 | 30 | 4.1 | 749 | 124.3 | 3 | 2.3 | 752 | 102.6 |
Arizona | 781 | 12.7 | 4 | 0.4 | 785 | 10.8 | 18,230 | 296.4 | 25 | 2.2 | 18,255 | 250.9 |
Arkansas | 338 | 13.4 | 0 | 0.0 | 338 | 11.2 | 6,225 | 245.9 | 8 | 1.6 | 6,233 | 206.0 |
California | 4,399 | 13.3 | 6 | 0.1 | 4,405 | 11.2 | 136,091 | 411.4 | 82 | 1.3 | 136,173 | 347.0 |
Colorado | 406 | 8.2 | 0 | 0.0 | 406 | 7.0 | 13,442 | 271.9 | 21 | 2.4 | 13,463 | 231.6 |
Connecticut | 233 | 7.5 | 0 | 0.0 | 233 | 6.5 | 10,638 | 342.5 | 10 | 2.0 | 10,648 | 295.3 |
Delaware | 81 | 9.5 | 0 | 0.0 | 81 | 8.1 | 3,515 | 410.2 | 3 | 2.0 | 3,518 | 350.6 |
District of Columbia | 195 | 34.1 | 0 | 0.0 | 195 | 29.1 | 13,622 | 2,381.8 | 7 | 7.1 | 13,629 | 2,034.0 |
Florida | 4,072 | 21.7 | 5 | 0.2 | 4,077 | 18.7 | 117,244 | 624.7 | 123 | 4.1 | 117,367 | 538.8 |
Georgia | 2,371 | 26.2 | 3 | 0.2 | 2,374 | 22.0 | 59,422 | 657.1 | 68 | 3.9 | 59,490 | 550.9 |
Hawaii | 65 | 5.3 | 0 | 0.0 | 65 | 4.5 | 2,384 | 195.6 | 2 | 0.9 | 2,386 | 165.5 |
Idaho | 54 | 3.4 | 0 | 0.0 | 54 | 2.8 | 1,311 | 83.2 | 4 | 1.2 | 1,315 | 69.2 |
Illinois | 1,195 | 11.1 | 4 | 0.2 | 1,199 | 9.5 | 35,731 | 333.3 | 70 | 3.6 | 35,801 | 282.5 |
Indiana | 528 | 9.3 | 1 | 0.1 | 529 | 7.8 | 12,347 | 217.0 | 49 | 4.4 | 12,396 | 182.1 |
Iowa | 124 | 4.6 | 0 | 0.0 | 124 | 3.9 | 3,055 | 114.2 | 8 | 1.5 | 3,063 | 95.9 |
Kansas | 154 | 6.3 | 0 | 0.0 | 154 | 5.2 | 3,493 | 143.2 | 9 | 1.8 | 3,502 | 119.3 |
Kentucky | 390 | 10.3 | 0 | 0.0 | 390 | 8.6 | 8,137 | 214.5 | 14 | 2.0 | 8,151 | 180.8 |
Louisiana | 899 | 23.3 | 1 | 0.1 | 900 | 19.5 | 21,552 | 559.0 | 27 | 3.5 | 21,579 | 466.7 |
Maine | 31 | 2.6 | 0 | 0.0 | 31 | 2.3 | 1,693 | 141.2 | 8 | 4.6 | 1,701 | 124.0 |
Maryland | 749 | 14.4 | 2 | 0.2 | 751 | 12.2 | 33,467 | 643.4 | 32 | 3.3 | 33,499 | 543.4 |
Massachusetts | 440 | 7.3 | 1 | 0.1 | 441 | 6.3 | 21,122 | 349.9 | 19 | 2.0 | 21,141 | 302.7 |
Michigan | 633 | 7.4 | 0 | 0.0 | 633 | 6.3 | 17,313 | 202.6 | 45 | 3.0 | 17,358 | 172.7 |
Minnesota | 297 | 6.2 | 0 | 0.0 | 297 | 5.2 | 9,223 | 193.0 | 27 | 2.9 | 9,250 | 162.1 |
Mississippi | 419 | 17.0 | 0 | 0.0 | 419 | 14.2 | 9,873 | 399.8 | 4 | 0.8 | 9,877 | 334.8 |
Missouri | 549 | 10.6 | 1 | 0.1 | 550 | 8.9 | 13,103 | 252.3 | 25 | 2.6 | 13,128 | 212.8 |
Montana | 22 | 2.3 | 0 | 0.0 | 22 | 2.0 | 722 | 76.9 | 2 | 1.2 | 724 | 65.6 |
Nebraska | 105 | 6.5 | 0 | 0.0 | 105 | 5.3 | 2,384 | 147.1 | 4 | 1.2 | 2,388 | 121.6 |
Nevada | 501 | 18.9 | 0 | 0.0 | 501 | 15.9 | 11,416 | 430.5 | 5 | 1.0 | 11,421 | 363.3 |
New Hampshire | 32 | 2.6 | 0 | 0.0 | 32 | 2.3 | 1,365 | 112.5 | 4 | 2.3 | 1,369 | 98.6 |
New Jersey | 1,143 | 14.6 | 0 | 0.0 | 1,143 | 12.3 | 35,207 | 448.5 | 39 | 2.8 | 35,246 | 380.3 |
New Mexico | 149 | 8.3 | 0 | 0.0 | 149 | 7.0 | 4,017 | 224.7 | 7 | 2.1 | 4,024 | 190.2 |
New York | 2,116 | 12.5 | 2 | 0.1 | 2,118 | 10.7 | 124,630 | 737.1 | 57 | 1.9 | 124,687 | 628.6 |
North Carolina | 1,390 | 15.5 | 1 | 0.1 | 1,391 | 13.2 | 34,327 | 383.9 | 49 | 3.0 | 34,376 | 325.8 |
North Dakota | 37 | 5.8 | 1 | 0.7 | 38 | 4.9 | 543 | 84.9 | 2 | 1.5 | 545 | 70.3 |
Ohio | 909 | 9.1 | 1 | 0.1 | 910 | 7.7 | 24,084 | 242.1 | 40 | 2.2 | 24,124 | 204.8 |
Oklahoma | 387 | 11.7 | 1 | 0.1 | 388 | 9.7 | 6,948 | 210.2 | 17 | 2.5 | 6,965 | 174.7 |
Oregon | 202 | 5.5 | 0 | 0.0 | 202 | 4.8 | 7,484 | 205.4 | 13 | 2.2 | 7,497 | 176.6 |
Pennsylvania | 913 | 8.2 | 2 | 0.1 | 915 | 7.1 | 36,881 | 332.5 | 39 | 2.1 | 36,920 | 284.8 |
Rhode Island | 68 | 7.2 | 0 | 0.0 | 68 | 6.2 | 2,713 | 285.6 | 3 | 2.1 | 2,716 | 247.9 |
South Carolina | 652 | 14.8 | 3 | 0.4 | 655 | 12.6 | 18,109 | 410.7 | 25 | 3.2 | 18,134 | 349.4 |
South Dakota | 31 | 4.2 | 0 | 0.0 | 31 | 3.5 | 723 | 98.0 | 3 | 1.9 | 726 | 81.1 |
Tennessee | 831 | 14.1 | 1 | 0.1 | 832 | 11.9 | 18,738 | 318.1 | 39 | 3.6 | 18,777 | 269.2 |
Texas | 4,363 | 18.0 | 3 | 0.1 | 4,366 | 14.8 | 100,700 | 415.3 | 115 | 2.2 | 100,815 | 341.4 |
Utah | 133 | 5.0 | 0 | 0.0 | 133 | 4.0 | 3,453 | 129.1 | 8 | 1.2 | 3,461 | 103.7 |
Vermont | 12 | 2.1 | 0 | 0.0 | 12 | 1.9 | 728 | 128.8 | 2 | 2.5 | 730 | 113.1 |
Virginia | 792 | 10.8 | 3 | 0.2 | 795 | 9.2 | 24,411 | 333.9 | 32 | 2.4 | 24,443 | 282.8 |
Washington | 461 | 7.0 | 4 | 0.3 | 465 | 6.0 | 14,591 | 222.9 | 23 | 1.9 | 14,614 | 188.8 |
West Virginia | 149 | 9.7 | 0 | 0.0 | 149 | 8.4 | 2,196 | 143.3 | 1 | 0.4 | 2,197 | 123.2 |
Wisconsin | 253 | 5.1 | 1 | 0.1 | 254 | 4.3 | 6,840 | 136.6 | 17 | 1.9 | 6,857 | 116.3 |
Wyoming | 7 | 1.4 | 0 | 0.0 | 7 | 1.2 | 377 | 77.5 | 0 | 0.0 | 377 | 65.1 |
Subtotal | 35,716 | 12.7 | 53 | 0.1 | 35,769 | 10.8 | 1,071,005 | 382.2 | 1,262 | 2.4 | 1,072,267 | 323.1 |
U.S. dependent areas | ||||||||||||
American Samoa | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.8 | 0 | 0.0 | 1 | 2.2 |
Guam | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 109 | 84.5 | 1 | 2.5 | 110 | 65.2 |
Northern Mariana Islands | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 15 | 36.2 | 0 | 0.0 | 15 | 29.0 |
Puerto Rico | 410 | 14.1 | 0 | 0.0 | 410 | 12.6 | 15,801 | 543.4 | 2 | 0.6 | 15,803 | 484.2 |
Republic of Palau | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 9 | 48.8 | 0 | 0.0 | 9 | 41.6 |
U.S. Virgin Islands | 10 | 11.4 | 0 | 0.0 | 10 | 9.4 | 563 | 640.6 | 1 | 5.6 | 564 | 532.7 |
Subtotal | 420 | 13.0 | 0 | 0.0 | 420 | 11.5 | 16,498 | 512.4 | 4 | 0.9 | 16,502 | 451.1 |
Total | 36,136 | 12.7 | 53 | 0.1 | 36,189 | 10.8 | 1,087,503 | 383.7 | 1,266 | 2.4 | 1,088,769 | 324.5 |
Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Prevalence data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022.
aData are based on residence at HIV diagnosis.
bRates are per 100,000 population.
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Area of residence | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated |
Alabama | 6 | 23.5 | 48 | 74.6 | 8,988 | 812.5 | 554 | 322.0 | 3 | 142.9 | 3,867 | 136.9 | 928 | 1,697.2 | 14,436 | 339.7 |
Alaska | 192 | 226.1 | 30 | 74.9 | 97 | 486.5 | 96 | 236.0 | 5 | 60.2 | 285 | 76.2 | 44 | 127.3 | 749 | 124.3 |
Arizona | 710 | 311.2 | 236 | 106.6 | 2,521 | 901.2 | 5,979 | 324.6 | 29 | 241.4 | 8,063 | 233.3 | 649 | 577.4 | 18,230 | 296.4 |
Arkansas | 6 | 29.4 | 27 | 62.9 | 2,653 | 702.2 | 504 | 270.2 | 4 | 45.1 | 2,654 | 143.2 | 373 | 897.3 | 6,225 | 245.9 |
California | 280 | 202.1 | 5,898 | 113.7 | 21,953 | 1,158.7 | 55,062 | 437.2 | 247 | 198.8 | 46,801 | 379.8 | 5,841 | 714.0 | 136,091 | 411.4 |
Colorado | 87 | 267.8 | 167 | 98.8 | 2,049 | 1,029.0 | 3,382 | 332.9 | 17 | 237.5 | 7,373 | 215.6 | 322 | 319.3 | 13,442 | 271.9 |
Connecticut | 10 | 152.2 | 110 | 73.4 | 3,486 | 1,075.0 | 3,721 | 742.5 | 7 | 653.6 | 3,034 | 146.1 | 269 | 576.3 | 10,638 | 342.5 |
Delaware | 3 | 110.6 | 15 | 43.0 | 1,957 | 1,048.1 | 354 | 470.1 | 1 | 348.4 | 1,034 | 191.3 | 150 | 918.0 | 3,515 | 410.2 |
District of Columbia | 15 | 1,214.6 | 77 | 289.9 | 9,516 | 3,848.4 | 1,242 | 2,075.0 | 7 | 2,564.1 | 1,962 | 872.6 | 799 | 6,731.3 | 13,622 | 2,381.8 |
Florida | 83 | 167.0 | 719 | 130.1 | 50,647 | 1,819.8 | 31,452 | 643.9 | 50 | 404.3 | 31,311 | 306.3 | 2,977 | 1,127.4 | 117,244 | 624.7 |
Georgia | 20 | 91.4 | 293 | 72.2 | 40,676 | 1,422.8 | 5,000 | 598.7 | 18 | 308.4 | 9,951 | 208.4 | 3,457 | 2,465.9 | 59,422 | 657.1 |
Hawaii | 3 | 107.6 | 393 | 83.9 | 116 | 488.1 | 326 | 289.4 | 215 | 188.7 | 1,029 | 371.4 | 302 | 137.2 | 2,384 | 195.6 |
Idaho | 12 | 70.7 | 13 | 53.6 | 121 | 1,026.7 | 245 | 129.3 | 1 | 35.3 | 867 | 66.6 | 52 | 182.0 | 1,311 | 83.2 |
Illinois | 33 | 193.0 | 487 | 76.1 | 15,657 | 1,052.3 | 7,713 | 426.4 | 18 | 570.2 | 9,046 | 136.8 | 2,776 | 1,872.0 | 35,731 | 333.3 |
Indiana | 11 | 78.4 | 234 | 157.6 | 4,646 | 865.1 | 1,319 | 336.8 | 4 | 175.7 | 5,581 | 123.8 | 552 | 627.9 | 12,347 | 217.0 |
Iowa | 10 | 123.8 | 71 | 99.2 | 694 | 688.0 | 335 | 212.3 | 5 | 121.9 | 1,759 | 76.6 | 181 | 493.4 | 3,055 | 114.2 |
Kansas | 14 | 69.2 | 58 | 75.5 | 881 | 638.6 | 630 | 225.7 | 1 | 41.3 | 1,738 | 93.0 | 168 | 312.6 | 3,493 | 143.2 |
Kentucky | 4 | 47.3 | 63 | 102.9 | 2,466 | 793.0 | 696 | 508.0 | 1 | 36.0 | 4,400 | 136.8 | 506 | 897.4 | 8,137 | 214.5 |
Louisiana | 34 | 130.6 | 82 | 115.4 | 14,468 | 1,183.3 | 1,295 | 670.9 | 4 | 266.5 | 5,196 | 226.5 | 470 | 999.6 | 21,552 | 559.0 |
Maine | 7 | 92.8 | 13 | 80.7 | 292 | 1,606.6 | 129 | 606.8 | 0 | 0.0 | 1,194 | 106.8 | 57 | 331.8 | 1,693 | 141.2 |
Maryland | 21 | 161.4 | 264 | 74.2 | 23,876 | 1,520.4 | 2,609 | 508.3 | 6 | 229.7 | 4,054 | 153.5 | 2,637 | 2,481.6 | 33,467 | 643.4 |
Massachusetts | 26 | 235.6 | 479 | 108.5 | 6,349 | 1,454.0 | 5,821 | 827.5 | 8 | 311.8 | 7,971 | 183.3 | 466 | 497.6 | 21,122 | 349.9 |
Michigan | 28 | 56.6 | 145 | 50.5 | 9,357 | 825.2 | 1,287 | 300.2 | 3 | 123.7 | 5,820 | 89.8 | 670 | 409.4 | 17,313 | 202.6 |
Minnesota | 114 | 239.1 | 195 | 81.0 | 3,394 | 1,102.4 | 1,104 | 446.2 | 5 | 200.9 | 3,926 | 102.1 | 480 | 538.7 | 9,223 | 193.0 |
Mississippi | 10 | 80.7 | 22 | 79.2 | 7,223 | 793.9 | 353 | 461.1 | 3 | 304.3 | 1,850 | 130.5 | 377 | 1,593.5 | 9,873 | 399.8 |
Missouri | 12 | 50.6 | 97 | 84.7 | 5,617 | 969.2 | 906 | 422.6 | 6 | 84.9 | 5,907 | 142.0 | 556 | 596.5 | 13,103 | 252.3 |
Montana | 26 | 51.0 | 5 | 53.9 | 21 | 414.3 | 64 | 178.8 | 1 | 143.1 | 562 | 68.8 | 43 | 206.7 | 722 | 76.9 |
Nebraska | 26 | 202.3 | 57 | 133.6 | 645 | 840.3 | 428 | 253.3 | 3 | 276.2 | 1,134 | 87.7 | 91 | 354.7 | 2,384 | 147.1 |
Nevada | 46 | 201.1 | 373 | 154.1 | 3,013 | 1,223.6 | 3,183 | 430.7 | 51 | 288.4 | 4,267 | 327.2 | 481 | 601.0 | 11,416 | 430.5 |
New Hampshire | 0 | 0.0 | 23 | 64.0 | 167 | 929.4 | 205 | 429.3 | 0 | 0.0 | 914 | 83.7 | 55 | 337.8 | 1,365 | 112.5 |
New Jersey | 13 | 110.8 | 395 | 49.9 | 14,840 | 1,460.1 | 11,016 | 695.9 | 9 | 339.6 | 6,398 | 147.3 | 2,488 | 2,424.9 | 35,207 | 448.5 |
New Mexico | 331 | 213.0 | 21 | 69.5 | 223 | 638.0 | 1,995 | 233.4 | 2 | 162.5 | 1,296 | 188.8 | 149 | 605.4 | 4,017 | 224.7 |
New York | 46 | 89.6 | 2,166 | 140.9 | 46,128 | 1,895.6 | 45,007 | 1,438.2 | 25 | 320.3 | 21,482 | 226.3 | 9,501 | 3,716.7 | 124,630 | 737.1 |
North Carolina | 172 | 175.6 | 219 | 76.7 | 20,378 | 1,078.6 | 3,317 | 419.1 | 14 | 230.8 | 8,205 | 143.3 | 2,015 | 1,377.1 | 34,327 | 383.9 |
North Dakota | 24 | 79.1 | 6 | 58.9 | 227 | 1,169.0 | 34 | 142.0 | 0 | 0.0 | 233 | 42.8 | 19 | 179.2 | 543 | 84.9 |
Ohio | 9 | 44.4 | 134 | 52.6 | 10,629 | 867.4 | 1,826 | 481.3 | 4 | 92.0 | 10,149 | 128.7 | 1,265 | 720.5 | 24,084 | 242.1 |
Oklahoma | 350 | 128.3 | 103 | 129.8 | 1,657 | 679.0 | 867 | 257.2 | 13 | 217.2 | 3,465 | 157.3 | 493 | 300.9 | 6,948 | 210.2 |
Oregon | 54 | 132.9 | 154 | 86.6 | 592 | 840.6 | 1,229 | 268.2 | 22 | 148.4 | 5,160 | 186.0 | 273 | 254.3 | 7,484 | 205.4 |
Pennsylvania | 37 | 224.7 | 317 | 75.6 | 16,915 | 1,439.0 | 6,892 | 841.5 | 15 | 454.8 | 10,557 | 124.1 | 2,144 | 1,392.4 | 36,881 | 332.5 |
Rhode Island | 6 | 152.3 | 39 | 118.2 | 609 | 1,057.8 | 803 | 555.2 | 2 | 355.9 | 1,161 | 167.5 | 93 | 543.1 | 2,713 | 285.6 |
South Carolina | 13 | 76.0 | 62 | 75.6 | 11,204 | 993.0 | 1,177 | 477.6 | 4 | 153.0 | 4,258 | 148.3 | 1,383 | 2,225.3 | 18,109 | 410.7 |
South Dakota | 109 | 201.5 | 6 | 49.4 | 159 | 1,018.3 | 74 | 265.2 | 0 | 0.0 | 340 | 55.3 | 35 | 266.2 | 723 | 98.0 |
Tennessee | 9 | 50.7 | 90 | 78.9 | 10,019 | 1,051.1 | 1,253 | 409.4 | 3 | 92.0 | 6,487 | 147.1 | 875 | 1,013.1 | 18,738 | 318.1 |
Texas | 37 | 43.8 | 1,103 | 85.0 | 35,728 | 1,197.1 | 36,249 | 391.2 | 25 | 111.4 | 22,165 | 215.6 | 5,385 | 1,718.1 | 100,700 | 415.3 |
Utah | 34 | 133.7 | 78 | 108.3 | 331 | 1,041.1 | 931 | 252.4 | 16 | 59.2 | 1,959 | 93.2 | 101 | 206.1 | 3,453 | 129.1 |
Vermont | 0 | 0.0 | 16 | 145.5 | 76 | 1,049.4 | 67 | 565.4 | 0 | 0.0 | 535 | 102.1 | 34 | 376.3 | 728 | 128.8 |
Virginia | 18 | 88.2 | 378 | 73.0 | 13,596 | 975.6 | 2,613 | 384.2 | 10 | 179.9 | 6,552 | 144.7 | 1,219 | 738.4 | 24,411 | 333.9 |
Washington | 120 | 147.2 | 539 | 82.5 | 2,479 | 937.9 | 2,499 | 316.7 | 62 | 131.9 | 7,819 | 174.6 | 1,068 | 458.5 | 14,591 | 222.9 |
West Virginia | 1 | 28.3 | 14 | 104.6 | 384 | 701.4 | 116 | 442.1 | 0 | 0.0 | 1,548 | 109.6 | 129 | 590.0 | 2,196 | 143.3 |
Wisconsin | 27 | 62.1 | 95 | 64.8 | 2,489 | 836.2 | 1,068 | 327.2 | 3 | 158.8 | 2,853 | 69.2 | 304 | 437.6 | 6,840 | 136.6 |
Wyoming | 11 | 113.3 | 3 | 59.3 | 18 | 352.3 | 74 | 160.5 | 0 | 0.0 | 256 | 62.0 | 15 | 197.9 | 377 | 77.5 |
Subtotal | 3,270 | 160.3 | 16,632 | 98.9 | 432,227 | 1,245.1 | 255,101 | 517.6 | 952 | 185.9 | 306,428 | 178.6 | 55,717 | 1,063.9 | 1,071,005 | 382.2 |
U.S. dependent arease | ||||||||||||||||
American Samoa | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 0 | — | 1 | — | 1 | 2.8 |
Guam | 0 | — | 56 | — | 5 | — | 8 | — | 21 | — | 11 | — | 8 | — | 109 | 84.5 |
Northern Mariana Islands | 1 | — | 5 | — | 0 | — | 0 | — | 5 | — | 2 | — | 2 | — | 15 | 36.2 |
Puerto Rico | 1 | — | 2 | — | 22 | — | 15,722 | — | 1 | — | 46 | — | 6 | — | 15,801 | 543.4 |
Republic of Palau | 0 | — | 2 | — | 0 | — | 1 | — | 6 | — | 0 | — | 0 | — | 9 | 48.8 |
U.S. Virgin Islands | 0 | — | 3 | — | 307 | — | 198 | — | 0 | — | 46 | — | 6 | — | 563 | 640.6 |
Subtotal | 2 | — | 68 | — | 334 | — | 15,929 | — | 33 | — | 105 | — | 23 | — | 16,498 | 512.4 |
Total | 3,272 | — | 16,700 | — | 432,561 | — | 271,030 | — | 985 | — | 306,533 | — | 55,740 | — | 1,087,503 | 383.7 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Data are based on address of residence at the end of the specified year (i.e., most recent known address).
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d Rates are per 100,000 population.
e Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
Diagnosis, 2021a | Prevalence of diagnosed HIV infection, year-end 2021b | |||||
---|---|---|---|---|---|---|
Metropolitan statistical area of residence | No. | Ratec | Rankd | No. | Ratec | |
Akron, OH | 49 | 7.0 | 80 | 1,127 | 161.0 | |
Albany-Schenectady-Troy, NY | 44 | 4.9 | 103 | 2,183 | 242.7 | |
Albuquerque, NM | 78 | 8.5 | 73 | 2,061 | 224.4 | |
Allentown-Bethlehem-Easton, PA-NJ | 47 | 5.4 | 100 | 1,737 | 200.7 | |
Atlanta-Sandy Springs-Alpharetta, GA | 1,562 | 25.4 | 3 | 40,931 | 666.2 | |
Augusta-Richmond County, GA-SC | 112 | 18.2 | 14 | 2,598 | 421.8 | |
Austin-Round Rock-Georgetown, TX | 282 | 12.0 | 40 | 6,967 | 296.2 | |
Bakersfield, CA | 182 | 19.8 | 8 | 2,112 | 230.1 | |
Baltimore-Columbia-Towson, MD | 343 | 12.1 | 38 | 16,677 | 587.6 | |
Baton Rouge, LA | 192 | 22.0 | 5 | 5,592 | 641.4 | |
Birmingham-Hoover, AL | 180 | 16.2 | 20 | 4,429 | 397.5 | |
Boise City, ID | 34 | 4.3 | 109 | 213 | 26.8 | |
Boston-Cambridge-Newton, MA-NHe | 335 | 6.8 | 83 | 14,507 | 296.1 | |
Boston, MA | 192 | 9.5 | — | 8,266 | 407.4 | |
Cambridge-Newton-Framingham, MA | 133 | 5.5 | — | 6,016 | 248.4 | |
Bridgeport-Stamford-Norwalk, CT | 66 | 6.9 | 82 | 2,687 | 280.0 | |
Buffalo-Cheektowaga, NY | 74 | 6.4 | 87 | 2,633 | 226.5 | |
Cape Coral-Fort Myers, FL | 79 | 10.0 | 62 | 2,339 | 296.8 | |
Charleston-North Charleston, SC | 97 | 11.9 | 42 | 2,699 | 332.0 | |
Charlotte-Concord-Gastonia, NC-SC | 416 | 15.4 | 22 | 9,418 | 348.7 | |
Chattanooga, TN-GA | 57 | 10.0 | 61 | 1,337 | 235.5 | |
Chicago-Naperville-Elgin, IL-IN-WI | 1,068 | 11.2 | 51 | 30,281 | 318.4 | |
Chicago-Naperville-Evanston, IL | 930 | 13.0 | — | 27,397 | 382.7 | |
Elgin, IL | 41 | 5.5 | — | 506 | 67.4 | |
Gary, IN | 53 | 7.4 | — | 1,294 | 179.8 | |
Lake County-Kenosha County, IL-WI | 44 | 5.0 | — | 1,084 | 123.2 | |
Cincinnati, OH-KY-IN | 220 | 9.7 | 63 | 4,789 | 211.9 | |
Cleveland-Elyria, OH | 198 | 9.5 | 65 | 5,808 | 279.8 | |
Colorado Springs, CO | 53 | 6.9 | 81 | 1,054 | 138.2 | |
Columbia, SC | 151 | 18.0 | 15 | 4,325 | 516.0 | |
Columbus, OH | 225 | 10.5 | 55 | 6,176 | 287.1 | |
Dallas-Fort Worth-Arlington, TX | 1,359 | 17.5 | 16 | 31,525 | 406.3 | |
Dallas-Plano-Irving, TX | 1,033 | 19.8 | — | 24,574 | 471.0 | |
Fort Worth-Arlington, TX | 326 | 12.8 | — | 6,951 | 273.4 | |
Dayton-Kettering, OH | 68 | 8.4 | 74 | 1,837 | 225.8 | |
Deltona-Daytona Beach-Ormond Beach, FL | 81 | 11.8 | 43 | 2,181 | 318.2 | |
Denver-Aurora-Lakewood, CO | 269 | 9.0 | 69 | 9,520 | 320.3 | |
Des Moines-West Des Moines, IA | 40 | 5.6 | 98 | 1,033 | 143.6 | |
Detroit-Warren-Dearborn, MI | 403 | 9.2 | 67 | 11,003 | 252.1 | |
Detroit-Dearborn-Livonia, MI | 256 | 14.4 | — | 7,241 | 408.0 | |
Warren-Troy-Farmington Hills, MI | 147 | 5.7 | — | 3,762 | 145.2 | |
Durham-Chapel Hill, NC | 89 | 13.6 | 28 | 2,629 | 402.0 | |
El Paso, TX | 119 | 13.7 | 27 | 2,521 | 289.4 | |
Fayetteville, NC | 103 | 19.6 | 9 | 2,019 | 384.9 | |
Fayetteville-Springdale-Rogers, AR | 49 | 8.7 | 71 | 704 | 125.6 | |
Fresno, CA | 143 | 14.1 | 24 | 2,199 | 217.0 | |
Grand Rapids-Wyoming, MI | 48 | 4.4 | 105 | 1,375 | 126.0 | |
Greensboro-High Point, NC | 144 | 18.5 | 13 | 2,929 | 376.1 | |
Greenville-Anderson, SC | 104 | 11.1 | 53 | 2,360 | 250.9 | |
Harrisburg-Carlisle, PA | 55 | 9.2 | 68 | 1,416 | 237.5 | |
Hartford-East Hartford-Middletown, CT | 79 | 6.5 | 86 | 3,535 | 291.7 | |
Honolulu (Urban), HI | 43 | 4.3 | 108 | 1,491 | 149.0 | |
Houston-The Woodlands-Sugar Land, TX | 1,389 | 19.3 | 11 | 33,246 | 461.3 | |
Huntsville, AL | 52 | 10.3 | 57 | 997 | 198.3 | |
Indianapolis-Carmel-Anderson, IN | 276 | 13.0 | 32 | 6,145 | 288.9 | |
Jackson, MS | 119 | 20.3 | 7 | 3,235 | 550.9 | |
Jacksonville, FL | 309 | 18.9 | 12 | 7,598 | 464.0 | |
Kansas City, MO-KS | 199 | 9.0 | 70 | 5,095 | 231.6 | |
Knoxville, TN | 99 | 11.1 | 52 | 1,429 | 159.9 | |
Lakeland-Winter Haven, FL | 123 | 16.3 | 19 | 2,786 | 369.7 | |
Lancaster, PA | 14 | 2.5 | 113 | 805 | 145.4 | |
Lansing-East Lansing, MI | 32 | 5.9 | 93 | 681 | 126.0 | |
Las Vegas-Henderson-Paradise, NV | 445 | 19.4 | 10 | 9,699 | 423.1 | |
Lexington-Fayette, KY | 61 | 11.8 | 44 | 1,301 | 251.2 | |
Little Rock-North Little Rock-Conway, AR | 125 | 16.6 | 18 | 2,444 | 325.5 | |
Los Angeles-Long Beach-Anaheim, CA | 1,753 | 13.5 | 30 | 57,717 | 444.1 | |
Anaheim-Santa Ana-Irvine, CA | 266 | 8.4 | — | 7,231 | 228.3 | |
Los Angeles-Long Beach-Glendale, CA | 1,487 | 15.1 | — | 50,486 | 513.6 | |
Louisville/Jefferson County, KY-IN | 215 | 16.7 | 17 | 3,981 | 309.9 | |
Madison, WI | 39 | 5.7 | 97 | 888 | 130.0 | |
McAllen-Edinburg-Mission, TX | 100 | 11.4 | 48 | 1,645 | 186.9 | |
Memphis, TN-MS-AR | 353 | 26.4 | 2 | 7,567 | 566.3 | |
Miami-Fort Lauderdale-Pompano Beach, FL | 1,783 | 29.3 | 1 | 55,691 | 914.2 | |
Fort Lauderdale-Pompano Beach-Sunrise, FL | 572 | 29.6 | — | 20,364 | 1,054.6 | |
Miami-Miami Beach-Kendall, FL | 937 | 35.2 | — | 27,167 | 1,020.3 | |
West Palm Beach-Boca Raton-Boynton Beach, FL | 274 | 18.3 | — | 8,160 | 544.7 | |
Milwaukee-Waukesha, WI | 122 | 7.8 | 77 | 3,421 | 218.4 | |
Minneapolis-St. Paul-Bloomington, MN-WI | 230 | 6.2 | 90 | 7,761 | 210.3 | |
Modesto, CA | 45 | 8.1 | 75 | 853 | 154.2 | |
Myrtle Beach-Conway-North Myrtle Beach, SC-NC | 49 | 9.6 | 64 | 1,305 | 256.0 | |
Nashville-Davidson-Murfreesboro-Franklin, TN | 204 | 10.1 | 59 | 5,766 | 286.5 | |
New Haven-Milford, CT | 67 | 7.8 | 78 | 3,349 | 387.8 | |
New Orleans-Metairie, LA | 275 | 21.8 | 6 | 8,219 | 651.4 | |
New York-Newark-Jersey City, NY-NJ-PAe | 2,647 | 13.4 | 31 | 135,633 | 686.1 | |
Nassau County-Suffolk County, NY | 148 | 5.1 | — | 5,937 | 203.5 | |
Newark, NJ-PA | 405 | 17.8 | — | 13,020 | 572.7 | |
New Brunswick-Lakewood, NJ | 174 | 7.0 | — | 5,377 | 215.0 | |
New York-Jersey City-White Plains, NY-NJ | 1,920 | 15.9 | — | 111,299 | 921.6 | |
North Port-Sarasota-Bradenton, FL | 91 | 10.6 | 54 | 2,264 | 263.3 | |
Ogden-Clearfield, UT | 16 | 2.3 | 114 | 469 | 66.4 | |
Oklahoma City, OK | 202 | 14.0 | 26 | 3,182 | 220.7 | |
Omaha-Council Bluffs, NE-IA | 52 | 5.4 | 101 | 576 | 59.3 | |
Orlando-Kissimmee-Sanford, FL | 612 | 22.7 | 4 | 13,348 | 495.9 | |
Oxnard-Thousand Oaks-Ventura, CA | 49 | 5.8 | 95 | 1,201 | 143.0 | |
Palm Bay-Melbourne-Titusville, FL | 64 | 10.4 | 56 | 1,762 | 285.7 | |
Pensacola-Ferry Pass-Brent, FL | 48 | 9.3 | 66 | 1,552 | 300.5 | |
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 702 | 11.3 | 50 | 26,162 | 420.0 | |
Camden, NJ | 160 | 12.4 | — | 3,214 | 248.7 | |
Montgomery County-Bucks County-Chester County, PA | 64 | 3.1 | — | 2,251 | 110.1 | |
Philadelphia, PA | 417 | 19.4 | — | 18,222 | 847.5 | |
Wilmington, DE-MD-NJ | 61 | 8.2 | — | 2,475 | 334.2 | |
Phoenix-Mesa-Scottsdale, AZ | 577 | 11.7 | 45 | 13,530 | 273.5 | |
Pittsburgh, PA | 112 | 4.8 | 104 | 3,476 | 147.7 | |
Portland-South Portland, ME | 18 | 3.2 | 112 | 915 | 164.3 | |
Portland-Vancouver-Hillsboro, OR-WA | 149 | 5.9 | 92 | 5,866 | 233.6 | |
Port St. Lucie, FL | 51 | 10.1 | 60 | 2,149 | 426.8 | |
Poughkeepsie-Newburgh-Middletown, NY | 41 | 5.8 | 94 | 1,881 | 268.1 | |
Providence-Warwick, RI-MA | 93 | 5.5 | 99 | 2,256 | 134.6 | |
Provo-Orem, UT | 24 | 3.4 | 111 | 282 | 40.5 | |
Raleigh-Cary, NC | 182 | 12.6 | 36 | 4,180 | 288.6 | |
Richmond, VA | 167 | 12.6 | 35 | 4,549 | 343.6 | |
Riverside-San Bernardino-Ontario, CA | 560 | 12.0 | 39 | 15,178 | 326.2 | |
Rochester, NY | 66 | 6.1 | 91 | 2,834 | 261.2 | |
Sacramento-Roseville-Folsom, CA | 208 | 8.6 | 72 | 5,594 | 232.0 | |
St. Louis, MO-IL | 322 | 11.5 | 47 | 7,377 | 262.6 | |
Salt Lake City, UT | 83 | 6.6 | 85 | 2,292 | 181.5 | |
San Antonio-New Braunfels, TX | 352 | 13.5 | 29 | 7,631 | 293.3 | |
San Diego-Chula Vista-Carlsbad, CA | 372 | 11.3 | 49 | 13,542 | 412.1 | |
San Francisco-Oakland-Berkeley, CAe | 538 | 11.6 | 46 | 22,782 | 492.8 | |
Oakland-Berkeley-Livermore, CA | 293 | 10.4 | — | 8,729 | 310.6 | |
San Francisco-San Mateo-Redwood City, CA | 232 | 14.9 | — | 13,280 | 855.1 | |
San Jose-Sunnyvale-Santa Clara, CA | 124 | 6.4 | 89 | 3,575 | 183.1 | |
San Juan-Carolina-Caguas, PR | 324 | 15.7 | 21 | 10,497 | 507.5 | |
Scranton-Wilkes-Barre, PA | 41 | 7.2 | 79 | 929 | 163.6 | |
Seattle-Tacoma-Bellevue, WA | 320 | 8.0 | 76 | 10,096 | 251.7 | |
Seattle-Bellevue-Kent, WA | 252 | 8.2 | — | 8,427 | 273.1 | |
Tacoma-Lakewood, WA | 68 | 7.3 | — | 1,669 | 180.3 | |
Spokane-Spokane Valley, WA | 26 | 4.4 | 107 | 789 | 132.9 | |
Springfield, MA | 36 | 5.2 | 102 | 2,224 | 319.9 | |
Stockton, CA | 100 | 12.7 | 33 | 1,508 | 191.0 | |
Syracuse, NY | 26 | 3.9 | 110 | 1,266 | 192.3 | |
Tampa-St. Petersburg-Clearwater, FL | 482 | 15.0 | 23 | 14,180 | 440.4 | |
Toledo, OH | 41 | 6.4 | 88 | 1,159 | 179.9 | |
Tucson, AZ | 129 | 12.3 | 37 | 2,815 | 267.6 | |
Tulsa, OK | 105 | 10.3 | 58 | 2,093 | 204.4 | |
Virginia Beach-Norfolk-Newport News, VA-NC | 254 | 14.1 | 25 | 6,681 | 370.5 | |
Washington-Arlington-Alexandria, DC-VA-MD-WV | 759 | 11.9 | 41 | 34,833 | 548.0 | |
Frederick-Gaithersburg-Rockville, MD | 107 | 8.0 | — | 4,468 | 334.8 | |
Washington-Arlington-Alexandria, DC-VA-MD-WV | 652 | 13.0 | — | 30,365 | 604.7 | |
Wichita, KS | 37 | 5.7 | 96 | 1,008 | 155.6 | |
Winston-Salem, NC | 86 | 12.6 | 34 | 2,150 | 315.5 | |
Worcester, MA-CT | 43 | 4.4 | 106 | 2,225 | 227.4 | |
Youngstown-Warren-Boardman, OH-PA | 36 | 6.7 | 84 | 875 | 162.6 | |
Subtotal for MSAs (population ≥ 500,000) | 29,185 | 12.6 | — | 889,947 | 384.0 | |
Metropolitan areas (population of 50,000–499,999) | 4,567 | 7.9 | — | 109,153 | 188.6 | |
Nonmetropolitan areas | 2,298 | 5.0 | — | 59,983 | 131.7 | |
Totalf | 36,179 | 10.8 | — | 1,088,070 | 324.6 |
Note: Data on persons living with diagnosed HIV infection in 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12, and trends based on these numbers, should be interpreted with caution. Because of the lack of U.S. census information for all U.S. dependent areas, table includes data for only the 50 states, the District of Columbia, and Puerto Rico.
MSA, metropolitan statistical area.
MSA definitions for this report can be found at https://www.census.gov/programs-surveys/metro-micro.html
a Data are based on residence at HIV diagnosis.
b Data are based on address of residence at the end of the specified year (i.e., most recent known address).
c Rates are per 100,000 population.
d Based on rate.
e Counts of diagnoses of HIV infection for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 2 metropolitan divisions with population of <500,000.
f Includes persons whose county of residence is unknown.
2020 (COVID-19 Pandemic) | 2021 | |||||||
---|---|---|---|---|---|---|---|---|
Persons aged ≥13 years | Total | Persons aged ≥13 years | Total | |||||
Area of residence | No. | Ratea | No. | Ratea | No. | Ratea | No. | Ratea |
Arizona | ||||||||
Maricopa County | 471 | 12.7 | 472 | 10.6 | 518 | 13.7 | 519 | 11.5 |
California | ||||||||
Alameda County | 159 | 11.1 | 159 | 9.5 | 185 | 13.1 | 185 | 11.2 |
Los Angeles County | 1,403 | 16.6 | 1,406 | 14.1 | 1,486 | 17.7 | 1,487 | 15.1 |
Orange County | 264 | 9.8 | 264 | 8.3 | 266 | 9.9 | 266 | 8.4 |
Riverside County | 237 | 11.8 | 239 | 9.9 | 258 | 12.7 | 258 | 10.5 |
Sacramento County | 154 | 11.7 | 154 | 9.7 | 175 | 13.2 | 175 | 11.0 |
San Bernardino County | 265 | 14.9 | 265 | 12.1 | 301 | 16.8 | 302 | 13.8 |
San Diego County | 328 | 11.8 | 328 | 9.9 | 369 | 13.2 | 372 | 11.3 |
San Francisco County | 154 | 19.7 | 154 | 17.7 | 185 | 25.3 | 185 | 22.7 |
District of Columbia | 194 | 32.9 | 194 | 28.1 | 195 | 34.1 | 195 | 29.1 |
Florida | ||||||||
Broward County | 424 | 25.7 | 425 | 21.9 | 570 | 34.6 | 572 | 29.6 |
Duval County | 231 | 27.8 | 232 | 23.3 | 280 | 33.5 | 281 | 28.1 |
Hillsborough County | 237 | 19.2 | 237 | 16.2 | 294 | 23.6 | 295 | 20.0 |
Miami-Dade County | 736 | 32.0 | 736 | 27.3 | 937 | 41.1 | 937 | 35.2 |
Orange County | 358 | 29.7 | 359 | 25.1 | 416 | 34.5 | 416 | 29.2 |
Palm Beach County | 201 | 15.6 | 201 | 13.5 | 273 | 21.0 | 274 | 18.3 |
Pinellas County | 149 | 17.5 | 150 | 15.6 | 122 | 14.3 | 122 | 12.8 |
Georgia | ||||||||
Cobb County | 135 | 21.0 | 135 | 17.6 | 152 | 23.5 | 154 | 20.1 |
DeKalb County | 264 | 41.5 | 265 | 34.7 | 342 | 54.0 | 342 | 45.1 |
Fulton County | 474 | 52.1 | 474 | 44.3 | 525 | 57.8 | 526 | 49.4 |
Gwinnett County | 144 | 18.4 | 144 | 15.0 | 165 | 20.8 | 165 | 17.1 |
Illinois | ||||||||
Cook County | 759 | 17.1 | 760 | 14.4 | 843 | 19.2 | 845 | 16.3 |
Indiana | ||||||||
Marion County | 169 | 21.1 | 170 | 17.4 | 216 | 27.1 | 216 | 22.2 |
Louisiana | ||||||||
East Baton Rouge Parish | 124 | 32.6 | 124 | 27.2 | 141 | 37.2 | 141 | 31.1 |
Orleans Parish | 102 | 31.1 | 102 | 26.6 | 145 | 44.8 | 145 | 38.5 |
Maryland | ||||||||
Baltimore City | 173 | 34.9 | 174 | 29.8 | 156 | 31.8 | 156 | 27.1 |
Montgomery County | 79 | 8.9 | 79 | 7.4 | 96 | 10.8 | 97 | 9.2 |
Prince George’s County | 218 | 27.0 | 218 | 22.6 | 229 | 28.5 | 229 | 24.0 |
Massachusetts | ||||||||
Suffolk County | 131 | 18.7 | 131 | 16.5 | 132 | 19.4 | 132 | 17.1 |
Michigan | ||||||||
Wayne County | 227 | 15.3 | 227 | 12.7 | 256 | 17.3 | 256 | 14.4 |
Nevada | ||||||||
Clark County | 346 | 18.2 | 346 | 15.2 | 445 | 23.1 | 445 | 19.4 |
New Jersey | ||||||||
Essex County | 200 | 28.0 | 200 | 23.2 | 266 | 37.5 | 266 | 31.1 |
Hudson County | 127 | 20.8 | 128 | 17.7 | 149 | 25.0 | 149 | 21.2 |
New York | ||||||||
Bronx County | 345 | 28.7 | 346 | 23.6 | 416 | 35.5 | 416 | 29.2 |
Kings County | 443 | 19.6 | 445 | 16.3 | 441 | 20.1 | 441 | 16.7 |
New York County | 298 | 19.8 | 298 | 17.7 | 317 | 22.5 | 317 | 20.1 |
Queens County | 322 | 15.8 | 322 | 13.4 | 333 | 16.7 | 334 | 14.3 |
North Carolina | ||||||||
Mecklenburg County | 208 | 22.3 | 208 | 18.6 | 278 | 29.6 | 279 | 24.9 |
Ohio | ||||||||
Cuyahoga County | 183 | 17.0 | 183 | 14.5 | 164 | 15.4 | 164 | 13.1 |
Franklin County | 206 | 18.8 | 207 | 15.6 | 187 | 17.0 | 187 | 14.2 |
Hamilton County | 132 | 19.1 | 132 | 15.9 | 122 | 17.7 | 123 | 14.9 |
Pennsylvania | ||||||||
Philadelphia County | 305 | 22.7 | 306 | 19.1 | 360 | 27.1 | 362 | 23.0 |
Tennessee | ||||||||
Shelby County | 234 | 30.8 | 234 | 25.2 | 294 | 38.8 | 295 | 31.9 |
Texas | ||||||||
Bexar County | 285 | 17.3 | 285 | 14.2 | 328 | 19.7 | 328 | 16.2 |
Dallas County | 663 | 31.2 | 664 | 25.4 | 798 | 37.7 | 798 | 30.9 |
Harris County | 934 | 24.4 | 938 | 19.8 | 1,161 | 30.2 | 1,161 | 24.6 |
Tarrant County | 294 | 17.0 | 294 | 13.9 | 302 | 17.3 | 302 | 14.2 |
Travis County | 164 | 14.9 | 164 | 12.7 | 225 | 20.2 | 225 | 17.2 |
Washington | ||||||||
King County | 199 | 10.2 | 199 | 8.8 | 218 | 11.3 | 219 | 9.7 |
Puerto Rico | ||||||||
San Juan Municipio | 77 | 25.3 | 77 | 22.6 | 99 | 32.8 | 99 | 29.4 |
Note: Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Data are based on residence at time of diagnosis of HIV infection.
aRates are per 100,000 population.
American Indian/Alaska Native | Asiana | Black/African American | Hispanic/Latinob | Native Hawaiian/other Pacific Islander | White | Multiracial | Totalc | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Area of residence | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated | No. | Rated |
Arizona | ||||||||||||||||
Maricopa County | 335 | 529.6 | 186 | 107.7 | 1,973 | 924.1 | 3,853 | 345.5 | 18 | 236.4 | 5,552 | 260.7 | 454 | 621.1 | 12,402 | 328.6 |
California | ||||||||||||||||
Alameda County | 12 | 346.8 | 416 | 88.5 | 2,209 | 1,551.6 | 1,408 | 470.4 | 20 | 174.1 | 1,632 | 375.3 | 288 | 571.1 | 5,986 | 423.9 |
Los Angeles County | 53 | 325.3 | 1,850 | 143.0 | 9,598 | 1,414.0 | 24,020 | 605.6 | 49 | 259.5 | 12,308 | 549.3 | 2,585 | 1,597.5 | 50,466 | 602.4 |
Orange County | 7 | 127.3 | 559 | 92.7 | 368 | 775.5 | 3,653 | 417.9 | 12 | 159.9 | 2,404 | 220.2 | 226 | 350.6 | 7,229 | 268.3 |
Riverside County | 23 | 238.5 | 168 | 115.7 | 863 | 652.4 | 2,862 | 284.8 | 8 | 129.3 | 5,835 | 833.5 | 358 | 870.4 | 10,117 | 496.1 |
Sacramento County | 20 | 296.2 | 192 | 84.3 | 1,131 | 870.2 | 1,091 | 360.5 | 18 | 112.7 | 1,991 | 338.3 | 201 | 359.0 | 4,644 | 349.8 |
San Bernardino County | 13 | 186.2 | 119 | 81.5 | 1,019 | 698.4 | 2,567 | 265.0 | 6 | 108.7 | 1,148 | 234.9 | 179 | 549.9 | 5,051 | 281.5 |
San Diego County | 27 | 224.8 | 427 | 121.4 | 1,591 | 1,193.6 | 5,670 | 618.5 | 20 | 169.2 | 5,328 | 416.6 | 461 | 561.2 | 13,524 | 485.3 |
San Francisco County | 32 | 2,231.6 | 801 | 294.0 | 1,477 | 3,952.0 | 2,886 | 2,665.8 | 29 | 1052.2 | 5,842 | 2,039.5 | 553 | 2,485.0 | 11,620 | 1,589.6 |
District of Columbia | 15 | 1,214.6 | 77 | 289.9 | 9,516 | 3,848.4 | 1,242 | 2,075.0 | 7 | 2,564.1 | 1,962 | 872.6 | 799 | 6,731.3 | 13,622 | 2,381.8 |
Florida | ||||||||||||||||
Broward County | 13 | 400.5 | 143 | 229.1 | 9,241 | 2,034.2 | 4,379 | 834.2 | 5 | 449.9 | 5,961 | 1033.0 | 608 | 2,639.8 | 20,350 | 1,236.3 |
Duval County | 5 | 184.8 | 60 | 142.3 | 4,312 | 1,793.6 | 501 | 561.5 | 2 | 294.6 | 1,389 | 313.5 | 226 | 1,315.9 | 6,495 | 777.4 |
Hillsborough County | 4 | 138.2 | 63 | 113.0 | 3,267 | 1,663.6 | 1,802 | 490.6 | 3 | 338.5 | 2,136 | 354.5 | 189 | 882.1 | 7,464 | 598.4 |
Miami-Dade County | 10 | 491.3 | 85 | 236.3 | 10,512 | 3,184.3 | 13,609 | 847.5 | 6 | 1,193.0 | 2,535 | 864.0 | 389 | 2,675.4 | 27,147 | 1,189.5 |
Orange County | 6 | 224.2 | 68 | 97.7 | 3,946 | 1,667.4 | 2,717 | 698.4 | 12 | 871.6 | 2,369 | 487.2 | 235 | 1,197.9 | 9,353 | 776.1 |
Palm Beach County | 5 | 235.8 | 38 | 99.7 | 4,707 | 2,039.2 | 1,454 | 491.1 | 2 | 306.9 | 1,757 | 245.3 | 190 | 1,268.2 | 8,153 | 627.6 |
Pinellas County | 2 | 96.6 | 64 | 211.9 | 1,452 | 1,776.9 | 594 | 709.6 | 0 | 0.0 | 2,644 | 413.2 | 171 | 1,269.0 | 4,927 | 578.5 |
Georgia | ||||||||||||||||
Cobb County | 1 | 84.3 | 17 | 46.9 | 2,213 | 1,227.0 | 459 | 575.2 | 2 | 769.3 | 728 | 216.1 | 233 | 1,939.0 | 3,653 | 564.9 |
DeKalb County | 4 | 412.5 | 72 | 181.7 | 6,679 | 1,963.2 | 751 | 1,624.4 | 4 | 1,213.3 | 1,126 | 574.7 | 503 | 4,965.6 | 9,140 | 1,442.9 |
Fulton County | 7 | 557.9 | 50 | 70.5 | 11,757 | 3,010.7 | 1,102 | 1,792.0 | 6 | 4,966.7 | 2,513 | 680.2 | 948 | 6,195.6 | 16,384 | 1,802.3 |
Gwinnett County | 1 | 75.7 | 61 | 57.1 | 1,922 | 843.9 | 665 | 407.9 | 1 | 316.0 | 510 | 183.8 | 187 | 1,231.4 | 3,347 | 422.6 |
Illinois | ||||||||||||||||
Cook County | 24 | 453.5 | 352 | 100.1 | 12,199 | 1,228.9 | 5,910 | 544.9 | 12 | 1,505.4 | 5,132 | 270.7 | 2,098 | 3,584.7 | 25,728 | 586.1 |
Indiana | ||||||||||||||||
Marion County | 3 | 194.1 | 138 | 450.3 | 2,484 | 1,114.6 | 551 | 699.6 | 3 | 1,857.5 | 1,565 | 350.7 | 240 | 1,407.4 | 4,984 | 625.1 |
Louisiana | ||||||||||||||||
East Baton Rouge Parish | 4 | 462.5 | 10 | 76.0 | 3,517 | 2,035.7 | 100 | 675.8 | 0 | 0.0 | 436 | 251.3 | 60 | 1,422.9 | 4,127 | 1,087.8 |
Orleans Parish | 6 | 751.4 | 24 | 245.8 | 3,250 | 1,741.1 | 304 | 1,810.0 | 0 | 0.0 | 1,139 | 1,079.9 | 135 | 3,485.9 | 4,860 | 1,502.5 |
Maryland | ||||||||||||||||
Baltimore City | 9 | 653.3 | 24 | 169.6 | 8,441 | 2,816.6 | 426 | 1,733.9 | 1 | 626.6 | 769 | 537.3 | 582 | 7,294.5 | 10,252 | 2,087.8 |
Montgomery County | 4 | 260.0 | 80 | 56.0 | 2,351 | 1,425.1 | 667 | 404.5 | 2 | 508.4 | 547 | 140.1 | 292 | 1,420.7 | 3,943 | 445.2 |
Prince George’s County | 3 | 150.2 | 41 | 116.5 | 6,116 | 1,211.0 | 702 | 485.2 | 0 | 0.0 | 359 | 353.3 | 857 | 6,068.2 | 8,078 | 1,006.0 |
Massachusetts | ||||||||||||||||
Suffolk County | 6 | 491.0 | 126 | 191.4 | 2,117 | 1,598.1 | 1,521 | 1013.6 | 1 | 252.7 | 1,771 | 558.1 | 117 | 919.5 | 5,659 | 832.2 |
Michigan | ||||||||||||||||
Wayne County | 7 | 133.8 | 29 | 54.8 | 5,545 | 1012.4 | 372 | 427.4 | 0 | 0.0 | 1,038 | 138.1 | 244 | 791.4 | 7,235 | 490.3 |
Nevada | ||||||||||||||||
Clark County | 31 | 342.5 | 346 | 163.6 | 2,814 | 1,222.1 | 2,790 | 477.8 | 51 | 355.2 | 3,262 | 400.7 | 400 | 637.9 | 9,694 | 503.4 |
New Jersey | ||||||||||||||||
Essex County | 0 | 0.0 | 27 | 62.6 | 5,882 | 2,168.3 | 1,824 | 1,116.0 | 2 | 687.2 | 506 | 228.7 | 625 | 6,821.1 | 8,883 | 1,250.9 |
Hudson County | 2 | 214.0 | 103 | 104.7 | 1,334 | 2,059.3 | 2,340 | 940.9 | 1 | 335.0 | 828 | 472.3 | 322 | 4480.3 | 4,936 | 828.8 |
New York | ||||||||||||||||
Bronx County | 6 | 177.1 | 101 | 203.2 | 11,455 | 3,300.7 | 13,565 | 2,084.9 | 1 | 174.0 | 837 | 753.1 | 1,308 | 12,643.8 | 27,313 | 2,328.8 |
Kings County | 5 | 115.9 | 382 | 135.4 | 14,223 | 2,150.3 | 7,111 | 1,749.1 | 6 | 1028.0 | 2,668 | 330.4 | 1,670 | 4,599.7 | 26,096 | 1,186.8 |
New York County | 8 | 387.7 | 587 | 325.1 | 7,246 | 4,074.3 | 8,801 | 2,460.8 | 7 | 1,182.0 | 7,718 | 1,165.2 | 1,654 | 6,622.3 | 26,131 | 1,858.5 |
Queens County | 13 | 175.9 | 812 | 150.8 | 4,998 | 1,388.0 | 7,133 | 1,314.7 | 9 | 366.7 | 1,917 | 379.2 | 1,268 | 3,553.9 | 16,180 | 812.2 |
North Carolina | ||||||||||||||||
Mecklenburg County | 8 | 273.0 | 42 | 71.6 | 4,227 | 1,422.9 | 626 | 531.5 | 1 | 256.0 | 987 | 221.2 | 381 | 2,324.7 | 6,275 | 667.9 |
Ohio | ||||||||||||||||
Cuyahoga County | 1 | 59.9 | 19 | 52.5 | 2,877 | 944.0 | 568 | 873.8 | 0 | 0.0 | 1,243 | 193.6 | 246 | 1,379.0 | 4,971 | 465.5 |
Franklin County | 4 | 189.4 | 34 | 53.1 | 2,373 | 961.9 | 363 | 619.5 | 1 | 236.4 | 2,154 | 308.6 | 311 | 1,142.2 | 5,256 | 479.1 |
Hamilton County | 0 | 0.0 | 18 | 90.6 | 1,838 | 1,056.6 | 136 | 621.6 | 0 | 0.0 | 990 | 215.4 | 172 | 1,320.9 | 3,159 | 457.8 |
Pennsylvania | ||||||||||||||||
Philadelphia County | 32 | 1119.1 | 167 | 157.9 | 10,650 | 2017.8 | 2,784 | 1,469.6 | 5 | 1,900.4 | 2,561 | 535.8 | 573 | 2,454.9 | 16,773 | 1263.5 |
Tennessee | ||||||||||||||||
Shelby County | 1 | 79.6 | 8 | 36.4 | 5,344 | 1,320.0 | 249 | 576.0 | 0 | 0.0 | 620 | 223.0 | 327 | 3,629.6 | 6,550 | 863.7 |
Texas | ||||||||||||||||
Bexar County | 3 | 72.8 | 47 | 89.9 | 946 | 742.0 | 4,549 | 455.8 | 1 | 46.3 | 1,047 | 227.0 | 320 | 1,463.1 | 6,913 | 414.6 |
Dallas County | 6 | 94.6 | 221 | 150.8 | 8,357 | 1,717.5 | 5,420 | 658.1 | 8 | 821.7 | 4,454 | 711.4 | 1,131 | 4,401.0 | 19,597 | 926.2 |
Harris County | 5 | 65.8 | 375 | 129.6 | 13,134 | 1,784.0 | 8,940 | 547.0 | 3 | 154.4 | 4,150 | 367.0 | 1,218 | 2,692.1 | 27,828 | 723.7 |
Tarrant County | 1 | 15.1 | 89 | 85.7 | 2,554 | 847.7 | 1,637 | 331.0 | 3 | 87.9 | 1,533 | 190.5 | 590 | 2,019.0 | 6,407 | 367.4 |
Travis County | 3 | 106.9 | 72 | 83.6 | 1,156 | 1,277.2 | 2,005 | 573.1 | 2 | 241.1 | 1,782 | 317.1 | 242 | 1225.6 | 5,262 | 473.2 |
Washington | ||||||||||||||||
King County | 38 | 333.2 | 330 | 82.2 | 1,441 | 1130.6 | 1,183 | 661.6 | 29 | 195.8 | 3,600 | 320.2 | 561 | 758.5 | 7,182 | 371.7 |
Puerto Ricoe | ||||||||||||||||
San Juan Municipio | 0 | — | 0 | — | 5 | — | 3,639 | — | 0 | — | 18 | — | 0 | — | 3,662 | 1,212.0 |
Note: Data for the year 2021 are preliminary and based on deaths reported to the Centers for Disease Control and Prevention as of December 2022. Numbers less than 12, and trends based on these numbers, should be interpreted with caution. Data are based on residence at the end of the specified year (i.e., most recent known address).
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanic/Latino persons can be of any race.
c Includes persons whose race/ethnicity is unknown.
d Rates are per 100,000 population.
e Rates by race/ethnicity are not provided because U.S. census information is limited for Puerto Rico.
Note. Electronic reports are not available for the following areas: American Samoa, the Northern Mariana Islands, and the Republic of Palau.